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RESUMO 
Atualmente, a Natureza permanece uma fonte importante de moléculas com 
atividades biológica e interesse para a saúde humana. 
Durante vários anos as plantas constituíram a única fonte de produtos naturais, no 
entanto este paradigma tem vindo a mudar em função da atenção dada a fontes 
alternativas de produtos naturais, tal como os organismos marinhos. 
Neste trabalho foram conduzidos estudos de caracterização metabolómica em 
várias espécies de organismos marinhos obtidos em ecossistemas de Portugal, sendo que o 
equinoderme Marthasterias glacialis L. (estrela-do mar de espinhos) foi selecionada para 
subsequentes estudos biológicos. 
Inicialmente, um extrato nativo foi obtido a partir de M. glacialis e analisado 
quando à sua composição em carotenóides. A análise por HPLC-DAD e APCI-LC-MS 
revelou vários isómeros destes compostos, tendo-se encontrado a astaxantina, zeaxantina 
e luteína como compostos mais relevantes. Esta fração do extrato mostrou exercer um 
forte efeito anti-proliferativo na linha celular cancerígena RBL-3H3 (leucemia basofílica 
de rato), enquanto que contra a linha celular não-cancerígena V79 (fibroblastos de pulmão 
de rato), a toxicidade foi marcadamente inferior. 
De forma a caracterizar outros metabolitos com relevância biológica, foi 
desenvolvido um método de GC-MS/MS para a análise simultânea de três classes de 
metabolitos: aminoácidos, ácidos gordos saturados/insaturados e esteróis. Este método 
provou ser rápido, reprodutível e depende da extração dos metabolitos com etanol, 
evitando assim solventes orgânicos mais perigosos e poluentes. Bons parâmetros 
analíticos foram obtidos para os 40 compostos sob a análise, incluindo 15 aminoácidos, 16 
ácidos gordos, 6 esteróis e 3 lupanos. Para validação da técnica foram utilizados extratos 
etanólicos de vários indivíduos de M. glacialis colhidos em diferentes pontos geográficos e 
em diferentes meses do ano. Este método foi posteriormente aplicado a outros organismos 
marinhos, nomeadamente os equinodermes Paracentrotus lividus Lamarck (ouriço-do-
mar), Holothuria forskali Chiaje (pepino-do-mar) e os moluscos gastrópodes Aplysia 
fasciata Poiret e Aplysia punctata Cuvier (lesmas-do-mar). Todas as espécies 
apresentaram os aminoácidos estudados, com a exceção de H. forskali, onde não foi 
possível encontrar glicina, prolina, trans-4-hidroxi-prolina ou fenilalanina e A. fasciata, a 
qual não apresentou prolina. Com a excepção de A. fasciata, os ácidos gordos insaturados 
eram os ácidos gordos predominantes, em particular os pertencentes à série omega-6. No 
caso dos esteróis, os únicos compostos encontrados foram o colesterol, o β-sitoesterol e 
um derivado não identificado do colesterol. A espécie P. lividus foi aquela que apresentou 
maior quantidade de esteróis.  
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Em trabalhos subsequentes foi obtido um extrato purificado de M. glacialis, o qual 
continha principalmente os ácidos palmítico, cis 11-eicosenoico e cis 11,14-eicosadienoico e 
o esterol ergosta-7,22-dieno-3-ol e que foi usado nos estudos biológicos. Este extracto, 
bem como os seus compostos predominantes, foram avaliados pela sua atividade anti-
inflamatória na linha de macrófagos de ratinho RAW 264.7, usando o LPS como estímulo 
pró-inflamatório e avaliando os níveis de expressão da COX-2, iNOS, IκB-α e CHOP. O 
composto ergosta-7,22-dieno-3-ol foi o composto mais potente, no entanto a atividade 
máxima foi atingida apenas quando todos os compostos foram utilizados em combinação. 
Os resultados demonstraram que a atividade anti-inflamatória do extrato e dos seus 
principais componentes envolve a prevenção da via de stress reticular mediado pela CHOP 
e ativação do NF-κB. 
De seguida, foi avaliado o impacto deste extrato purificado na viabilidade, 
integridade membranar e densidade celular de 3 linhas celulares humanas cancerígenas 
(SH-SY5Y, neuroblastoma; MCF-7, cancro da mama recetor do estrogénio positivo; Caco-
2, cancro do cólon) e 2 linhas humanas não-cancerígenas (HDF, fibroblastos da derme; 
HFF, fibroblastos do antebraço). Os resultados demonstraram a atividade distinta do 
extrato de acordo com a linha celular testada, sendo a linha SH-SY5Y a mais sensível. As 
células não-cancerígenas revelaram ser menos sensíveis que as cancerígenas. Estes 
resultados preliminares foram posteriormente confirmados ao estudar o mecanismo de 
ação responsável pelo efeito anticancerígeno encontrado. Foram utilizadas as linhas 
celulares MCF-7 e SH-SY5Y e a avaliação da síntese de DNA mostrou uma diminuição 
significativa, sendo a linha celular SH-SY5Y a mais suscetível. Observou-se paragem do 
ciclo celular na fase G0/G1, um efeito atribuído ao esterol ergosta-7,22-dieno-3-ol. 
Estudos morfológicos mostraram que o extrato causava o aparecimento de vesículas 
citoplasmáticas de conteúdo lipídico e condensação de cromatina compatível com 
apoptose, tendo este processo de morte celular sido confirmado por avaliação da atividade 
da caspase-9 e da caspase-3/7. O ácido palmítico revelou ser o principal responsável por 
este efeito pro-apoptótico, o qual foi demonstrado ser independente da ceramida e 
envolvendo a ativação da via de stress do reticulo endoplasmático. 
Com esta tese de doutoramento, a composição química de vários macroorganismos 
marinhos de Portugal foi elucidada. O equinoderme M. glacialis foi selecionado para 
subsequentes estudos biológicos, tendo a sua atividade anticancerígena e anti-inflamatória 
demonstrada, estabelecendo assim este organismo como uma potencial fonte de 
moléculas bioativas com aplicação em várias patologias. 
 
Palavras-chave: Marthasterias glacialis; Ácidos Gordos; Inflamação; Apoptose; Stress 
reticular 
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ABSTRACT 
Nowadays, Nature still remains a very important source of biologically active 
molecules with application in human health. 
For many years, plants have been the only natural products being studied, however 
this paradigm is being shifted towards alternative source of natural products, of which 
marine organism are a good example. 
In this work, metabolite profiling was conducted in several species of marine 
macroorganisms obtained in Portuguese ecosystems, with Marthasterias glacialis (spiny 
sea star) being selected for further biological evaluation. 
Initially, a crude extract obtained from M. glacialis was analyzed for its carotenoid 
composition. By employing HPLC-DAD and APCI-LC-MS, identification and 
differentiation of carotenoids isomers was achieved, with astaxanthin, zeaxanthin and 
lutein being the most important compounds. This carotenoid-enriched fraction displayed 
a strong cell proliferation inhibition against the rat basophilic leukemia cell line RBL-2H3, 
while against non-cancer rat lung fibroblasts the effect was weaker. 
In order to evaluate other biologically-relevant metabolites in M. glacialis, a GC-
MS/MS method for the simultaneous analysis of three classes of metabolites, amino acids, 
saturated/unsaturated fatty acids and sterols, was developed. This method was shown to 
be fast, reproducible and relied on extraction with ethanol without using organic solvents 
such as chloroform and ether. Good analytical parameters were obtained for the 40 
compounds under analysis (15 amino acids, 16 fatty acids, 6 sterols and 3 lupanes). Crude 
ethanolic extracts of several individuals of M. glacialis, collected in different temporal and 
geographical points, were used for validating this technique. This method was later used in 
other marine organisms from Portuguese waters, the echinoderms Paracentrotus lividus 
Lamarck (sea urchin) and Holothuria forskali Chiaje (sea cucumber) and the gastropod 
mollusks Aplysia fasciata Poiret and Aplysia punctata Cuvier (sea hares). In general, all 
species presented the amino acids covered by the method, with the exceptions of H. 
forskali, in which no glycine, proline, trans 4-hydroxy-proline or phenylalanine were 
found, and of A. fasciata which did not contain proline. In what regards fatty acids, among 
all species studied 14 compounds were detected and 12 could be quantified. Apart from A. 
fasciata, unsaturated fatty acids were predominant compounds in all species, with those 
from the ω-6 series being in higher amounts than their ω -3 homologues. In the case of 
sterols, the only compounds found were cholesterol, β-sitosterol and one unidentified 
cholesterol derivative. P. lividus was the species with the highest sterol content. 
After a deeper knowledge of the chemical composition of M. glacialis was achieved, 
a purified lipophilic extract containing mainly palmitic, cis 11-eicosenoic and cis 11,14-
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eicosadienoic acids, as well as ergosta-7,22-dien-3-ol was evaluated for its biological 
properties. Initially, attention was given to the anti-inflammatory activity of the extract 
and its components. The purified extract, as well as the predominant compounds cis 11-
eicosenoic and cis 11,14-eicosadienoic acids and the unsaturated sterol ergosta-7,22-dien-
3-ol were evaluated for anti-inflammatory activity in the macrophage cell line RAW 264.7 
challenged with LPS, as assessed by the expression levels of COX-2, iNOS, IκB-α and 
CHOP. Ergosta-7,22-dien-3-ol was the most active compound, although maximum activity 
was obtained only when all compounds were tested in combination. In addition, the anti-
inflammatory activity of the extract from M. glacialis and its compounds was shown to 
involve prevention of CHOP pathway-mediated ER stress and NF-κB activation.  
After the anti-inflammatory activity of the extract and its compounds was 
established, the anticancer activity of the same matrix was evaluated. Initial studies 
evaluated the impact of this purified extract (78-625 µg/mL) on cell viability, density and 
membrane integrity of three human cancer cell lines (SH-SY5Y, human neuroblastoma; 
MCF-7, human oestrogen receptor-positive breast cancer; Caco-2, human colon cancer) 
and two human non-cancer cell lines (HDF, human dermal fibroblasts; HFF, human 
foreskin fibroblasts). Differential activity towards the cell lines was found, being SH-SY5Y 
cell line the most susceptible. No activity was found for Caco-2 cell line and the non-
cancer cell lines revealed to be less susceptible than cancer ones. These preliminary results 
were further investigated by studying the mechanism of action behind this activity. MCF-7 
and SHSY-5Y cell lines were selected and evaluation of DNA synthesis revealed that both 
cell lines were markedly affected in a concentration-dependent way, being SH-SY5Y cell 
line more susceptible. G0/G1 cell cycle arrest was observed, an effect induced by the sterol 
ergosta-7,22-dien-3-ol present in the extract. Morphological studies showed that 
incubation with the extract caused the advent of lipid droplets and chromatin 
condensation, the latter compatible with apoptosis, which was confirmed by the 
evaluation of caspase-3/7 and -9 activities. Palmitic acid was the main compound 
responsible for this apoptotic effect by a ceramide-independent mechanism that involved 
activation of the CHOP-mediated ER stress pathway. 
With the doctoral thesis presented herein, the chemical composition of several 
marine macroorganisms from Portuguese waters was established. The echinoderm M. 
glacialis was further studied and its anticancer and anti-inflammatory capacity was 
demonstrated, thus establishing this organism as a potential source of bioactive molecules 
with application in several pathologies. 
 
Keywords: Marthasterias glacialis; Fatty acids; Inflammation; Apoptosis; ER stress 
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1.1.  Nature as a source of bioactive molecules 
 
Even in the periods of pre-technical medicine, humans have always pursued to 
counter diseases with medicines. For thousands of years, natural products have been the 
sole option for treating a number of pathological conditions in the form of tinctures, 
powders and decocts, among others (1). This happens due to the fact that Nature is, and 
has been, an undeniable source of bioactive molecules. In recent History, the development 
of medicine and chemotherapy led to an obvious convergence to the use of isolated 
molecules within a formulation rather than chemically complex mixtures, thus providing 
us with molecules such as morphine, codeine, digitoxin and vincristine.  
The interest in natural products is a consequence of the success of natural 
molecules as biologically active agents, which, in turn, arises from their complex chirality 
and ring systems and the number of heteroatoms and aromatic rings, thus allowing them 
to bind to complex proteins and other three-dimensional biological targets (2). For this 
reason, natural products have been addressed as “privileged structures”, as their 
molecular scaffolds are able to accommodate several pharmacophores, hence displaying 
multiple biological activities by fitting biological targets that are frequently conserved 
across species  (3). 
As it has been reviewed by Cragg and Newman in 2009, between 1981 and 2006, 
66% of the 974 small molecule drugs introduced in clinical practice were synthetic. 
However, deeper insights revealed that 17% of these molecules contained a 
pharmacophore directly derived from natural products and 12% were derived from natural 
products. Thus, directly or indirectly, Nature remains a very important source of bioactive 
molecules (4). Nevertheless, it is undeniable that in the last 15 years there has been a 
decline in the approvals of Nature-derived molecules and many pharmaceutical industries 
have terminated their natural drug discovery pipeline (5). However, more than a threat 
this constitutes an opportunity, as the paradigm of drug discovery from natural products 
is changing with new hotspots of bioactivity under study and techniques for structure 
elucidation and target characterization.  
Marine environment remains, to this day, the most diversified ecosystem on Earth 
and simultaneously the least studied. Marine organisms have to cope with the several 
challenges that marine life represents, including high pressures, low temperatures and 
light availability. In addition, many organisms have primitive immune systems and soft 
bodies and, for this reason, what they lack in physical defences is frequently balanced with 
remarkable chemical defences. In fact, organisms with lower physical defences, such as 
sponges and molluscs, are usually the ones with the most bioactive molecules. Marine 
natural products have proved to be an amazing source of chemical diversity and, 
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consequently, many sea-derived molecules were shown to exhibit a number of different 
pharmacological activities and are currently under clinical trials to treat various 
pathological conditions, such as cancer, inflammation and pain (6-9). Among the several 
classes of marine natural products described, the most relevant in a biological context are 
terpenes, alkaloids, peptides, fatty acids and sterols. In the next chapters, the chemical 
classes relevant for this thesis will be presented from a chemical, analytical, biosynthetic 
and biological point of view. 
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1.2. Fatty acids 
1.2.1. Chemistry 
Fatty acids (FA) are a class of lipophilic molecules that can be found in all living 
organisms. They can occur in their free form or, alternatively, integrate more complex 
lipids, such as triglycerides (TG), phospholipids or glycolipids, as presented in Figure 1. 
In addition, FA can be part of lipoproteins, lipopolysaccharides and alkaloids. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 – Lipid classes.  
FA exhibit a very diversified chemistry, which results in several possible structures 
such as saturated/unsaturated, branched and cyclic, which can, in turn, display distinct 
functional groups, such as hydroxyl, keto and epoxy, hence adding to the diversity of these 
molecules. 
Classical nomenclature for FA indicates chain length, number and position of 
double bonds when present (example: 20:2 Δ5,11. In this example, there are 20 atoms of 
carbon, with 2 double bonds, which are located in the position 5 and 11). The carbon 
associated with the methyl end group is designated ω carbon and, accordingly, 
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unsaturated FA in which the position of the first double bond is located 3, 6 and 9 carbons 
away from the ω carbon are named ω-3 (omega-3), ω-6 (omega-6) and ω-9 (omega-9). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 – Most common saturated and unsaturated fatty acids. Image obtained from (10). 
 
In mammals, FA with a maximum chain length of 16-18 carbons constitute about 
90% of total FA (11). FA consisting of 20 or more carbon atoms are referred as Very Long 
Chain Fatty Acids (VLCFA). 
Saturated FA, as the name indicates, are molecules with no double bonds. These 
compounds usually have between 12 and 24 carbon atoms (12) (Figure 2). On the other 
hand, when unsaturation is present the compounds are called either mono unsaturated 
fatty acids (MUFA) or polyunsaturated fatty acids (PUFA). In the case of the latter, double 
bonds are frequently in an non-conjugated arrangement, with —(CH=CHCH2)n— 
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repeating units (Figure 2), although some exceptions are known, as it will be presented 
later. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 – Non-methylene interrupted FA. Image obtained from (10). 
 
The cis (Z) stereochemistry of the double bond causes a kink in the alkyl chain that 
has consequences in the physical properties of the molecules, like fluidity, which is 
important in a biological context, namely in cellular membranes. 
In the last few years, great advances have been made in the study of the chemistry 
of FA. In particular, the study of marine organisms has led to the discovery of new and less 
conventional classes of FA with remarkable chemistry, such as halogenated FA, acetylenic 
FA, non-methylene interrupted FA (NMIFA, Figure 3) and methoxylated FA (Figure 4). 
NMIFA are compounds that display unusual unsaturation features, namely double bonds 
with more than one methylene group between ethylenic bonds. These compounds are, in 
general, of marine origin and have been described in algae, mollusks and sponges (10, 13). 
A review on the chemistry of marine FA has been published recently (10). 
Methoxylated FA are rare compounds, presenting limited distribution in Nature 
and described recently. These compounds are frequently found in cyanobacteria, bacteria 
and sponges (10, 14-16). 
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Figure 4 – Methoxylated FA. Image obtained from (10). 
1.2.2. Biosynthesis 
Biosynthesis of FA, as it happens in most biological reactions, is not simply a 
reversal of its degradative pathway, of which β-oxidation is the most relevant. In general 
terms, FA biosynthesis takes place in cytosol and requires the action of fatty acid synthase, 
which comprises several enzymes pivotal to the synthesis. The building block of FA is 
acetic acid in the form of acetyl-S-Coenzyme A (CoA), which is exported from 
mitochondrion and acts as the direct initiator. Further elongation is assured by malonyl-
CoA which, in turn, derives from acetyl-CoA by the action of acetyl Co-A carboxylase. 
Sequential elongation of the growing FA chain takes place by two units of carbon. 
Elongation stops when C14-C18 FA are obtained, typically in the C16:C18:C14 proportion 
of 7:1:2 (17). FA with higher carbon number, VLCFA, can be synthesized, however 
additional enzymes are required. In all cases, intermediates are covalently linked to the 
sulfhydryl groups of an acyl carrier protein (ACP). A four-step repeating cycle, which 
comprises condensation, reduction, dehydration and reduction once again, results in the 
addition of 2 carbons. While these steps are, in general, sufficient for saturated FA, 
biosynthesis of the unsaturated homologues requires additional steps, frequently 
microsomal dehydrogenation. A long-standing question has been whether or not multiple 
microsomal elongation systems exist in the cell with different saturation and/or chain 
length specificities (18). The simplest ω-3 FA is α-linolenic acid (18:3 ω-3) and its 
biosynthesis differs according to the organism. In plants, α-linolenic acid is synthesized 
from linoleic acid (18:2 ω -6) via desaturation, catalysed by delta-15 desaturase.  
Animals, however, do not possess this enzyme and, for this reason, cannot 
synthesize α-linolenic acid, which must be obtained from the diet. Despite this fact, 
animals are still able to metabolize α-linolenic acid, mainly by the means of further 
desaturation and elongation. In particular, α-linolenic is an important source of 
eicosapentaenoic acid (EPA), as depicted in Figure 5. 
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Figure 5 – Biosynthesis of DHA. 
 
When it comes to the biosynthesis of VLCFA, it is well accepted that the major site 
for biosynthesis of these molecules is the membranes of the endoplasmic reticulum (ER) 
(19). 
 
1.2.3. Analysis 
Extraction  
Given the high chemical diversity in FA, extraction and analysis must be optimized 
to each class. In the case of free FA, soft and quick extraction procedures are required and 
they should minimize autoxidative degradation and formation of artefacts. Two reference 
methods are largely used for FA extraction, namely those of Folch (20) and of Bligh & 
Dyer (21), both of them based on the mixture of two immiscible solvents, one polar and 
one non-polar. In the case of the Bligh & Dyer method, lower final volumes are used 
(approximately 2 mL) and, for this reason, is considered a green method and adaptation of 
the Folch procedure. In this method, the fat fraction in the sample is extracted by the polar 
solvent mixture of chloroform, methanol and water, which gives a one-phase system. After 
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extraction, the one-phase system is separated into chloroform and methanol/water phases 
by addition of more chloroform and water. The non-polar phase, containing both neutral 
and polar lipids, can be further divided into the different lipid classes, by applying 
techniques like preparative thin-layer chromatography (TLC), high pressure liquid 
chromatography (HPLC) and silicic acid or alumina chromatography. Moreover, the 
extraction and enrichment of specific classes of FA can be also attained by several 
techniques: solid-phase extraction (SPE) for the extraction and purification of free FA 
(22), formation of silver ion complex for the enrichment in halogenated FA (23) and by the 
separation of molecules with different degrees of unsaturation by partial hydrogenation of 
their concentrates with hydrazine hydrate and subsequent isolation of the monoenoate 
products by argentation TLC (24).  
 
Derivatization and analysis 
Nowadays, gas chromatography (GC) is one of the most widely used analytical 
techniques for the analysis of FA. Although GC can render very efficient separation of FA, 
one of its drawbacks resides in the need of a derivatization step prior to the analysis that 
improves the volatility of the analytes. Several derivatization agents can be used. The most 
frequent FA derivatized form is the fatty acid methyl ester (FAME), which requires a 
methylation reaction, sometimes called transesterification or transmethylation. Several 
different procedures can be found in literature, namely multistep or direct methylation 
methods.  
In multistep methods, FA are extracted and subsequently methylated into FAMEs, 
which are then re-extracted and analysed by GC (24-29). Differently, in direct methylation 
methods, extraction and derivatization is combined in one single step, thus reducing some 
of the drawbacks of multistep methods, such as high volumes of solvents or loss of analyte 
(30). 
Nowadays silylation is widely used as derivatization method for gas 
chromatography-mass spectrometry (GC-MS) metabolic profile studies, since it allows the 
determination of metabolites from different classes. Among silylation agents, N-methyl-N-
(trimethylsilyl)-trifluoroacetamide (MSTFA) has been increasingly used due to its ability 
to react with primary amines and amides, alcohols, phenols, carbohydrates and carboxylic 
groups (31, 32). Another type of derivatizing agents are nitrogen-bearing molecules, of 
which pyrrolidides, 4,4-di-methyloxazoline (DMOX) and piconyl ester derivatives are the 
most representative (33). Several reviews can be found in literature regarding each of 
these compounds (34-36), with each technique having its advantages and disadvantages. 
The technique of choice should be adapted to the type of sample and compounds under 
study. Piconyl esters frequently use mild temperatures, while DMOX derivatization 
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usually requires temperatures around 180 °C, which can be a problem in the case of some 
labile compounds. Also, the MS spectra of DMOX derivatives can be more informative 
regarding the location of the double bond in conjugated dienes, such as in conjugated 
linoleic acid (CLA) (36). Many other differences between the two methods are found in the 
above referred reviews. 
 
1.2.4. Biological properties  
Lipids in general, FA in particular, serve three major roles in an organism: they are 
structural components of biological membranes, provide energy reserves and serve as 
biologically active molecules exerting a wide range of functions. 
FA are endogenous ligands of several nuclear receptors, which in part play 
important roles in controlling a number of metabolic pathways.  Unsaturated FA with 18-
20 carbon atoms are precursors of prostaglandins, thromboxanes and leucotrienes, which 
display several autocrine and paracrine effects and have a number of regulatory 
properties. These mediators will be discussed in Section 2.4 when inflammation is 
addressed. FA with 20 and 22 carbon atoms are precursors of other biologically important 
molecules, such as non-classic eicosanoids, which include resolvins, lipoxins and 
neuroprotectins (37). For example, sphingolipids and glycerolipids are involved in DNA 
replication, cell recognition, signaling and transduction pathways and cell trafficking. In 
combination with diacylglycerols they can be involved in processes such as conformational 
changes of enzymes, cell division and apoptosis (38). 
The number of biological properties attributed to FA and their derivatives has been 
increasing (8). There is a growing body of evidence that FA can be successful in the 
treatment of cancer, as it will be discussed later. Antimicrobial properties, not addressed 
herein, have also been extensively studied (39-41). 
In the last few years we have assisted the rising importance of lipid rafts, 
membrane microdomains, in several biological processes, including infectious diseases, 
signal transduction and cytoskeleton reorganization (42-45). These microdomains are rich 
in cholesterol as well as saturated lipids such as sphingolipids. They also include a 
characteristic protein composition which can be important for signal transduction or even 
targeted membrane trafficking. In this regard, sterols have been increasingly regarded as 
pivotal for the formation of these structures (46, 47), as it will be presented later. 
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1.2.4.1. Fatty acids in inflammation 
The effect of FA on the onset and maintenance of inflammatory conditions is 
highly dependent on their chemistry. In this regard, it is important to highlight that 
saturated and unsaturated FA frequently exhibit opposing activities. 
Several studies have shown that some saturated FA are able to induce the 
expression of pro-inflammatory markers such as cyclooxygenase-2 (COX-2), inducible 
nitric oxide synthase (iNOS) and interleukin-1α (IL-1α) as a consequence of the activation 
of Toll-like receptor 4 (TLR4). Among saturated FA, lauric and palmitic acids have been 
described as some of the most potent pro-inflammatory FA (48). 
Differently, unsaturated FA are increasingly regarded as molecules that may 
exhibit anti-inflammatory properties, an effect that often results from several mechanisms 
of action. Among FA or their derivatives, with anti-inflammatory properties, PUFAs are 
particularly important (49). 
Regarding FA necessary for the equilibrium of the human organism, with the 
exception of two compounds, linoleic acid (LA, C18:2 ω-6) (precursor of the ω-6 series of 
FA) and α-linolenic acid (ALA, C18:3 ω-3) (precursor of the ω-3 series of FA), all 
compounds are produced by humans. 
 Many inflammatory conditions result from an excessive production of pro-
inflammatory mediators like eicosanoids, prostaglandin E2 (PGE2) and leukotriene B4 
(LTB4). At this point, it is important to highlight that these molecules are synthesized in 
the organism from the ω-6 FA arachidonic acid (C20:4 ω-6). If we consider that western 
diet results in high ω-6 and low ω-3 ratio of PUFA (50), it may be postulated that 
correction of these proportions, by increasing the consumption of ω-3 FA like EPA (C20:5 
ω-3) and docosahexaenoic acid (DHA, C22:6 ω-3) may change this trend (51), as they may 
replace arachidonic acid as an eicosanoid substrate in cell membranes (52). In addition, 
several works have shown that the anti-inflammatory properties of FA can also occur 
downstream of phospholipase A2 (PLA2)-mediated production of arachidonic acid. In 
particular, C22:6 ω-3, C20:5 ω-3, C20:4 ω-6, C18:2 ω-6 and C18:1 ω-9 have proved to be 
able to prevent saturated FA-induced increase in the expression levels of COX-2 at 5 µM 
(48). Another work evaluated the effect of a mixture containing high concentrations (200 
µM) of oleic and palmitic acids in mouse peritoneal macrophages. Results showed that, in 
wild type (WT) macrophages, nuclear factor of kappa light polypeptide gene enhancer in 
B-cells inhibitor (IκB), a marker of Nuclear factor kappa-light-chain-enhancer of activated 
B cells (NF-κB) activation, was degraded, while in macrophages obtained from TLR4-/- 
animals no effect was noticed. A similar trend was found for other inflammatory markers, 
namely tumor necrosis factor α (TNF-α) and IL-6 mRNA (53). 
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In addition to NF-κB pathway inhibition, activation of peroxisome proliferator-
activated receptors (PPAR) is referred as another mechanism for the anti-inflammatory 
activity of FA. Several PUFAs have been shown to activate PPAR (54-56), however the 
precise mechanism of cross-talk between this transcription factor and NF-κB is still not 
completely understood. 
 
1.2.4.2. Fatty acids in cancer 
The fact that populations of eskimos, which consume substantial amounts of long 
chain ω-3 polyunsaturated FA, EPA and DHA, exhibit lower incidence of cancer (57), 
launched the debate about the potential interest of these compounds as anti-carcinogenic 
molecules. Subsequent epidemiological studies showed an inverse relationship between 
blood levels of EPA and DHA and the risk of prostate (58) and colon (59, 60) cancers. 
These epidemiological data have been further confirmed by experimental models that 
showed the ability of some marine lipids to prevent the conversion of healthy cells to 
cancerous cells (61). 
In a study by Hossain et al. (62) several FA (arachidonic acid, EPA and DHA) were 
tested for their ability to inhibit the growth and induce apoptosis in three colon cancer cell 
lines, HT-29, Caco-2 and DLD-1, both in their free form and as constituents of 
phospholipids. DHA was the most effective compound in the HT-29 cell line, especially 
when in the phospholipid form, with 100 µM causing a loss of 60 % in cell viability. The 
antioxidant butylated hydroxytoluene (BHT) was able to prevent DHA-mediated toxicity, 
suggesting that the mechanism of action of that FA may be related with the induction of 
oxidative stress. The finding of increased levels of thiobarbituric acid reactive substances 
(TBARS), a marker of lipid peroxidation, after incubation with DHA confirmed that 
hypothesis (62). 
 The effect of EPA on the human leukemia cell line HL60 was also evaluated (63). 
EPA inhibited cell growth, though in the econazole (Ec)-resistant HL60 clone E2R2 this 
compound was not so effective. Econazole is known to deplete calcium from the ER and to 
inhibit calcium influx in mammalian cells, thus leading to the activation of the unfolded 
protein response (UPR) and apoptosis. Gene expression analysis of HL60 cells revealed 
extensive changes in transcripts related to ER homeostasis, calcium homeostasis and cell 
cycle/apoptosis (63).  
In addition to the above mechanism of action, which frequently involve pro-
apoptotic mechanisms, FA can also exert their anti-cancer effect via inhibition of 
topoisomerase I, a key enzyme in the breaking and repair of DNA strands (64-66). While 
saturated FA seem to be devoid of interest as topoisomerase I inhibitors, several 
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unsaturated FA have proved to be active (64, 66, 67), including oleic acid (66), EPA (68, 
69), very long chain (C26-C30) Δ5,9 FA (70) and phospholipids containing unsaturated FA 
(65). FA with one double bond strongly inhibit this enzyme (66), an activity that is even 
higher in the case of conjugated FA (68). Palmitic acid has also been reported to be 
cytotoxic to several leukemic cell lines in the range of 10–15 μg/ml, an effect mainly 
attributed to its ability to inhibit topoisomerase I (71).  
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1.3. Sterols 
1.3.1. Chemistry 
Sterols are, typically, C27 steroid alcohols that are widespread in Nature, being 
synthesized by higher plants, algae, virtually all fungi and also vertebrates, although 
through different biosynthetic pathways. Curiously, insects are unable to synthesize these 
molecules and obtain them from diet. While sterols can exist in their free form, the 
presence of the C3 hydroxyl group turns esterification a possibility and, hence, sterols can 
be esterified with FA, hydroxycinnamic acids, hexoses or 6-fatty acyl hexoses. 
From a chemical point of view, the general structure of sterols comprises a 4 ring 
system comprising cyclopenta[a]phenanthrene in trans junctures, methyl groups at C18 
and C19 with β-stereochemistry and a carbon side chain at C17 (Figure 6). In a general 
way, the hydroxyl group at C3 also displays β-stereochemistry. Saturated derivatives of 
sterols are known as stanols and they usually occur in trace amounts in plants, with the 
exception of cereal grains where they are present in considerable levels (12, 72). 
Major sterols in plants include campesterol (24-methyl cholesterol), β-sitosterol 
(24-ethyl cholesterol) and stigmasterol (22-dehydro sitosterol) and they all have a double 
bond in position 5. They are similar to cholesterol, differing in the side chain. The 
additional unsaturation in the side-chain, trans Δ22, is trait common in plants sterols but 
not in mammalian, as well as a one- or two-carbon substituent with variable 
stereochemistry in the side chain at C-24 which is conserved during metabolism. 
 
 
 
 
 
 
 
 
                Figure 6 – General structure and numeration of sterols. 
 
 
Ergosterol, a sterol with a β-24-methyl group, a trans Δ22 double bond and another 
unsaturation in Δ7 is the predominant sterol found in fungi. If we take a structural criteria, 
plant sterols can be divided into 4-desmethyl sterols (no substituent on C4), 4-α-
monomethyl sterols and 4,4-dimethyl. The first family, in turn, can be categorized as Δ5, 
Δ7 and Δ5,7, according to the position of double bonds in the B ring. 
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1.3.2. Biosynthesis 
Plant sterols are biosynthesized via the isoprenoid pathway. In this pathway, 
isoprene is not directly used in the biosynthesis, instead two C5 derivatives are possible: 
3,3’-dimethylallyl diphosphate (DMAPP) and 3-isopentenyl diphosphate (IPP). For a long 
time, the mevalonate pathway, which starts with the production of acetoacetyl-CoA from 
two molecules of acetyl-CoA, was believed to be the sole and universal route leading to the 
production of IPP and DMAPP. Nowadays, this pathway is known to occur in a large 
number of animal species, eubacteria as well as in the cytosol and mitochondria of plants, 
fungi and some parasites. In fact, the pathway used can be highly dependent of the cellular 
compartment, as depicted in Figure 7. 
An alternative pathway for IPP and DMAPP formation was described recently. This 
route, usually addressed as the non-mevalonate, 1-deoxy-D-xylulose-5-phosphate (DOXP) 
or 2-C-methyl-D-erythritol-4-phosphate (MEP) pathway, occurs in plant and algae 
chloroplasts, cyanobacteria and apicomplexan parasites (73, 74).  
Mevalonic acid arises from the condensation of three molecules of acetyl-SCoA, 
thus originating β-hydroxy-β-methylglutaryl-CoA (HMG-CoA). Hydrolysis and enzymatic 
reduction will eventually yield mevalonic acid. 
Differently, in the 1-deoxy-D-xylulose-5-phosphate pathway, two products of 
glycolysis, pyruvic acid and glyceraldehyde are responsible for the synthesis of the 
intermediate 1-deoxy-D-xylulose-5-phosphate via the enzyme thiamine diphosphate. 
In the case of sterols, mevalonate is the biosynthetic precursor. Biosynthesis of 
sterols differs between animals and plants. While in animals (75, 76) and fungi (77, 78) the 
tetracycle backbone is obtained from lanosterol, in the case of plants, the pentacycle 
cycloartenol is used instead. An additional enzyme, cycloeucalenol-obtusifoliol isomerase, 
opens the cyclopropyl ring, thus yielding a tetracycle moiety (79) (Figure 8). 
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Figure 7 - Major biosynthetic steps of the mevalonate /  1-deoxy-D-xylulose-5-phosphate pathways and 
their cellular compartments. 
In animals, lanosterol originates cholesterol in a process that requires the loss of 
three methyl groups, reduction of the carbon side-chain double bond and generation of a 
Δ5,6 double bond instead of Δ8,9. The precise order by which the reactions take place are 
thought to be species-dependent and cytochrome P450 enzymes participate in these 
reactions (12). 
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Figure 8 – Origin of the sterol backbone in animals and plants. 
 
 
1.3.3. Analysis 
Nowadays, most common techniques involve the extraction of the lipid fraction, 
saponification, extraction of non-saponifiables, derivatization, separation and detection by 
GC using a capillary quantification. Extraction is mainly performed by employing mixtures 
of different solvents, frequently chloroform-methanol, chloroform-methanol-water, 
hexane, methylene chloride  or acetone (80). SPE using neutral alumina has also been 
reported (81, 82), as well as the combination of SPE with supercritical CO2 (83).  
Traditionally, GC is the main technique for the separation of sterols and detection 
is conducted by either flame ionization detector (FID) (84) or mass spectrometry (MS) 
(85). The latter has been increasingly used as a powerful tool to the identification of many 
sterols given the extensive information provided by the mass fragmentation spectra. In 
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these regards, GC analysis of trimethylsilyl (TMS) derivatives of sterols is a highly used 
technique for their study (80, 86, 87). 
HPLC is also an option, in which case detection by ultraviolet (UV) (88, 89) or 
diode array detector (DAD) (90) is usually the most common option for detection due to 
their absorption maxima in the 190-230 nm range. 
Recently, liquid chromatography-mass spectrometry (LC-MS) has been increasingly 
regarded as an excellent source for the analysis of sterols due to its low detection limits 
and the possibility of analyzing complex biological matrices. In this area, the widespread 
use of electrospray ionization (ESI) has been hindered by the difficulty of neutral sterols to 
be ionized and, therefore, achieve the sensitivity that can be obtained by using 
atmospheric pressure chemical ionization-mass spectrometry (APCI-MS) (91) or APCI-
MS/MS (92). Recent works have addressed these drawbacks in ESI and have successfully 
enhanced the efficiency by including charged moieties in the 3β-hydroxyl group via 
derivatizing agents (93).    
 
1.3.4. Biological properties 
For the study of the biosynthesis and biological functions of sterols, the discovery 
of Arabidopsis thaliana L. sterol mutants has been fundamental, as has been reviewed 
before (94, 95). 
Sterols play a pivotal role in most organisms, mainly due to their function as 
membrane constituents. Membrane dynamics is essential for cell survival. A delicate 
balance between a highly fluid membrane with great permeability and a rigid membrane 
that yields any transfer across the bilayer impossible could only be achieved through 
millions of years of evolution. Sterols are one of the mechanisms by which eukaryotic cells 
are able to control and modulate the properties of biological membranes, such as fluidity. 
Even organisms that lack sterols, such as some bacteria, have developed surrogates that 
play the same role, in this case hopanoids like bacteriohopanetetrol (96, 97). 
The barrier properties of cell membranes and other lipid bilayer are strongly 
affected by the qualitative and quantitative profile of sterols included, which are frequently 
addressed as membrane-active sterols. The knowledge that all membrane active-sterols 
share similar chemical and physical properties allowed the identification of the minimum 
requirements for membrane-active sterols, which includes a polar group in C3, virtually 
always an hydroxyl, a C17 side-chain similar to that of cholesterol, a flat fused ring system 
and low area (<40 A/molecule) (98). 
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In the case of plants, several genetic and functional studies showed the 
involvement of these molecules in processes as diverse as cell division and growth, 
embryonic formation and cellulose accumulation (99-102). 
Without a doubt, the most explored biological property of sterols in humans is 
related to their well-established capacity to lower total cholesterol and low density 
lipoproteins without major effects on high density lipoprotein, an effect described over 40 
years ago (103, 104). Several studies show that the effect is dose-dependent, with a dose in 
the range of 2-2.5 g/day eliciting a reduction of about 10%-15% (105) . This value, albeit 
low, can have a positive impact both in individual patients and populations and has been 
shown to equally lower the risk of coronary heart disease when used in primary prevention 
(106). When higher reduction values are required, supplementation with sterols has been 
shown to act synergically with pharmacotherapy involving cholesterol-lowering agents, 
such as statins (107). 
One of the most widely studied mechanisms involved in cholesterol-lowering 
capacity of sterols is their ability to interfere with intestinal absorption of dietary 
cholesterol, which has been quantified in an extent around 30-50% (106).  Dietary 
cholesterol is known to be absorbed in the intestinal lumen in the form of bile 
salt/phospholipid micelles. Both in vivo and in vitro studies have shown the ability of 
several plant sterols to compete with cholesterol and displace them from these micelles 
(106). 
Yet another approach involving sterols can be used for the modulation of blood 
cholesterol levels. While the above-mentioned treatment targets the absorption of dietary 
sterols, modulation of the biosynthetic pathway of sterols is also a widely used strategy to 
reduce blood cholesterol of endogenous origin. In this regard, the inhibition of HMG-CoA 
reductase is widely exploited by drugs of the statin family, of which lovastatin, a natural 
product isolated from the Red yeast rice (the yeast Monascus purpureus grown on rice) 
was a lead drug. Nowadays, lovastatin and other members of this group such as 
atorvastatin, rosuvastatin and simvastatin are first line options in cholesterol-lowering 
pharmacotherapy, both in monotherapy and in association with other drugs. 
 
 
1.3.4.1. Sterols in inflammation  
Due to their chemical similarity with glucocorticoids, it has been hypothesized that 
sterols could retain some of the anti-inflammatory properties of that class of drugs. Sterols 
have already proved to be associated to the reduction of inflammatory conditions both in 
animal and human models (108-110), with the advantage of not causing significant side-
effects and toxicity. Sterols have been implicated in decreased levels of the pro-
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inflammatory cytokines IL-6 and TNF-α and increased levels of the anti-inflammatory IL-
10 in LPS-stimulated spleen cells from mice (110).  
Sterols extracted from transgenic Panax ginseng C. A. Meyer successfully inhibited 
the synthesis of TNF-α and other pro-inflammatory interleukins, as well as the expression 
of COX-2 in phorbol-myristate acetate (PMA) plus calcium ionophore-stimulated human 
mast cells (111). The fungal-derived ergosterol and ergosterol peroxide have also been 
studied for their anti-inflammatory properties in macrophage-like cells, and showed their 
ability to inhibit LPS-induced TNF-α secretion, IL-1α/β expression and binding of NF-κB 
to DNA (112).  
A mixture of β-sitosterol and its corresponding sterolin, β-sitosterol glucoside was 
shown to enhance the cellular response of T lymphocytes both in vivo and in vitro (113). 
In endotoxin-activated monocytes, the same mixture was able to completely prevent IL-6 
and TNF-α release. In addition, a purified sterol fraction (1 mg/mL) obtained from 
Sideritis foetens Clemente ex Lag consisting of campsterol, stigmasterol and β-sitosterol 
prevented 12-O-Tetradecanoylphorbol-13-acetate (TPA)-induced mouse ear oedema by 
about 50% (114).  
A review on the anti-inflammatory properties of sterols and their derivatives has 
been published recently (115). 
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1.4. Carotenoids 
1.4.1. Chemistry 
Carotenoids constitute a class of natural products widely distributed in Nature, 
mainly in lower levels of trophic systems. They can be found both in terrestrial and aquatic 
environments and they are present in several taxonomical groups. The most common 
carotenoids in Nature include fucoxanthin, neoxanthin, violaxanthin and lutein (116). The 
presence of these molecules in animals usually arises from diet. 
The designation carotenoid includes two different groups: carotenes, which are 
hydrocarbons, and xanthophyls or oxycarotenoids, which are oxygenated derivatives. 
Another division can be made between primary carotenoids, which are required for 
photosynthesis (β-caroten, violaxanthin, neoxanthin, among others), and secondary 
carotenoids, which are compounds present in fruits and flowers (α-caroten, zeaxanthin, 
antheraxanthin, β-cryptoxanthin, among others) (117). 
Due to the long system of conjugated double bonds, which constitutes the 
chromophore (Figure 9), nearly all carotenoids absorb light in the 400-500 nm range. 
This chromophore, however, turn carotenoids unstable in the presence of light, heat or 
oxidative atmosphere and they are prone to isomerization from all-trans (all-E) to cis (Z) 
isomers, although cis forms are also known to occur naturally, albeit in low amounts (118-
120). The effect of storage and processing techniques on carotenoid content in several 
foodstuffs has been reviewed before (121). The chemical differences between the two 
isomer forms have biological consequences: while all-trans carotenoids are linear and 
rigid molecules, their cis isomers display a kink in the chain with marked consequences in 
their ability to interact with enzymes, assemble in supramolecular structures and fit 
cellular structures. For example, in a biological context, cis carotenoids display lower 
tendency to aggregate and thus influencing parameters such as solubilization, chemical 
reactivity and light absorption (122, 123). 
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Figure 9 – General chemical structure of carotenoids, including end-group classification. Adapted from 
(124). 
 
Taking into account the diverse chemistry of carotenoids, which usually display 40 
atoms of carbon (C40), these compounds can be sorted in different sub-classes.  
Apo/diapo carotenoids are derivatives in which one or two terminal fragments, 
respectively, have been removed, and include compounds such as crocetin (Figure 10) 
and bixin (124).  
Homocarotenoids are compounds that result from the addition of more than 8 
units of isoprene. As it will be presented later, carotenoids arise from the condensation of, 
normally, 8 units of isoprene, which present 5 atoms of carbon each. The designation of 
homocarotenoids includes all the compounds with over 40 atoms of carbon, as in the case 
of C50 carotenoids (124). 
Norcarotenoids display an unusual number of carbons, such as C37, C38 and C39 . 
(124) Differently, norisoprenoids are frequently C13 fragments, although other carbon 
numbers are possible. 
Given the presence of free hydroxyl groups, carotenoids can also be esterified with 
other molecules, notably FA. These FA-esterified carotenoids have been described in 
several taxonomical groups (125-127). Other compounds can be used in the esterification, 
for example sugars. One of the most widely known carotenoid ester is crocin, the pigment 
responsible for the color of saffron and that corresponds to the diester of the disaccharide 
gentiobiose and the carotenoid carboxylic acid crocetin, responsible for the color of crocus 
flowers (Figure 10). 
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Figure 10 – Crocetin and its gentiobioside diester, crocin. 
1.4.2. Biosynthesis  
Carotenoids are terpenes, in particular tetraterpenes (C40 terpenes). Biosynthesis 
of carotenoids begins with the 5 carbon molecule DMAPP, which is successively 
conjugated with further DMAPP building blocks, thus originating molecules with 10, 15 
and 20 atoms of carbon (geranyl diphosphate, farnesyl diphosphate and geranylgeranyl 
diphosphate, respectively) (Figure 11).  
Several molecules can be obtained from geranylgeranyl diphosphate, namely 
diterpenes, chlorophyls, geranylgeranylated proteins and carotenoids. In the case of 
carotenoids, biosynthesis proceeds by condensing 2 molecules of the C20 geranylgeranyl 
into a C40 molecule called phytoene. Phytoene is considered by some authors the first true 
carotenoid, although its incomplete chromophore renders it colorless, thus being devoid of 
one of the characteristics of true carotenoids. From this point, a number of enzymes 
perform dehydrogenation reactions, originating sequentially phytofluoene, ζ-carotene, 
neurosporene and lycopene (Figure 11). Starting with lycopene, all the remaining 
carotenoids can be obtained through a number of reactions that include, but are not 
limited to: dehydrogenation, hydrogenation, cyclization, double bond migration, chain 
elongation and chain shortening (128).  
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Figure 11.  – Biosynthesis of carotenoids from DMAPP. Major differences through the biosynthesis are 
highlighted in yellow. 
1.4.3. Analysis 
The diversity of carotenoids can render their analysis challenging. When studying 
this class of compounds, several levels of information can be obtained. Nowadays, the 
study of carotenoids should include: UV-vis spectrum (spectral fine structure, peak cis 
intensity), chromatographic properties verified in two systems, co-chromatography with 
an authentic standard and mass spectrum. When differentiation of stereoisomers is 
intended, NMR must be used (129, 130). 
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Chromatographic techniques are widely used for the analysis of carotenoids. GC-
MS is regarded as not suitable to this class of metabolites due to their heat-lability. 
Differently, HPLC is the technique more widely reported in literature. The most 
commonly used detectors are DAD and MS as they provide very useful spectroscopic and 
mass information, respectively. The very rich chemistry of carotenoids results in several 
different isomers possible for each compound.  
The separation of carotenoids mixtures can be attained both by normal and 
reversed phase column, although the latter are preferred owing to their excellent 
resolution, reproducibility and column stability. In the case of reversed phase-high 
pressure liquid chromatography (RP-HPLC), C18 and C30 columns are widely reported in 
literature. In the case of C18 columns, different carotenoids can be separated although, in 
general, no isomer differentiation is possible and, for this reason, it is usually employed in 
screening studies where the identification of isomeric forms is not required. On the other 
hand, C30 columns render the separation of geometrical and structural isomers possible. 
In addition, the C30 stationary phase is uniquely capable of resolving geometrical 
carotenoids in which cis bonds are present at the same carbon number but at opposite 
ends of the molecule (131). In a general way, polar xanthophylls elute first and are 
followed by the less polar carotenes (132, 133). 
Within natural products, some classes of secondary metabolites display optical 
properties that render the analysis of their UV-vis spectra a very important tool. In the 
case of carotenoids, both the shape and maxima of the spectrum can provide, to some 
extent, information regarding their chemical structure. For instance, the number of 
conjugated double bonds is known to affect the position of long-wave absorbance bands 
and thus, an increase in this number results in an increase in the wavelength of maximal 
absorption (124). 
In most carotenoids, the UV-spectrum displays three maxima, as depicted in 
Figure 12-A and is commonly addressed as the fine structure. Apart from the maxima of 
each peak, which can lead to the identification of the compound, the relative proportion 
between the peak with the highest wavelength (band III) and the middle peak (band II) is 
a valuable tool for identifying these molecules. 
When a carbonyl group is present in a cyclic end-group in conjugation with the 
polyene chain, the spectra suffer marked changes. The most evident one is the loss of the 
fine structure, resulting in a single, sometimes symmetrical, peak (Figure 11-B). A 
bathochromic shift can also be found. 
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Figure 12 – Spectrum and maxima of (A) lutein and (B) astaxanthin. In these compounds, the effect of a 
carbonyl group in conjugation with the polyene chain on the fine structure is visible. This functional group is 
present in astaxanthin and absent in lutein. 
 
The use of MS renders two levels of information, equally important: molecular 
weight and fragmentation pattern. Molecular weight, although limited can be useful for 
ruling out compounds that do not fit the expected molecular weight for a given compound. 
In the case of fragmentation patterns, much richer information is provided, which can 
help identify functional groups and the type of chemical linkages present.  
Several ionization sources are available for MS analysis and, in the case of 
carotenoids, they are particularly important, with APCI and ESI being the most relevant to 
this class of molecules. As it happens in the case of ESI, in APCI ionization takes place at 
atmospheric pressure. However, in the case of APCI a heated nebulizer is used, while in 
ESI ionization is obtained via an electromagnetic field that facilitates solvent evaporation. 
In positive-mode APCI molecular ions and protonated molecules are observed, 
while molecular ions and deprotonated molecules are found in negative-mode APCI. As it 
happens with other ionizations processes, in APCI the solvent and mobile phases used 
affect the abundance and proportion of the several fragments detected. In the particular 
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case of carotenoids, polar solvents such as alcohols increase the abundance of protonated 
carotenoids, while apolar solvents facilitate the advent of molecular ions (133).  
Other analytical parameters are equivalent between ESI and APCI. The latter has 
the advantage of yielding higher linearity of detector response over carotenoid 
concentrations, frequently achieving three orders of magnitude, which is particularly 
relevant when quantification is intended (133). For obvious reasons, no analytical 
technique is without drawbacks and, in the case of APCI, abundant fragmentation is 
known to occur, which may lead to reduced abundance of molecular ions. 
1.4.4. Biological properties  
Apart from their physical properties, mainly color, carotenoids exert several 
physiological functions in organisms across different trophic levels. 
In a general way, carotenoids exhibit different functions in plants and animals. In 
photosynthetic organisms carotenoids are used in light harvesting processes in 
cooperation with chlorophyll and as protectors against photooxidative processes (134). 
This happens as a consequence of the marked antioxidant capacity of many carotenoids, a 
characteristic also exploited by animals. In humans, carotenoids can be found in plasma 
and also in the eye, were they integrate the macular antioxidant system, where a 
xanthophyll-binding protein has been reported (135). 
Biological properties exhibited by carotenoids are often a consequence of several 
bioactivities, namely the pro-vitamin A activity of some of these compounds, their 
antioxidant activity, modulation of immune responses and their ability to induce gap-
junction communications (136, 137). In order to exhibit pro-vitamin A activity, a 
carotenoid must display at least one unsubstituted β-ionone ring and a correct number 
and position of methyl groups in the polyene chain. 
Carotenoid absorption and metabolism have been extensively reviewed (138-140). 
Several works address the effect of carotenoid-enriched diets in cancer prevention. 
Although there seems to be enough evidence to support these claims, it should be 
highlighted that in some situations, high intakes of carotenoids can lead to the opposite 
effect, that is, increased changes of developing cancer. As it has been reviewed recently, 
high intakes of carotenoids in individuals with lung damage, such as smokers or workers 
exposed to asbestos, can result in an increase in the probability of developing cancer up to 
30% (141). 
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1.5. Inflammation 
Inflammation is a complex process that constitutes one of the first lines of defense 
against a number of stimuli that are perceived as harmful, such as bacteria, trauma and 
irritants. While acute inflammatory processes may serve to protect the organism, chronic 
inflammation is the base of a number of pathological conditions that include asthma, 
rheumatoid arthritis, inflammatory bowel diseases, atherosclerosis, among many others 
(142).  
Inflammation is a process tightly regulated by several chemical mediators that 
include cytokines, eicosanoids, platelet-activating factor (PAF), nitric oxide (NO) and 
neuropeptides, among others. Eicosanoids, comprising prostaglandins, prostacyclins, 
thromboxanes and leukotrienes, play a major role in inflammation. These molecules are 
active at very low concentrations and constitute a family of oxygenated FA derivatives 
obtained from arachidonic acid via COXs and lipoxygenases (LOX). While COXs are 
mainly responsible for the production of prostaglandins and thromboxanes, LOXs mediate 
the synthesis of 5-hydroperoxyeicosatetraenoic acid (5-HPETE), which, in turn, originates 
leukotrienes and other mediators.  
Several different approaches for the management of inflammatory conditions can 
be designed, ranging from upstream inhibition of arachidonic acid synthesis via PLA2 
inhibition, to downstream modulation of pro-inflammatory cytokines. 
 
1.5.1. Targets in inflammation 
Phospholipases A2 
PLA2s are a group of enzymes responsible for the hydrolysis of membrane 
phospholipids into arachidonic acid and have been increasingly regarded as an interesting 
target for anti-inflammatory drug discovery (143-148).  
These enzymes can be found in almost all types of cells and hydrolyze the 2-acyl 
ester bond of 1,2-diacyl-sn-3-glycerophospholipids, of which arachidonic acid is an 
example. The several PLA2s described so far (over 15) are divided into four families: 
cytosolic PLA2s (cPLA2s), secreted PLA2s (sPLA2s), lipoprotein associated PLA2s 
((Lp)PLA2s) and calcium-independent PLA2s (iPLA2s). Notably, (Lp)PLA2s display anti-
inflammatory properties, as they are able to degrade pro-inflammatory molecules, such as 
PAFs (143). In the particular case of inflammation, cPLAS2 are very important for the 
synthesis of eicosanoids, being critical for the signaling pathways involving these bioactive 
lipids.  
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cPLA2s are calcium-dependent enzymes activated by extra-cellular stimuli, like 
pathogens, tissue injury, physical or chemical stress. Noteworthy, cPLA2s are the only 
PLA2s with specificity for arachidonic acid at the phospholipase sn-2 position. 
Although the role of sPLA2s in inflammation remains poorly understood, it has 
been suggested that sPLA2s induce an increase of cPLA2-dependent eicosanoid release and 
that they synergize with other pro-inflammatory mediators (143). 
As referred, arachidonic acid is formed after PLA2-mediated hydrolysis of 
membrane phospholipids. After this point several different routes can be followed, like 
metabolization by COX or LOX. In addition to the above mentioned arachidonic acid, the 
action of PLA2 on membrane phospholipids originates yet another set of molecules, the 
lysophospholipids. These compounds, precursors of PAFs, are not deprived of biological 
activity, as they are involved in the secretion of histamine by mast cells and in the 
activation of leukocytes (149-151). 
 
 
COX Enzymes and Prostanoids 
Arachidonic acid is a ω-6 polyunsaturated FA with an important role in both 
homeostasis and pathological conditions. In its free form, arachidonic acid is a substrate 
to COX, also known as prostaglandin H synthases, being readily oxidized and originating 
prostaglandin G2 (PGG2) and subsequently prostaglandin H2 (PGH2) (Fig 13).  
Three isoforms of cyclooxygenase are known: COX-1, COX-2 and COX-3. While 
COX-1 is constitutively expressed in most mammalian tissues, being responsible for the 
physiological production of prostanoids, COX-2 is usually not detectable in normal 
tissues. It can be induced by either mitogenic and/or pro-inflammatory stimuli (152), 
causing an elevated production of prostanoids, thus triggering inflammatory effects (153). 
For this reason, COX-2 is widely targeted for the treatment of inflammation, while non-
specific inhibition of COX-1 is usually responsible for the side-effects of anti-inflammatory 
drugs. In fact, the first generation of non-steroidal anti-inflammatory drugs suffer from 
strong side-effects as consequence of their inability to distinguish between the two 
isoforms. Nowadays, COX-2-selective drugs are able to prevent most of these side-effects. 
Recently, a third isoform of COX was described: COX-3. In fact, this isoform results from 
the same gene of COX-1, but with alternative splicing that leads to the retention of intron 1 
in its mRNA. For this reason, some authors claim that it should be named COX-1b (153).  
 Regardless the COX isoform, arachidonic acid is converted into PGG2, which 
subsequently originates PGH2 via COX peroxidase activity. From this point forward, 
several different molecules can be synthesized according to the enzymes involved in the 
reaction (Figure 13). Given the fact that these enzymes are heterogeneously distributed 
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in tissues, distinct biological effects are possible, including vasodilatation (PGD2, PGE2, 
PGI2), gastric cytoprotection (PGI2), as well as fever mediation, pain sensitivity, and 
inflammation (PGE2) (154, 155). Other functions include involvement in the contraction of 
bronchial airways and regulation of platelet aggregation (TXA2) (155). 
 As it will be presented later, arachidonic acid can also be metabolized by LOX, thus 
originating hydroxyeicosatetraenoic acids, leukotrienes and lipoxins. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 13 – COX pathway. PLA2 hydrolyzes membrane phospholipids, originating arachidonic acid, 
which is further metabolized by COX. Tissue-specific enzymes are responsible for the end-products formed. 
 
 
Lipoxygenase 
 LOX belong to a super family of enzymes that have polyunsaturated FA as 
substrates. These enzymes are responsible for several biological functions in cells, which 
include signaling as well as structural and pathological changes, according to the products 
obtained. LOXs can be found in plants and animals and are absent in yeast, while their 
presence in insects is not yet consensual. Nowadays, several LOXs are known to occur in 
humans, 5-LOX, 12-LOX and 15-LOX being the most important in physiological and 
pathological processes (156).  
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 In the particular case of inflammatory processes, arachidonic acid is a substrate for 
LOX, originating 5-HPETE, which is spontaneously converted to 5-
hydroxyeicosatetraenoic acid (5-HETE) that, in turn, is converted in LTA4 and then 
sequentially to LTC4, LTD4 and LTE4 (Figure 14). 
 
 
FIGURE 14 – LOX pathway. PLA2 hydrolyzes membrane phospholipids, originating arachidonic acid. 
According to the LOX isoform involved, different metabolites are obtained.   
 
 
Nitric oxide synthases 
 Nitric oxide synthase (NOS) is the main enzyme involved in the synthesis of NO, 
whereas NO is synthesized from L-arginine in a reaction that also yields L-citrulline. It 
requires nicotinamide adenine dinucleotide phosphate (NADPH) and oxygen as co-
substrates and (6R)-tetrahydrobiopterin (BH4), flavin adenine dinucleotide (FAD), flavin 
mononucleotide (FMN) and iron protoporphyrin IX as co-factors. Three different NOS 
isoforms are known. The neuronal NOS (nNOS, NOS I) is expressed predominantly in the 
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brain and peripheral nervous system (157). Other tissue-dependent isoform of this enzyme 
is the endothelial NOS (eNOS, NOS III) that, as it can be easily inferred by the name, is 
found mainly in endothelial cells. Both NOS I and NOS III isoforms are usually described 
as being constitutively expressed in resting cells, where they exert physiological actions. 
When certain stimuli are triggered, mostly related with an increase of the intracellular 
concentration of calcium, the enzymes are activated and the synthesis of NO takes place 
(158). The third isoform is inducible (iNOS) and is responsible for many of the deleterious 
effects experienced in some pathological conditions, such as inflammation (158, 159). The 
exposure to microbial products, such as lipopolysaccharide (LPS) and double-stranded 
RNA (dsRNA), or to pro-inflammatory cytokines, like IL-1, TNF-α and interferon-γ (IFN-
γ), induces the expression of iNOS gene in various cell types in different tissues. Binding of 
calmodulin to iNOS is tight even at low calcium concentrations, and, therefore, iNOS is 
also called calcium-independent NOS and it can produce high levels of NO for prolonged 
periods (158, 159).  
 The biological properties of NO can result from a direct effect or, instead, as a 
consequence of the formation of reactive nitrogen species (RNS), of which peroxynitrite, 
generated by reaction with superoxide anion, is the best example. Several physiological 
processes are regulated by NO, including blood pressure, host defense and platelets 
function. 
 In the particular case of inflammation, NO can enhance the production of TNF-α 
(160) and IL-1β (161) and hence acts synergically in the production of inflammatory 
mediators. In addition, NO is cytotoxic and can react with proteins and nucleic acids and 
be responsible for the onset of the so called NO-induced apoptosis. This is known to occur 
in several cells such as microglia, macrophages and β-pancreatic cells, and for which ER-
stress has been shown to contribute (162-164). Thus, the ability to prevent NO production 
following a pro-inflammatory stimulus is commonly used to screen compounds for anti-
inflammatory activity. 
 
 
NF-κB 
NF-κB is an ubiquitous and inducible transcription factor. It is one of the most 
important regulators of the inflammatory response and immune system, being conserved 
across several species. It is also involved in cell proliferation and apoptosis (165). 
Under basal conditions, this transcription factor is located in the cytosol, in an 
inactive form that is a consequence of the binding to a group of inhibitory proteins, named 
IkB, which include IkBα, IkBβ, IkBε and IkBγ. 
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Figure 15 - Representation of NF-κB activation and crosstalk with ER stress. Under basal conditions NF-
κB is inhibited by IκB-α which, upon phosphorylation by IKK, is marked for degradation by 26s proteasome 
complex, thus leaving NF-κB free to be translocated to the nucleus where it modulates gene expression.  
 
 
In the particular case of mammalian cells, five NF-κB family members are known: 
RelA/p65, RelB, c-Rel, p50/p105 (NF-κB1) and p52/p100 (NF-κB2). In turn, NF-κB is 
composed by homodimers and heterodimers of different proteins of the Rel family; 
however, the most common forms of NF-κB are dimeric complexes of p50/RelA 
(p50/p65) (166, 167). 
Following phosphorylation by the IκB kinase complex (IKK), IκB is marked for 
degradation via the proteasome, thus leaving NF-κB free. Once free, NF-κB translocates to 
the nucleus, where it binds to the promoter region of several genes, thus exerting a 
number of actions (Figure 15) (168). Target genes include cytokines, COX-2, iNOS, 
proteases and many others. At this point it is important to highlight that nowadays, two 
different activation pathways for NF-κB are known: the canonical and the alternative 
pathways. The proteasome degradation of the inhibitor complex IκB takes place in both 
cases, but different stimuli trigger this action. While in the classical canonical pathway 
CHOP
IKK
COX-2
iNOS
IL-6
LPS
MyD88TRIF
CHOP
ER STRESS
ROS
IκB-α
P P
TLR4
NF-κB Pathway
MD-2
IκB-α
Proteasomal
degradation
ROS
ROS
ROS
ROS
p50 p65
p50 p65
p65p50
p65p50
32 
 
Introduction                                                                                                                                Inflammation 
NF-κB can be activated by several pro-inflammatory signals, such as cytokines and 
activation of toll-like receptors (TLRs), in the alternative pathway the activation of B-cells 
is required (169, 170). 
The knowledge of the events that take place in NF-κB activation allows the 
identification of distinct mechanisms by which inhibition can occur: prevention of the IKK 
complex activation, modulation of proteasome activity and modulation of NF-κB 
translocation to the nucleus/prevention of binding to DNA. In the case of molecules of 
marine origin, several mechanisms of action have been already referred (9).  
 
 
PPAR 
PPARγ is a transcription factor that belongs to the nuclear receptor family of 
ligand-activated transcription factors. Nowadays, three members of this family are known: 
PPARα, PPARδ and PPARγ. Contrary to PPARδ and PPARγ, PPARα is indeed a 
transcription factor whose activation results in proliferation of peroxisomes. PPARγ forms 
heterodimers with the retinoid X receptor and then exerts its effects by binding to a DNA 
element, known as the PPAR response element (PPRE). This transcription factor was 
initially linked to the regulation of adipocyte differentiation and lipid metabolism (171). 
Nowadays, however, several physiological and pathological events are known to be PPAR-
mediated, the effect depending on the cell type (172). 
In what concerns the involvement of PPAR in inflammatory pathways, it is known 
that the activation of this transcription factor in macrophages results in anti-inflammatory 
effects, such as decreased cytokine production or iNOS expression. These effects can be 
the result of direct negative modulation of target genes or, alternatively, of the prevention 
of NF-κB activation (172-174). In fact, PPAR activators have been shown to prevent NF-κB 
activation via physical interaction with both p65 and p50 (175, 176). Activation or 
increased levels of PPAR-γ have been linked to decreased levels of intracellular reactive 
oxygen species (ROS) in several cells types (177, 178). 
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1.6. Cancer 
Cancer is a pathological condition with increasing incidence and prevalence, being 
the leading cause of death in economically developed countries and the second leading 
cause of death in developing countries (179). Taking into account the numbers from the 
World Health Organization (WHO), in 2008 13% of all deaths were due to cancer, which 
represents 7.6 million people (180).  
From a physiopathological point of view, cancer is a complex genetic disease 
involving changes in metabolic pathways and gene expression. For many years 
carcinogenesis has been primarily attributed to abnormalities in oncogenes and tumor-
suppressing genes, however in recent years other players, such as micro RNA (miRNA), 
have been recognized for their importance in cancer onset and progression (181). 
Carcinogenesis, a process by which normal cells are transformed into cancer cells, 
is a multi-step process that includes initiation, promotion and progression. In all cases, a 
number of epigenetic and genetic alterations affecting both oncogenes and tumor 
suppressor genes take place (182). 
While the initiation stage can be inhibited by agents that either prevent the action 
or inactivate carcinogens or act as antioxidants, later stages are prone to inhibition by 
drugs that suppress tumor growth or stimulate apoptosis. In fact, defects in apoptosis are 
common traits found across several types of cancer, being one of the critical steps in 
tumorigenesis and resistance to therapy. For this reason, apoptotic pathways are 
important targets in cancer therapy (183). 
 
 
1.6.1. Targets in cancer 
Apoptosis  
Many of the drugs used in chemotherapy are able to elicit apoptosis, as the loss of 
the ability to undergo apoptosis is currently accepted as one of the most important 
changes that mark the onset of cancer cells (184). 
Apoptotic cell death displays a number of morphological and biochemical traits 
that are typical in this type of programmed cell death. From a morphological point of view, 
cells undergoing apoptosis display condensed chromatin and, in later stages, chromatin 
fragmentation. The plasma membrane is also affected and, although it never loses its 
integrity, protrusions commonly referred as “blebs” are usually present. In later stages, 
apoptotic bodies, which are membrane-bound vesicles that contain several cellular 
contents, from cytosolic organelles to fragments of condensed nuclei, are formed (185). 
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This type of cell death can be induced by the intrinsic/mitochondrial pathway, in 
which mitochondrion play a pivotal role, and by the extrinsic/death receptors (DR) 
pathway, which involve the activation of DR. 
In the mitochondrial pathway, formation of permeability transitions pores (PTP) is 
critical for the subsequent chain of events. These pores are formed across the 
mitochondrial membranes and are constituted mainly by 3 protein components: voltage-
dependent anionic channel (VDAC), cyclophilin A (CypD) and adenine nucleotide 
translocase (ANT) (186). Upon several stimuli, including high calcium levels and ROS, 
formation of PTP is triggered and leads to a loss of mitochondrial membrane potential 
(∆ψm) (187). These events result in the leakage of pro-apoptotic molecules, such as 
cytochrome c, Smac/DIABLO, HtrA2/Omi, apoptosis inducing factor (AIF) and 
endonuclease G. Once in cytosol, cytochrome c triggers the assembly of apoptotic 
protease-activating factor 1 (Apaf-1) and procaspase-9 into a complex called apoptosome, 
which in turn induces activation of the initiator caspase-9 (188) and subsequently, of the 
effector caspase-3 and/or -7, depending on the cell type. These caspases trigger some of 
the above referred hallmarks of apoptosis, like oligonucleosomal DNA fragmentation. 
However, it should be highlighted that different expression of caspases in different cell 
types may result in distinct apoptotic traits. 
At the same time, the Bcl-2 family proteins also play an important role in this 
pathway. Bcl-2 family members can act either as anti-apoptotic or as pro-apoptotic 
factors. Proteins with anti-apoptotic activity are predominantly found within the outer 
mitochondrial membrane (OMM) or in the ER, while the pro-apoptotic molecules exist in 
the cytosol or loosely bound to the OMM as monomers. The major anti-apoptotic factors 
are Bcl-2, Bcl-2 long isoform (Bcl-xL), Bcl-2-related gene A1, and myeloid cell leukaemia 1 
(Mcl-1) (189). In what concerns pro-apoptotic proteins, one further division includes 
effector proteins (Bcl-2 antagonist killer 1 – Bak; Bcl-2 associated protein x- Bax) and 
BH3-only proteins (Bid, Bim, Bad). 
In the extrinsic pathway, membrane receptors with pro-apoptotic activity that 
belong to the TNF superfamily, are activated by ligands such as TRAIL, TNF-α or Fas 
ligand (FasL), which activate DR 4/5, tumor necrosis factor receptor (TNFR) and Fas, 
respectively (190). Following activation, these receptors undergo conformational changes 
that lead to the assembly of death-inducing signaling complex (DISC). After this point, the 
receptors recruit Fas-associated death domain (FADD) and procaspase-8. The association 
of procaspase-8 to DISC results in its autoproteolytic cleavage, releasing two subunits that 
form the active enzyme (191). After this point, two different pathways may occur, 
depending on the cell type. In type I cells, the activity of caspase-8 per si is enough to 
activate effector caspase-3, -6 and -7, thus triggering the apoptotic response. Differently, 
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in type II cells, caspase-8 cleaves Bid giving rise to truncated Bid (tBid) which promotes 
the oligomerization of Bax/Bak found in the mitochondrial membrane. These proteins will 
then cause the release of cytochrome c and smac/DIABLO that activate the intrinsic 
pathway and increase even more the active caspase-8 by a positive feedback (190-192). 
Due to the fact that production of superoxide is a physiological process, cells have 
developed a number of strategies to counter its deleterious effects. One of these strategies 
relies on conversion of superoxide to hydrogen peroxide by superoxide dismutase (SOD). 
Two isoforms are found in cells: Mn-SOD in the matrix and Cu/Zn-SOD in the cytoplasm. 
The hydrogen peroxide formed is then converted to oxygen and water by either catalase 
(CAT) or glutathione peroxidase (GPrx) (193). Although very efficient, these antioxidant 
systems are not perfect and there are several points when ROS may leak: superoxide itself 
can escape from SOD and thus cause oxidative stress per si or, alternatively, the less 
reactive hydrogen peroxide can form the highly reactive hydroxyl radical via the Fenton 
reaction that can initiate lipid peroxidation, particularly in membranes. Taken together 
these ROS can cause several cellular damage by oxidizing lipids, proteins and DNA, 
eventually triggering apoptosis (193). 
 
 
Tubulin 
Tubulin-containing structures are important for several cellular functions, 
including chromosome segregation during cell division, intracellular transport, 
development and maintenance of cell shape, cell motility, and, in some cases, localization 
of molecules on cell membranes (194). 
Several anticancer drugs exert their effect by affecting microtubules dynamics via 
interactions with tubulin, either as tubulin polymerization inhibitors or promoters, (195). 
The microtubule cytoskeleton environment is highly dynamic due to the transitions 
between growing and shrinking phases, caused by exchanges of tubulin dimmers at 
microtubule end (2, 196). This equilibrium, tightly regulated by microtubule-associated 
proteins (MAPs), can be disturbed by microtubule targeting agents (MTAs). As a 
consequence of their effect on microtubules dynamics and activity, these molecules act as 
stabilizer or destabilizers, which ultimately can lead to cell cycle arrest or cell death. 
Four tubulin binding sites are currently known, namely the taxane/epithilones site, 
the laulimalide/peloruside A site, the colchicine site and the vinca alkaloids site. 
According to the binding site involved, different mechanisms of interference with tubulin 
take place. Drugs that bind to the first two sites stabilize microtubules while binding to the 
latter two results in tubulin depolymerization (196). 
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Protein kinases 
Protein kinases are enzymes that act as key regulators of several intracellular signal 
transduction pathways. These enzymes are frequently involved in cascades of signal 
amplification and transduce most extracellular signals, either by receptor-activated 
tyrosine phosphorylations or by receptor coupling to guanosine-5'-triphosphate (GTP)-
binding proteins (197). In normal conditions, several cellular processes are tightly 
regulated by the appropriated function of protein kinases, however, abnormal protein 
kinase activity has been increasingly identified in cancer. In fact, an increasing number of 
kinases have been associated to processes that ultimately lead to tumor proliferation and 
survival, frequently due to the fact that they become refractory to the regulatory 
mechanisms by either genetic mutation or translocation (198). Given the fact that normal 
cells usually tolerate inhibition of these enzymes, a therapeutic opportunity for the 
selective killing of cancer cells was established (199). About 600 protein kinases and 150 
phosphatases are known, all of which can be grouped in 3 main categories: tyrosine-
specific, serine/threonine specific and those specific for both tyrosine and 
serine/threonine. 
The factors that affect protein kinase function, as well as the state-of the art in 
what regards new drugs have been reviewed elsewhere (199, 200), however, it is worth 
mentioning that natural products have also given their contribution to this new area of 
research (201-204). Given the widespread presence of protein kinases in nearly all cellular 
processes, their inhibition can ultimately result in modifications of other targets, such as 
cell cycle, apoptosis and angiogenesis.  
 
 
 
Angiogenesis 
Angiogenesis, the process by which new blood vessels are formed, is a very 
important phenomenon both in physiological and pathological processes (205, 206).  
Vascular endothelial growth factor (VEGF) is one of the most important proteins that 
stimulate vasculogenesis and angiogenesis. One of the major stimulus that trigger VEGF, 
and hence angiogenesis, is hypoxia (oxygen levels below 1%), a common trait in tumors 
given their high metabolic rate and increasing distance from the blood vessels (207). 
Hypoxia inducible factor 1 (HIF-1) is a heterodimer that comprises two subunits, HIF-1α 
and HIF-1β, and one of the key modulators of the transcription of VEGF gene. While HIF-
1β is constitutively expressed, HIF-1α is oxygen dependent and, thus, highly influenced by 
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hypoxia. Several studies have shown that HIF-1α is over-expressed in many human tumor 
cells including pre-invasive and invasive breast cancer (201, 208). 
Due to the fact that malignant neoplasms require a constant supply of nutrients 
and oxygen, they cannot grow beyond a limited size without an adequate blood supply. 
Thus, inhibition of tumor-associated neoangiogenesis represents a promising target for 
antineoplastic therapy. In particular, the critical role of VEGF (209-211) has turned it a 
successful strategy for therapeutic intervention (211). In addition to treatment, tumor 
vasculature has also been increasingly regarded as a valuable marker for tumor grading 
and metastasis (212). 
The major receptor and mediator for VEGF is vascular endothelial growth factor 
receptor 2 (VEGFR2), also named Flk1, and is involved in several signaling pathways that 
regulate angiogenesis, like mitogen-activated protein kinases (MAPK) (213), focal 
adhesion kinase (FAK) (214), AKT8 virus oncogene cellular homolog 8 (215) and the 
JAK/STAT signaling pathway, especially STAT3. All these targets are currently being 
studied for drug discovery. 
Upon binding to its receptor(s), VEGF activates the MAPK and Akt signaling 
pathways, which induce endothelial cell growth, migration, homeostasis and microtubules 
formation. Therefore, many anti-angiogenic agents, currently used clinically and ⁄ or under 
clinical trials, are either antibodies against VEGF or target VEGF signaling by inhibiting 
VEGF receptor (VEGFR) tyrosine kinase activity (216, 217). Although several natural 
compounds have shown to inhibit tumor angiogenesis (4, 201, 218-221), at the moment 
their use is still very limited. 
Another approach to target vasculature is the vascular disrupting approach. 
Vascular disrupting agents (VDA) mainly target the established tumor blood vessels of 
larger, solid tumors with a major effect on the central part of the tumor, causing vessel 
occlusion and necrosis (222).  
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1.7. ER stress in inflammation and apoptosis 
 
Though the involvement of ER stress in different biological processes is not totally 
clarified, the crosstalk between ER stress and inflammation/apoptosis has been described. 
The ER is constituted by a network of branching tubules and sacs that is present in 
all eukaryotic cells and is contiguous with the nuclear envelope. From a functional point of 
view, ER is mainly responsible for the synthesis, folding and modification of several 
proteins (223). The newly ER-synthesized proteins fold into their correct tridimensional 
structure, after which they are targeted to several cellular organelles or to the extracellular 
matrix.   
Several signals can alter ER homeostasis, from physiological states that increase 
the demand for protein folding to stimuli that disrupt protein folding, originating an 
imbalance between the protein-folding load and the capacity of the ER (224, 225). The 
results are misfolded or unfolded proteins that accumulate in the ER lumen, a condition 
referred to as ER stress.  
To this moment, three major proteins are known to act as stress sensors in the ER: 
double-stranded RNA-dependent protein kinase PKR-like ER kinase (PERK), inositol-
requiring 1α (IRE1α) and activating transcription factor 6 (ATF6). Each of these proteins 
display an ER-luminal domain that senses unfolded proteins, a transmembrane domain 
and a cytosolic domain that communicates with translational and transcriptional 
pathways (224, 226, 227). Two of these sensor proteins have also catalytic activity: PERK 
has a protein-kinase activity and phosphorylates eukaryotic translation-initiation factor 
2α (eIF2α). On the other hand, IRE1α has both protein-kinase activity and 
endoribonuclease (RNase) activity and it removes a 26-nucleotide intron from the ATF6-
induced XBP1 mRNA, thus originating the sXBP1 splice which will be further discussed in 
the next section. In cells that are not undergoing stress, these ER stress sensors are in 
their inactive form via association with an ER chaperone, immunoglobulin-heavy-chain-
binding protein (BiP/HSPA5/GRP78). Dissociation of GRP78 from PERK triggers the 
dimerization and subsequent autophosphorylation of the kinase, thus yielding the active 
form of PERK. After this point, phosphorylation of eIF2α inhibits protein translation 
(Figure 16) as demonstrated by experiments with PERK-/- mouse embryonic fibroblasts 
that failed to inhibit protein translation following an ER stress elicitor (228). 
Due to the deleterious effect of ER stress, eukaryotic cells have developed sensor 
pathways, such as the UPR that allow detection of ER stress and trigger response 
pathways.  When the UPR is activated, several emergency systems can be activated in 
order to cope with stressful and potentially harmful consequences of protein folding 
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impairment, including induction of ER chaperones, such as BiP/GRP78 and GRP94, 
degradation of unfolded proteins via ER degradation-enhancing α-mannosidase-like 
protein (EDEM), translational attenuation and NF-κB activation (224-226, 229, 230). The 
activation of the latter appears to be associated to the above-mentioned attenuation in 
protein translation, which results in decreased levels of the NF-κB inhibitor, IκB-α. 
Increased levels of calcium have also been linked with NF-κB activation in ER-stressed 
cells. This is related with another physiological role of ER, namely to act as the cell’s 
calcium store. Several studies show that antioxidants and calcium chelators can mitigate 
the activation of the NF-κB as a consequence of ER stress (231). 
ROS are an important link between ER stress and inflammation. Increased levels 
of ROS are a common trait found in inflammatory condition and it is now believed that 
they, too, can be a consequence of ER dysfunction. In order to carry its folding functions, 
two proteins are involved in the formation of intra and intermolecular disulphide bridges 
and serve as electron transporters in ER: protein disulphide isomerase (PDI) and ER 
oxidoreductin 1 (ERO1) (232). In this process ROS are frequently generated. Although this 
is a controlled mechanism, in situations involving ER stress the amounts of ROS produced 
increase, thus triggering the activation of antioxidant mechanisms that involve several 
defense factors, such as glutathione S-transferase and NAD(P)H-quinone oxidoreductase 
(227, 233). When these defenses are not enough to counter the deleterious effects of ROS, 
they can oxidize several proteins in the ER and leak to the cytoplasm where they can 
attack several cellular targets. In addition, ROS-mediated activation of the NF-κB pathway 
has also been described.  
Several ER-stress inducers are known, although their mechanisms of action are 
distinct. The Streptomyces sp.-derived nucleoside antibiotic tunicamycin acts by blocking 
protein glycosylation and inducing ROS as presented above, the lactone sesquiterpene 
thapsigargin causes depletion of ER calcium reserves and dithiothreitol disrupts disulfide 
bond formation (230).  
In certain cellular stress factors, notably ER stress, DNA-damage-inducible gene 
153 (GADD153), also known C/EBP homologous protein (CHOP, a member of the C/EBP 
transcription factor family that heterodimerizes with other C/EBPs) is induced and is 
responsible for several biological functions, from apoptosis to inflammation (234). In a 
general way, CHOP is ubiquitously expressed in most cells, albeit at very low levels (230). 
ER stress causes the proteolytic degradation of the ER transmembranar protein p90ATF6, 
thus releasing p50ATF6 which is then transported into the nucleus where it binds to the 
ER stress responsive element (ERSE) of CHOP gene and, hence, upregulates the levels of 
the protein (235, 236) . 
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Figure 16 - Major proteins involved in ER stress sensing and signal transduction. 
 
In the particular case of LPS-induced inflammation, several studies have 
demonstrated that LPS causes an increase of CHOP and NO levels. Deeper insights on the 
subject showed that, although LPS can elicit several molecules involved in NO-induced 
apoptosis, they were detected only after the upregulation of the protector molecules BiP, 
EDEM, Derlin-1 and Derlin-2. Differently, when other stimuli are used that are able to 
trigger an increase in CHOP and NO before the defense mechanisms can be activated, 
apoptosis takes place (237). 
Nowadays, the role of ER stress in apoptosis is well established, however the 
precise mechanisms linking these two events are not fully understood. The characteristic 
attenuation of protein translation found in ER-stressed cells is not absolute as some genes 
can bypass this eIF2-α-mediated translational block. Such is the case of ATF4, which 
encodes C/EBP and is involved in several survival pathways that include amino acid 
metabolism, stress response and protein secretion, however ATF4 is also involved in pro-
apoptotic pathways via upregulation of CHOP (Figure 17). 
 In the case of ATF6, after dissociation from GRP78 it is cleaved to its active form 
by site-1 and site-2 proteases and moves the nucleus, where it modulates genes that are 
part of the ERSE (Figure 16) (224, 238). At the moment it seems that there is no direct 
link between ATF6 and ER stress induced apoptosis. However, ATF6 seems to be related 
with pro-survival pathways and activation of mechanisms to cope with ER stress (224, 
228). 
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As presented before, IRE1α originates the sXBP1 splice form XBP1. This molecule 
targets ER chaperones and the P58IPK, a HSP40 family member. After this point, P58IPK 
inhibits PERK and provides a negative feedback signal that attenuates PERK-mediated 
blockage of translation. At this point it is important to highlight that upregulation of 
P55IPK is not an immediate event, taking place only several hours after phosphorylation of 
PERK and eIF2a. At the moment, it is believed that upregulation of P58IPK marks the end 
of the UPR. If this time-gap is enough to correct the factors that triggered UPR, then the 
cell survives. If, however, the stress is maintained, then apoptotic cell death is triggered by 
activating death cascades that include CHOP,c-Jun N-terminal kinase (JNK) and the Bcl2 
family proteins (Figure 17). 
Several studies show that activation of UPR is responsible for the activation of 
caspase-12, which in turn triggers the intrinsic pathway of apoptosis by downstream 
activation of caspase-9 and -3 (239, 240). It is important to highlight that in this ER-
mediated apoptosis, although the intrinsic pathway is initiated, some of the common traits 
present in this type of controlled cell death, such as cytochrome c release, may not be 
found. While the contribution of caspase-12 to ER-mediated apoptosis is fairly understood 
in mice, in humans some controversy remains, mainly due to the fact that most humans 
do not express active caspase-12, with only a small part of the population being able to 
express the full-fledged active enzyme (241, 242). For this reason, caspase-4 is believed to 
fulfill in humans many of the functions of caspase-12 in mice. Similarly to caspase-12, 
caspase-4 is also part of the caspase-1 subfamily and is bound to the ER membrane, being 
cleaved following ER stress (243). 
ER stress-mediated apoptosis can be inhibited by increased levels of Bcl-2 or one 
of its homologues, thus indicating that this process is started by pro-apoptotic BH3-only 
proteins (243). Some studies refer Bim as the sole responsible for this process, without 
involvement of Puma or Bid, and a calcium-independent mechanism involving Bim 
dephosphorylation is proposed (244). Although Bim mRNA levels are known to be 
increased in ER-stressed cells, the most relevant mechanism that results in increased 
expression involves changes in the protein turnover. In cells that are not undergoing ER 
stress, Bim is phosphorylated by ERK1/2 and thus marked for ubiquitination and 
proteasomal degradation. In the case of ER stress, phosphatase 2 A (PP2A) is activated 
and results in Bim dephosphorylation and consequent changes in the protein turnover. In 
fact, PP2A-mediated dephosphorilation prevents ubiquitination and proteosomal 
degradation of Bim. This result was further confirmed by studying the effect of ER-
stressers in Bim-deficient cells, which showed a higher survival rate (244). 
 
 
42 
 
                                                                                                       ER stress in inflammation and apoptosis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 17 – Major pathways connecting ER stress and apoptosis. 
 
Differently, in studies using the estrogen receptor positive human breast cancer 
cell line (MCF-7), Puma was found to be the most important pro-apoptotic protein (245) 
while in the mouse embryonic fibroblast cell line (MEF) Puma and Noxa were the 
predominant pro-apoptotic proteins (246). Taken together these results show that there is 
a cell type-specificity regarding ER stress induction of BH3-only proteins. Regardless of 
the proteins involved, in most cases Bim, Bid, Noxa or Puma are not enough to trigger 
apoptosis. Instead, they interact with other pro-apoptotic proteins which in turn are 
responsible for the effective part of cell death. Among these proteins, Bax and Bak are 
pivotal to this process, as demonstrated by early reports in which deficient levels of these 
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proteins conferred protection against ER-mediated apoptosis (247). In resting cells, Bax 
and Bak proteins can be found in the ER-membrane where they are inhibited by the anti-
apoptotic protein Bcl-2. In situations when the UPR is not sufficient to restore 
homeostasis, several events take place. Bcl-2 levels drop, which disturbs the equilibrium 
between pro- and anti-apoptotic proteins. As so, Bak and Bax are freed from the ER and 
translocated to the mitochondria membrane where they induce the formation of pores that 
leads to a loss of ΔΨm (228) (Figure 17). This event results in the leakage of cytochrome c 
which, in turn, will trigger the classical intrinsic pathway presented in section 2.5.1. 
Although the role of Bcl2 proteins to ER-mediated apoptosis is clear, the precise link 
between the ER-insult and the apoptotic trigger remained elusive for a long time. 
Nowadays, CHOP and JNK are thought to be this link. When CHOP is expressed via the 
above-mentioned ER-stress sensors, it represses Bcl2 gene family, thus favoring the 
referred pro-apoptotic proteins. At the same time JNK, which is critical for the 
phosphorylation of Bcl2 proteins, is activated by the IRE1α-TRAF2-ASK1 pathway of the 
UPR. This results in phosphorylation of Bcl2 which, in turn, prevents Bax and Bak 
inhibition and ultimately leads to mitochondrial translocation and activation of the 
intrinsic pathway of apoptosis (228). 
It is also important to refer that, following an unresolved UPR, other function of 
the ER are lost, such as its ability to store calcium. Calcium levels within the ER are about 
500 times higher than in cytosol, with calcium fluxes being largely controlled by 
dephosphorylated BCL2. When this protein is phosphorylated by JNK, it loses the ability 
to modulate calcium levels which, upon translocations to mitochondrion, via uniport 
transporters can further aggravate the loss the mitochondrial potential and accelerate the 
intrinsic pathway of apoptosis. 
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2. Objectives 
 
The role of Nature as a source of bioactive molecules is undeniable and, recently, 
marine organisms have been increasingly regarded as a remarkable source of new 
chemical entities, most of them displaying several biological properties. In this regard, 
only fully characterized molecules can be further used for biological studies and thus 
adequate instrumental techniques and methods are required. At the same time, cancer 
and inflammatory conditions are among the most prevalent diseases in developed 
countries. Taking into account that many marine-derived products have already been 
proved to be effective in these diseases, the main objectives of this research project 
include: 
 
1. The development of instrumental techniques for the analysis of natural products of 
marine origin with potential application in human health. 
 
2. Contribute to the knowledge of the chemical composition of several marine macro-
organisms of Portuguese ecosystems, namely Marthasterias glacialis, Holothuria 
forskali, Paracentrotus lividus and Aplysia sp. 
 
3. Investigate the potential use of M. glacialis as a source of pro-apoptotic molecules 
with application in cancer. 
 
4. Investigate the potential use of M. glacialis as a source of anti-inflammatory 
molecules and the mechanism of action involved. 
 
5. Contribute to the growing body of proof that establishes marine organisms as an 
interesting source of bioactive molecules with application in human health. 
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Research Article
HPLC-PAD-atmospheric pressure chemical
ionization-MS metabolite profiling of
cytotoxic carotenoids from the echinoderm
Marthasterias glacialis (spiny sea-star)
An HPLC-PAD-atmospheric pressure chemical ionization-MS metabolite profiling
analysis was conducted on the marine echinoderm Marthasterias glacialis (spiny sea-star).
Bio-guided purification of the methanolic extract led to the isolation of several carotenoids,
namely zeaxanthin, astaxanthin and lutein. These compounds were characterized using
both UV–Vis characteristics and MS spectra interpretation. No previous works addressed
the MS analysis of carotenoids present in this organism. The purified carotenoid fraction
displayed a strong cell proliferation inhibition against rat basophilic leukemia RBL-2H3
(IC255 268 mg/mL) cancer cell line. Against healthy V79 (rat lung fibroblasts (IC255
411 mg/mL)) cell line, however, toxicity was lower, as it is desired for anti-cancer mole-
cules. This study suggests that M. glacialis may constitute a good source of bioactive
compounds that can be used as lead compounds for the pharmaceutical industry.
Keywords: Carotenoids / Cytotoxic / HPLC-PAD-atmospheric pressure chemical
ionization-MS / Marthasterias glacialis
DOI 10.1002/jssc.201000197
1 Introduction
Carotenoids are a class of hydrocarbons (carotenes) and
their oxygenated derivatives (xanthophylls). Their basic
structure reflects their biosynthetic pathway and consists
of eight isoprenoid units. A series of conjugated double
bonds constitute the characteristic chromophore. Carote-
noids are quite widespread in nature and marine organisms
are no exception. In fact, the higher degree of diversity
seems to be in the aquatic environment [1].
These compounds can play an important role in human
health by acting as antioxidants, protecting cells and tissues
from the damaging effects of reactive species. Lutein and
zeaxanthin and xanthophylls found in corn and in leafy
greens, such as kale and spinach, are believed to function as
protective antioxidants in the macular region of the human
retina, to protect against cataract formation, coronary heart
diseases and stroke. Astaxanthin, a xanthophyll found in
several marine organisms, is another naturally occurring
compound with potent antioxidant properties. Other health
benefits of carotenoids that may be related to their anti-
oxidative potential include enhancement of immune system
function and inhibition of the development of certain types
of cancers [2]. The most well-known physiological role of
carotenoids is provitamin A activity, although not all
compounds exhibit this property [3].
Marthasterias glacialis (spiny sea-star) is an asteroid
echinoderm, a group that has demonstrated to play one of
the most influential roles in benthic ecosystems on a variety
of scales [4]. During the period 1940–1950s, this species
received great attention, mainly due to its asterosaponins [5].
At the same time, carotenoids in this organism were also
studied by means of the analytical techniques common at
the time, namely absorption spectrum, comparison of Rf
values by TLC and partition coefficient [6]. To our knowl-
edge, no previous study provided the LC-MS analysis of the
carotenoid fraction ofM. glacialis and its biological potential.
Due to the heat-lability of carotenoids, GC-MS is not
suitable for their analysis, the most convenient method
being HPLC with UV–Vis detection or, if possible, MS
detection. Xanthophylls and carotenes form both molecular
ions and protonated molecules during positive-ion atmo-
spheric pressure chemical ionization (APCI). APCI is an
ideal method of ionization for low to medium polar
compounds, which also include carotenoids and related
compounds. Since their molecular mass does not exceed
2000 u, even in the case of glycosides or esters, this method
is suitable for their analysis, as has been recently reviewed
by Rezenka et al. [7].
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In this study, an HPLC-PAD-APCI-MS metabolite
profiling analysis of the marine organism M. glacialis
was carried out. A methanol extract was used in order to
extract a wide range of metabolites. A bio-guided purifica-
tion of this extract led to the finding of a fraction rich in
carotenoids, which were further confirmed by applying the
extraction techniques usually used for these compounds,
namely extraction with acetone. The cytotoxic effect
of this fraction was tested against both the cancer cell
line rat basophilic leukemia (RBL)-2H3 and the healthy cell
line V79.
2 Materials and methods
2.1 Chemicals
Lutein, zeaxanthin, b-carotene, sulphorhodamine B (SRB),
methanol and ether were from Sigma-Aldrich (St. Louis,
MO, USA). Cryptoxanthin was from Extrasynthese (France)
and astaxanthin from CaroteNature (Switzerland).
DMEM, fetal bovine serum (FBS), PBS and antibiotic
were from GIBCO (Invitrogen, UK). Tris-base, acetic acid
and trichloroacetic acid were from Merck (Germany).
2.2 Sample
M. glacialis individuals were collected at the rocky coast at
Cabo Carvoeiro, West Portugal, in March 2009, placed on ice
and immediately transported to the laboratory in ice-boxes.
The macro-invertebrates were then cleaned and washed
with sea water and kept at 201C, prior to their lyophiliza-
tion in a Labconco 4.5 Freezone apparatus (Kansas City,
MO, USA). The dried material was powdered before
extraction. The sample corresponded to a mixture of three
individuals.
2.3 Extract preparation
Methanol extracts were prepared by exhaustively extracting
two to three powdered individuals (ca. 22.5 g each) of M.
glacialis with methanol (3 100 mL of methanol, orbital
shaker at 250 rpm for 15 min) and subsequent evaporation.
Acetone extracts were prepared by exhaustively extracting
5 g of powdered specimen with 3 100mL of acetone
(orbital shaker at 250 rpm for 15 min). The extract was then
evaporated to dryness.
All procedures were conducted in the dark in order to
prevent photodegradation of the compounds.
2.4 Lobar column separation
A preliminary separation was achieved by injecting the
extract in a Lobar LiChroPrep RP18 (40–63 mm) column
(Merck). The mobile phase was methanol and separation
was monitored by means of a UV lamp set to 365 nm.
Carotenoid fraction corresponded to the orange one.
2.5 HPLC-PAD-APCI-MS/MS analysis
Chromatographic separations were carried out on a
250 4.6 mm, 5 mm, Luna RP-C18 (2) (Phenomenex, UK)
column at room temperature. Elution was performed with
acetonitrile at a flow rate of 0.5 mL/min isocratic conditions
and the injection volume was 40 mL. The HPLC system
was equipped with an Agilent 1100 Series diode array
and a mass detector in series (Agilent Technologies,
Waldbronn, Germany). It consisted of a G1312A binary
pump, a G1313A autosampler, a G1322A degasser and a
G1315B photo-diode array detector, controlled by ChemSta-
tion software (Agilent, v. 08.03). Spectroscopic data from all
peaks were accumulated in the range of 300–650 nm, and
chromatograms were recorded at 420, 440, 460 and 480 nm.
The mass detector was a G2445A ion-trap mass spectro-
meter equipped with an APCI interface system and
controlled by LCMSD software (Agilent, v. 4.1). Nitrogen
was used as nebulizing gas at a pressure of 15 psi and the
flow was adjusted to 5 L/min. The heated capillary, voltage
and current corona were maintained at 3501C, 4 kV and
4000 nA, respectively. The full scan mass covered the range
from m/z 200 to 1500. Collision-induced fragmentation
experiments were performed in the ion trap using helium as
collision gas, with voltage ramping cycles from 0.3 up to 2 V.
MS data were acquired in the positive and negative
ionization modes. MS2 was carried out in the automatic
mode.
2.6 HPLC-PAD analysis
Twenty microlitres of either methanolic or acetonic extract
redissolved in methanol were analysed using an HPLC unit
(Gilson) and a Luna RP-C18 (2) (Phenomenex)
4.6 250mm, 5 mm particle size column. Elution was
performed with a flow of 0.5 mL/min and isocratic
acetonitrile. Compounds’ elution was monitored at 280,
320 and 450 nm with a Gilson diode array detector. The data
were processed on a Unipoint Software system (Gilson
Medical Electronics, Villiers le Bel, France).
Quantification was achieved by using calibration curves
for each compound, with at least five different concentra-
tions. Lutein (y5 9.527 106x) and zeaxanthin
(y5 1.148 107x) were quantified at 450 nm and asta-
xanthin (y5 3.586 108x) at 475 nm.
2.7 Screening for epoxide carotenoids
The procedure described by Davies [8] was followed. An
ether solution of carotenoid fraction was shaken with
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aqueous 20% hydrochloric acid. In this situation, 5,6- and
5,8-epoxides react to yield a blue colour; more stable colours
are formed in the case of di-epoxides.
2.8 Screening for carotenoid esters
For carotenoid ester screening we followed a described
procedure [9]. Briefly, the carotenoids fraction re-dissolved
in methanol was incubated in 1 mL of either 0.2 or 0.02
NaOH for 6 h, in the dark, at room temperature (221C).
After incubation, we added 1mL of saturated sodium
chloride in deionised water to each tube and shook
the tubes vigorously by hand for 30 s. We then added
2mL of deionised water to each of the tubes and
shook them. Finally, we added 3mL of 1:1 hexane/ether
to each of the tubes and shook them again. The tubes
were centrifuged for 5 min at 3000 rpm. The organic layer
was transferred to a 9 mL culture tube, evaporated to
dryness under a stream of nitrogen and prepared for HPLC
analysis.
2.9 Cell culture
Rat basophile leukemia (RBL-2H3) cell line was acquired
from American Type Culture Collection (ATCC). V79 cell
line was a kind gift from Professor Fernando Remia˜o,
(Laboratory of Toxicology of the Faculty of Pharmacy, Porto
University). RBL-2H3 and V79 cells between passages 5–15
and 89–98, respectively, were used. RBL-2H3 cells were
maintained in DMEM with 15% FBS and 2% penicillin and
V79 cells were cultured in DMEM with 10% FBS and 2%
penicillin and in an incubator with 5% CO2.
2.10 SRB assay
We followed the method described by Houghton et al. [10],
with modifications. Cells were plated with a density of
1 104 cells/well and allowed to attach for 24 h at 371C, with
5% CO2. On the following day, medium was removed and
cells were gently washed with warm PBS. Samples were
redissolved in methanol, diluted with medium, added to
wells in several concentrations and incubated for 48 h.
Three independent assays were conducted, each one of
them in triplicate. Vehicle was used as control.
After the 48 h incubation period, medium was removed,
100 mL of cold 40% trichloroacetic acid was added, and
plates maintained at 41C for 60 min. After this time, plates
were washed five times with tap water and allowed to dry in
the air. Afterwards, 50 mL of 0.4% SRB in 1% acetic acid was
added and plates were incubated for 30 min.
After the incubation period, plates were quickly washed
with 1% acetic acid in order to remove unbound dye and
plates were allowed to dry in the air. 100 mL of tris-base was
added and shaken for 15 min.
Absorbance was read in a multi-plate reader at 492 nm.
OD values were plotted against concentration and the IC50
and IC25 determined using GraphPad Prism.
3 Results and discussion
3.1 HPLC-PAD analysis
HPLC-PAD analysis of carotenoids is a precious tool for a
preliminary study of this class of compounds, due to the fact
that the chemical characteristics responsible for UV spectra
shape and maxima are fairly understood.
The position of long-wave absorbance bands is a func-
tion of the number of conjugated double bonds. An increase
in this number results in an increase in the wavelength of
maximal absorption, an effect that may be modified by
cyclization [8].
The introduction of a carbonyl group in a cyclic end
group in conjugation with the polyene chain bears two
effects: for one, there is a marked loss of persistence,
resulting in rounded, sometimes symmetrical, shape.
Second, a bathochromic shift takes place.
In the screening of carotenoids from M. glacialis, two
kinds of UV spectra could be noticed: spectra with rounded
shape with just one maximum and spectra with a fine
structure with three UV absorption maxima.
Taking into account that a carbonyl group that is not in
conjugation with the polyene chain does not result in loss of
fine structures, compound 1 (Fig. 1), with no fine structure
and a maximum at 474 nm (Table 1), had to be a xantho-
phyll with a carbonyl group in conjugation with the chro-
mophore.
Due to the presence of a fine structure and multiple UV
maxima for the remaining compounds (2 and 3), these were
thought to be either carotenes or xanthophylls with no
conjugated carbonyl groups. Their UV maxima are listed in
Table 1.
UV spectra can also provide information regarding
the compound’s fine structure. The spectra of most
carotenoids show not just a single absorption band but
three distinct peaks. The value of %III/II indicates the
relationship between the peak heights of the longest-
wavelength absorption band (III) and the middle
absorption band (II) [11]. Although compounds 2 and 3
exhibited similar spectra (Fig. 1), with three maxima, they
could be distinguished by their different %III/II, as
summarized in Table 1, while the round shape of
compound 1 UV spectrum renders that no such value can
be calculated.
3.2 HPLC-PAD-APCI-MS/MS analysis
The HPLC-PAD-APCI-MS/MS study of the acetone and
methanol extracts of M. glacialis originated similar qualita-
tive results, although the proportion of the several
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compounds was different. The major compounds had been
described previously [6].
The characterization of the compounds was done by
comparison of their UV and MS spectra, and also by co-
chromatography with authentic standards. As so, the
xanthophylls detected in the acetone and methanol extracts
were astaxanthin (1), lutein (2) and zeaxanthin (3)
(Figs. 1–4, Table 1).
With the MS conditions used herein, it was noticed that
in the process of ion transfer a loss of water occurred in
compounds 2 and 3, thus originating the ion [M1H18]1,
being very abundant in the case of lutein (m/z 551.6), with
the protonated molecule being frequently absent (Figs. 3B
and 4B).
In the MS2[M1H]1 fragmentation of all detected
carotenoids, a base peak corresponding to the loss of water
from the protonated molecular ion ([M1H)18]1) was
observed, as well as another ion, less abundant, arising from
the loss of two molecules of water ([M1H)36]1) (Figs. 3
and 4, Table 1). This ion was not observed in the MS2
fragmentation of the ions at m/z 551.6 from lutein (Fig. 3B),
probably because they arise from the protonated molecule
that had already lost one molecule of water in the ion
transfer process, as stated before.
Table 1. Rt, UV, %III/II and MS data of carotenoids from M. glacialisa)
Compounds Rt min UV nm %III/II [M1H]1 MS2[M1H]1
18 18–18 56 18–56 92 18–80
1 Astaxanthin 15.1 474 – 597.5 579.3(100) 561.4(16)
2 Lutein 20.3 422, 446, 474 55 551.6b) 533.4(100) 495.3(23) 477.1(8) 459.3(14) 453.4(6)
3 Zeaxanthin 21.8 428, 452, 478 27 569.6c) 551.3(100) 533.4(19) 513.3(21) 477.1(8)
a) Main observed fragments. Other ions were found but they have not been included.
b) The ion observed is not the protonated molecule of lutein ([M1H]1: 569.6) but instead 551.6 (M1H18]1).
c) m/z 551.6 [569.618]1 was also observed as parent ion.
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Figure 1. Structures and UV spectra of (1) astaxanthin, (2) lutein; (3) zeaxanthin. UV data as in Table 1.
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Other observed ions are those resulting from the loss of
fragments 56 u and/or 56118 u and 80118 u (Table 1), typi-
cal of the fragmentation of this class of compounds [12, 13].
It should be highlighted that some minor carotenoids,
previously described for this species [6], were not noticed in
the individuals studied herein, namely b-carotene, crypto-
xanthin, echinenone and lutein 5,6-epoxide. The main ions
corresponding to these compounds were searched, but no
compounds were found. This result could be explained by
the different geographical origin of M. glacialis, which in
this study was collected in the Atlantic Ocean and in the
work of Czeczuga [6] were from the Adriatic Sea. Taking
into account that in sea-stars carotenoids arise from the diet,
it is plausible that different diets result in different carote-
noid compositions of these echinoderms. Regarding lutein
5,6-epoxide, a quick screening for the detection of epoxide
carotenoids was conducted, with a negative result being
found.
Another compound, 2,4-didehydro-a-carotene was
previously described [6]. However, according to Britton et al.
[11] to this day this is the only reference to this compound in
nature, which, together with the fact that no MS or NMR
studies were conducted in this compound, turns that its
occurrence cannot be confirmed.
Likewise, one carotenoid ester has been previously
described in M. glacialis [6]. We performed two different
saponification procedures in order to identify the presence
of these compounds, but no such compounds were found.
In the fractionation of the methanol extract by Lobar
chromatography assisted with a UV lamp, a green–white
fluorescent spot was noticed. This behavior was compatible
with the presence of phytofluene and its derivatives [8]. For
this reason, the green fluorescent fraction was isolated and
subjected to HPLC-PAD analysis. The characteristic UV
spectra of phytofluene and its derivatives include three main
absorption bands, located at around 331, 347 and 367 nm
(phytofluene, 1,2-dihydrophytofluene). Although some
peaks were found in the isolated fraction, no compound
presented a UV spectrum compatible with phytofluene or its
derivatives.
From a quantitative point of view, the sum of the
identified carotenoids accounted for some 945.06 mg/100 g
(dry basis, Table 2) in the acetone extract. The major
compound was zeaxanthin, both in methanol and in acetone
extracts, whereas lutein was in considerably lower amounts
in the methanolic one (Table 2). Astaxanthin was a minor
compound in both extracts.
In general, the differences between using methanol or
acetone affected mainly astaxanthin, detected in consider-
able amounts only when methanol was used, and lutein,
which was detected in higher quantity in acetone extracts,
being almost as high as zeaxanthin. In both extracts, the
1
2
3
1
2 3
A
B
Figure 2. HPLC-PAD chromatographic
profile of M. glacialis (A) methanol and (B)
acetone extract. Detection at 450 nm.
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presence of cryptoxanthin, echinenone, b-carotene and
carotenoids esters, described before, was not confirmed.
3.3 Cell assays
The native methanol extract was tested against the cancer
cell line RBL-2H3. At the highest tested concentration,
2.5 mg/mL, the extract was able to inhibit cell proliferation
ca. 79.4171.88% (Fig. 5). These results led us to the
purification of the extract by the means described above in
order to elucidate the role of carotenoids in the displayed
activity.
The IC50 obtained for this carotenoid fraction was
575 mg/mL, and a concentration-dependant activity was
found (Fig. 6). Given the fact that compounds with anti-
cancer properties are only interesting for therapeutics if their
toxicity is higher toward cancer cells than healthy ones, we
tested the same carotenoid fraction against the cell line V79.
The toxicity against this cell line was much lower than that
observed for RBL-2H3, with the highest tested concentration
presenting ca. 50% inhibition (Fig. 6). Given the weak activity
in healthy V79 cells, it was not possible to calculate the IC50
and compare it with that of RBL-2H3. For this reason, IC25
was calculated and the value found, 411 mg/mL, was higher
than that obtained for RBL-2H3 cells, 268 mg/mL (Figs. 5 and
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Figure 3. MS2 spectra of (A) astaxanthin
(1) (1MS2[M1H]1) and (B) lutein (2)
(1MS2[(M1H)18]1).
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6). The ideal anticancer compound should have no toxicity
against healthy cells. However, this requisite cannot always
be fulfilled, and sometimes compounds that show some
degree of toxicity against healthy cells are used, as long as this
effect is more pronounced against cancer cells. A good
example of this fact is vincristine or paclitaxel [14].
Carotenoids constitute a class of compounds well
known for their positive impact on human health, mainly as
antioxidants and, for those compounds with pro-vitamin A
activity, in the prevention of age-related macular degenera-
tion. Among natural molecules, carotenoids usually are not
among the most cytotoxic ones. However, the cytotoxic
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Figure 4. MS2 spectra of zea-
xanthin (3): (A)1MS2[M1H]1
and (B)1MS2[(M1H)18]1.
Table 2. Quantification of carotenoids in M. glacialis purified
methanol extract and native acetone extract (mg/100 g,
dry sea-star)a)
Compound Extract
Methanol Acetone
1 Astaxanthin 10.497 0.06 1.407 0.035
2 Lutein 151.337 2.44 427.067 9.13
3 Zeaxanthin 761.537 0.06 516.607 13.78
S 923.35 945.06
a) Results are expressed as means7standard deviations of three
determinations.
2.5 mg/mL = 79.41±1.88% RBL-2H3 proliferation  
inhibition
BA
CarotenoidsOther 
metabolites
Cell testing
Cell testing
Native MeOH extract  
Figure 5. Experimental design for the
purification of M. glacialis methanol
extract and values for cell cytotoxicity.
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activity of carotenoids, in particular xanthophylls, has been
described in the literature and, in line with the findings that
we present herein, this activity is usually higher against
cancer cells than against healthy ones [15, 16].
The activity found forM. glacialis cannot be attributed to
single compounds, and, given the chemical diversity of the
matrix, synergy between several compounds is likely to
occur. Among the identified compounds, astaxanthin has
been implied in cytotoxicity against cancer cells [17, 18].
However, it should be highlighted that some compounds
found in this study, although presenting UV spectra char-
acteristic of carotenoids, could not be fully identified by LC-
MS and could be new compounds that contribute to the
displayed activity. In addition, although the extraction
procedures used, as well as the purification process by
means of Lobar column chromatography, enabled to obtain
a carotenoid fraction, minimizing the contribution of other
compounds to the displayed activity, the presence of other
nonpolar components in the extract cannot be excluded.
4 Concluding remarks
Overall, in this study HPLC-PAD-APCI-MS was used for the
first time to study carotenoids from the echinoderm M.
glacialis. Methanol and acetone extracts yielded a very
similar carotenoid profile, although in different amounts.
The purified methanol extract proved to be cytotoxic, an
activity that was higher against the cancer cell line RBL-2H3
than against the healthy cell line V79, a trend that could be
useful in the development of new bioactive compounds for
use in human health.
In both methanol and acetone extracts, the identified
carotenoids accounted for almost 1% of sea-star (dry weight), a
value that is underestimated due to the fact that only identified
carotenoids were included. With this data, we proved that M.
glacialis could be a good source of bioactive carotenoids to be
used in human health, which merits further studies.
David M. Pereira (SFRH/BD/62663/2009) acknowledges
FCT for the grant.
The authors have declared no conflict of interest.
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Abstract: In this study, the carotenoid profile of the echinoderm Marthasterias glacialis L. 
was established using HPLC-DAD-APCI-MS/MS equipped with a C30 column. This 
approach rendered the identification of 20 compounds, eight of them reported for the first 
time in this marine organism. Differentiation of carotenoid isomers was also achieved. 
Keywords: Marthasterias glacialis L.; carotenoids; isomers; echinoderm; 
HPLC-DAD-APCI-MS/MS 
1. Introduction
Carotenoids constitute a class of isoprenoids widespread in nature, with over 700 compounds
documented to this day [1]. These metabolites are responsible for the colors of some plants, algae, 
microbes and also some animals. For many years, this class of molecules was thought to be present in 
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animals solely as a result of predation upon organisms from lower trophic levels. However, in 2010 the 
first carotenoid-synthesizing animal, the pea aphid, was described and is thought to be a result of 
lateral gene transfer in a context of co-evolution [2]. 
In plants, carotenoids act as antioxidants, regulators of membrane fluidity and as light-harvesting 
molecules in photosynthetic systems [3]. In terms of human health, these metabolites are very 
important due to their strong antioxidant [4] and provitamin A activity displayed by some compounds 
of this group [5]. A recent meta-analysis showed that a diet rich in carotenoids was effective in the 
prevention of late age-related macular degeneration [6], although the contribution of these molecules 
to the treatment of this pathology requires further study. 
The presence of carotenoids in the echinoderm Marthasterias glacialis L. (spiny sea star) was 
reported in the 1970’s [7]. At the time, several carotenoids had been identified, such as lutein, 
zeaxanthin and astaxanthin. While the presence of these compounds was recently confirmed, other 
compounds that have been previously reported, such as echinenone and 5,6-epoxy lutein, were not 
found [8]. In both works, no characterization of carotenoid isomers was attempted. 
Atmospheric pressure chemical ionization (APCI) forms abundant positively or negatively 
charged molecular ions or protonated and deprotonated molecules of both carotenes and xanthophylls, 
and their fragmentation pattern can also help with the identification of this type of compounds. In the 
present work, we deepen the study of the carotenoid composition of M. glacialis using a C30 column 
in a high performance liquid chromatography-diode array detector-mass spectrometry detector 
(HPLC-DAD-APCI-MS/MS) system. Using this type of column, it is possible to separate some of the 
carotenoid isomers that cannot be resolved with most C18 columns. Furthermore, given the fact that 
some carotenoid isomers are not commercially available, we have conducted isomerization and 
reduction procedures starting from available standards, in order to be able to confirm the identity of 
some peaks. 
2. Results and Discussion
The carotenoids, extracted from the echinoderm M. glacialis, were chromatographically separated
and subsequently tentatively identified, based on the combined information obtained from 
chromatographic elution, UV-vis and mass spectra characteristics (Table 1). The HPLC chromatogram 
(Figure 1) demonstrates the presence of 20 carotenoids in the extract of the spiny sea star. Since a 
detailed description of carotenoid identification using the above information is available in literature [9], 
only considerations regarding carotenoids not identified in previous reports, along with the mass 
spectroscopy data obtained by negative APCI, are discussed in the present work. 
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Table 1. Chromatographic, UV-vis and mass spectrometry characteristics of carotenoids from Marthasterias glacialis (spiny sea star), 
obtained by HPLC-DAD-MS/MS. 
Peak a Carotenoid tR b(min) λmax c (nm) 
% 
III/II 
[M + H]+
(m/z) 
MS/MS fragment ions (positive mode) 
(m/z) 
M−• or 
[M − H]−
(m/z) 
MS/MS fragment ions (negative mode) (m/z) 
1 not identified 1 8.7–8.8 419, 445, 469 nc d 597 579 [M + H − 18]+, 561 [M + H − 18 − 18]+, 
505 [M + H − 92]+ 
595 f 577 [M − H − 18]−, 559 [M − H − 18 − 18]−
2 crustaxanthin 9.1–9.2 422, 449, 470 nc 601 583 [M + H − 18]+ 599 f 581 [M − H − 18]−, 563 [M − H − 18 − 18]−, 507 [M − H − 92]− 
3 13-cis-astaxanthin 10.4–10.5 371, 466 0 597 579 [M + H − 18]+, 561 [M + H − 18 − 18]+, 
379, 285, 173 
596 g 581 [M − 15]−, 578 [M − 18]−, 504 [M − 92]−, 429 [M − 167]−, 389,  
363 [M − 233]−, 337 [M − 167 − 92]−, 323, 297, 233 
4 all-trans-astaxanthin 11.2–11.6 475 0 597 579 [M + H − 18]+, 561 [M + H − 18 − 18]+, 
505 [M + H − 92]+, 379, 285 
596 g 
595 f 
581 [M − 15]−, 577 [M − H − 18]−, 559 [M − H − 18 − 18]−,  
541 [M − H − 18 − 18 − 18]−, 504 [M − 92]−, 429 [M − 167]−,  
490 [M − 106]−, 389, 363 [M − 233]−, 337 [M − 167 − 92]−, 323, 297, 
233, 203 
5 all-trans-lutein 11.9–12.2 421, 445, 472 67–71 nd e 551 h [M + H − 18]+, 533 [M + H − 18 − 18]+, 
495 [M + H − 18 − 56]+,  
459 [M + H − 18 − 92]+, 430, 175 
568 g 
567 f 
549 [M − H − 18]−, 531 [M − H − 18 − 18]−, 535 [M − 18 − 15]−, 429 
6 astaxanthin derivative 1 13.0–13.2 472 0 597 579 [M + H − 18]+, 561 [M + H − 18 − 18]+, 
379, 285, 173 
596 g 581 [M − 15]−, 578 [M − 18]−, 542 [M − 18 − 18 − 18]−,  
429 [M − 167]−, 490 [M − 106]−, 389, 363 [M − 233]−,  
337 [M − 167 − 92]−, 323, 297, 233, 203 
7 all-trans-zeaxanthin 13.8–14.2 423, 451, 476 25–40 569 551 [M + H − 18]+, 533[M + H − 18 − 18]+, 
459, 416, 175 
567 f 549 [M − H − 18]−, 534 [M − H − 18 − 15]−, 531 [M − H − 18 − 18]−, 
465, 201, 187 
8 astaxanthin derivative 2 14.8–15.0 459 nc 597 579 [M + H − 18]+, 561 [M + H − 18 − 18]+, 
285, 173 
595 f 
596 g 
581 [M − 15]−, 577 [M−H − 18]−, 429 [M − 167]−, 389,  
363 [M − 233]−, 337 [M − 167 − 92]−, 323, 297, 233, 203 
9 9-cis-astaxanthin 15.5 470 0 597 579 [M + H − 18]+, 561 [M + H − 18 − 18]+ 596 g 581 [M − 15]−, 578 [M − 18]−, 560 [M − 18 − 18]−, 504 [M − 92]−,  
429 [M − 167]−, 490 [M − 106]−, 363 [M − 233]−, 337 [M − 167 − 92]−, 
323, 297, 233, 203 
10 astaxanthin derivative 3 16.2–16.4 454, 475 nc 597 579 [M + H − 18]+, 379, 285 596 g 581 [M − 15]−, 578 [M − 18]−, 504 [M − 92]−, 429 [M − 167]−,  
490 [M − 106]−, 389, 337 [M − 167 − 92]−, 233 
11 not identified 2 16.8 422, 452, 472 nc 565 nd 564 g nd 
12 all-trans-canthaxanthin 18.3 470 0 565 nd 564 g nd 
13 5,6-epoxy-β-cryptoxanthin 19.2 419, 447, 472 67 569 551 [M + H − 18]+, 221 567 f 549 [M − H − 18]− 
14 not identified 3 20.5–20.7 423, 452, 478 20–25 601 585, 548, 507, 441, 413 600 g 581, 543, 416 
15 all-trans-β-cryptoxanthin 22.6 422, 450, 476 25 nd nd 552 g 534 [M − 18]−, 519 [M − 18 − 15]−, 269, 243 
16 not identified 4 23.3 422, 450, 472 25 nd nd nd nd 
17 15-cis-β-carotene 25.4 420, 448, 471 nc 537 413 [M + H − 124]+ 536 g 295, 269, 189 
18 13-cis-β-carotene 26.5 418, 447, 471 nc 537 269 536 g 444 [M − 92]−, 295, 269 
19 all-trans-β-carotene 33.1–34.7 422, 451, 477 20 537 444 [M + H − 92]+, 413 [M + H − 124]+,  
400 [M + H − 137]+, 269, 177 
536 g 444 [M − 92]−, 295, 269 
20 9-cis-β-carotene 35.1–36.8 419, 448, 472 nc 537 444 [M + H − 92]+, 269 535 f 295, 269 
a Numbered according to Figure 1; b Retention time on the C30 column; c Linear gradient methanol/MTBE; d Not calculated; e Not detected; f [M − H]−; g M−•; h Fragmentation in source.
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Figure 1. Chromatogram (processed at 450 nm), obtained by HPLC-DAD, of the 
carotenoids from Marthasterias glacialis. See text for chromatographic conditions. Peak 
identification and characterization are given in Table 1. 
As carotenoids are well-known to form stable protonated molecules ([M + H]+) upon positive 
ionization, the sample was firstly analyzed in the positive ion mode. As expected, for most of the 
peaks, the protonated molecule, as well as the respective fragment ions formed, both from the polyene 
chain and functional groups, were generated. However, an extremely high background noise, probably 
originating from residual lipids present in the sample also forming positive ions, impaired the 
identification of the protonated molecules or the interpretation of the fragmentation pattern even by 
MS/MS. As an example, a very intense signal at m/z 369, which corresponds to cholesterol [M + H]+, 
could be observed from 16 to 20 min. Therefore, the sample was also analyzed in the negative mode 
and under this condition, negatively charged molecular ions (M−•) were formed, whilst deprotonated 
molecules [M − H]− were formed in just a few cases. The formation of M−• in the negative mode has 
previously been described for lutein, α-carotene, β-carotene [10] and astaxanthin esters [11]. 
The thermal-induced isomerization of all-trans-astaxanthin standard solution was carried out in 
order to indicate the presence of cis isomers in the sample. The chromatographic separation of the 
heated astaxanthin standard solution on the C30 column is shown in Figure 2. The relative amounts of 
the eight compounds derived from all-trans-astaxanthin were 1.0% of apo-10′-astaxanthinal, 2.8%, 
1.7% and 0.6% of different di-cis-isomers of astaxanthin, 3.2% of mono-cis-astaxanthin, 29.2% of 
13-cis-astaxanthin, 50.2% of all-trans-astaxanthin and 3.9% of 9-cis-astaxanthin. The peaks were 
tentatively identified based on spectral features, chromatographic elution, mass spectra characteristics 
(Table 2) and literature data [12–15]. Moreover, four oxidation products of astaxanthin were detected 
by the extracted ion chromatograms obtained at m/z 315, m/z 341, m/z 381 and m/z 447, corresponding 
to apo-15′-astaxanthinal (13.3 min), apo-14′-astaxanthinal (6.7 min), apo-12′-astaxanthinal (4.2 min) 
and apo-8′-astaxanthinal (5.6 min), respectively. When the trans-form of carotenoids is isomerized to 
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the cis-isomers, a small and large hypsochromic shift in the absorption maximum for, respectively, 
mono-cis carotenoids and di-cis carotenoids occurs, as well as the intensity of the cis-peak, which 
increases as the cis double bond approaches the centre of the molecule [16]. Peak 4 corresponds to 
all-trans-astaxanthin and the two main isomers formed were assigned as 13-cis-astaxanthin (peak 3) 
and 9-cis-astaxanthin (peak 9), with hypsochromic shifts of 8 and 5 nm, respectively, whilst an 
additional absorption band was present at 370 nm for the 13-cis isomer. These characteristics are in 
agreement with the data presented by Holtin et al. [14], which confirmed the identity of these two 
isomers by nuclear magnetic resonance (NMR). Peak 25 was identified as a cis-astaxanthin and 
presents similar UV-vis characteristics to 13-cis-astaxanthin, i.e., hypsochromic shift of 7 nm and a 
cis-peak at 368 nm, but it is probably not a 15-cis isomer since it should present a more intense 
cis-peak than 13-cis isomer. Apart from peak 21 (m/z 406) and 23 (no molecular ion was detected), all 
the other compounds presented in Figure 2 (peaks 3, 4, 9, 22, 24 and 25) showed the molecular ion 
(M−•) at m/z 596 when analyzed by negative ion APCI. However, by positive ion mode, the protonated 
molecule at m/z 597 was present only in the mass spectra of peaks 3, 4, 9 and 25. Peaks 22 to 24 
presented hypsochromic shifts between 17 and 21 nm, relative to the absorption maxima of the 
all-trans isomer, and were identified as di-cis-astaxanthin, based on comparison with literature data [14]. 
Peak 21 was identified as apo-10′-astaxanthinal, which is an oxidation product of astaxanthin with a 
molecular weight of 406 Da. The MS spectra of apo-10′-astaxanthinal presented the protonated 
molecule at m/z 407 [M + H]+ in positive ion mode and the molecular ion at m/z 406 (M−•) in negative 
ion mode. In addition, in both ionization modes, the MS/MS fragments corresponded to the loss of one 
hydroxyl group (18 u).  
Figure 2. Chromatogram (processed at 450 nm), obtained by HPLC-DAD, of astaxanthin 
standard submitted to heat under reflux. See text for chromatographic conditions. Peak 
identification and characterization are given in Table 2. 
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Table 2. Chromatographic, UV-vis and mass spectrometry characteristics of astaxanthin standard submitted to heat under reflux, obtained by 
HPLC-DAD-MS/MS. 
Peak a Carotenoid tR b (min) 
λmax c  
(nm) 
Δλ 
% 
III/II 
% 
AB/AII 
[M + H]+ 
(m/z) 
MS/MS fragment ions  
(positive mode) (m/z) 
M−• 
(m/z) 
MS/MS fragment ions (negative mode) (m/z) 
21 apo-10′-astaxanthinal 4.4–4.5 428 48 0 407 389 [M + H − 18]+ 406 388 [M − 18]− 
22 di-cis-astaxanthin 1 8.2–8.3 457 19 0 nd d nd 596 578 [M − 18]−, 564 [M − 18 − 18]−, 504 [M − 92]− 
23 di-cis-astaxanthin 2 8.6–8.8 455–457 21 0 nd nd nd nd 
24 di-cis-astaxanthin 3 9.5 459–457 17 0 nd nd 596 nd 
25 cis-astaxanthin 10.2–10.3 368, 469 7 0 58 597 285 596 581 [M − 15]−, 578 [M − 18]−, 504 [M − 92]−, 429 [M − 167]−, 389, 
363 [M − 233]−, 337 [M − 167 − 92]−, 233 
3 13-cis-astaxanthin 10.7–10.8 370, 468 8 0 51 597 579 [M + H − 18]+,  
561 [M + H − 18 − 18]+,  
379, 285, 173 
596 581 [M − 15]−, 578 [M − 18]−, 504 [M − 92]−, 429 [M − 167]−, 389, 
363 [M − 233]−, 337 [M − 167 − 92]−, 233 
4 all-trans-astaxanthin 11.8–11.9 476 0 597 579 [M + H − 18]+,  
505 [M + H − 92]+, 379, 285, 173 
596 581 [M − 15]−, 578 [M − 18]−, 504 [M − 92]−, 429 [M − 167]−, 389, 
363 [M − 233]−, 337 [M − 167 − 92]−, 297, 233, 167 
9 9-cis-astaxanthin 15.5–15.7 471 5 0 597 579 [M + H − 18]+,  
561 [M + H − 18 − 18]+, 379, 285 
596 581 [M − 15]−, 578 [M − 18]−, 504 [M − 92]−, 429 [M − 167]−, 389, 
363 [M − 233]−, 337 [M − 167 − 92]−, 233 
a Numbered according to Figure 2; b Retention time on the C30 column; c Linear gradient methanol/MTBE; d Not detected. 
Table 3. Chromatographic, UV-vis and mass spectrometry characteristics of astaxanthin standard submitted to reduction with NaBH4, 
obtained by HPLC-DAD-MS/MS. 
Peak a Carotenoid 
tR b  
(min) 
λmax c (nm) 
%  
III/II 
% 
AB/AII 
[M + H]+ 
(m/z) 
MS/MS fragment ions (positive mode) (m/z) 
[M − H]− 
(m/z) 
MS/MS fragment ions (negative mode) (m/z) 
26 crustaxanthin 7.9 422, 449, 476 40 0 601 583 [M + H − 18]+, 565 d [M + H − 18 − 18]+,  
547 [M + H − 18-18-18]+, 509 [M + H − 92]+ 
599 581 [M − 18]−, 563 [M − 18 − 18]−,  
545 [M − 18 − 18 − 18]−, 507 [M − 92]−, 493 [M − 106]− 
27 crustaxanthin 8.5 422, 449, 476 35 0 601 583 [M + H − 18]+, 565 [M + H − 18 − 18]+,  
547 d [M + H − 18 − 18 − 18]+, 509 [M + H − 92]+ 
599 581 [M − 18]−, 563 [M − 18 − 18]−,  
545 [M − 18 − 18 − 18]−, 507 [M − 92]− 
28 cis-crustaxanthin 9.0 337, 422, 449, 
476 
40 6 601 583 [M + H − 18]+, 565 [M + H − 18 − 18]+,  
547 [M + H − 18 − 18 − 18]+, 509 [M + H − 92]+ 
599 581 [M − 18]−, 563 [M − 18 − 18]−,  
545 [M − 18 − 18 − 18]−, 507 [M − 92]−
29 cis-crustaxanthin 9.3 337, 420, 444, 
470 
20 39 601 583 [M + H − 18]+, 565 [M + H − 18 − 18]+,  
547 [M + H − 18 − 18 − 18]+, 509 [M + H − 92]+ 
599 581 [M − 18]− 
a Numbered according to Figure 3; b Retention time on the C30 column; c Linear gradient methanol/MTBE; d Fragmentation in source. 
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Crustaxanthin was synthesized by astaxanthin reduction with NaBH4, and the result of this reaction 
was separated on C30 column, as shown in Figure 3. Four crustaxanthin isomers were separated; 
however, by chromatographic and MS data we could only tentatively differentiate among trans and cis 
isomers, since this carotenoid has four asymmetric carbons and thus 10 different optical R/S isomers. 
The peaks were tentatively identified, based on spectral features, chromatographic elution, mass 
spectra characteristics (Table 3) and literature data [1]. The four peaks presented protonated molecule 
at m/z 601 and deprotonated molecule at m/z 599, which indicates that both keto groups of astaxanthin 
were reduced to hydroxyl groups. The fragmentation pattern was also similar for all the crustaxanthin 
isomers with fragments corresponding to the loss of one (18 u), two (36 u) and three (54 u) hydroxyl 
groups, as well as toluene (92 u) and xylene (106 u) from the polyene chain, both in the positive and 
negative fragmentation ion modes. Peaks 28 and 29 were assigned as cis-crustaxanthin due to the 
presence of a cis-peak at 337 nm. 
Figure 3. Chromatogram (processed at 450 nm), obtained by HPLC-DAD, of astaxanthin 
standard submitted to reduction with NaBH4. See text for chromatographic conditions. 
Peak identification and characterization are given in Table 3. 
In the spiny sea star (Figure 1, Table 1), the astaxanthin isomers, all-trans-astaxanthin (peak 4), 
13-cis-astaxanthin (peak 3) and 9-cis-astaxanthin (peak 9) were identified considering the UV-vis 
spectra characteristics, chromatographic behavior, co-elution with isomerized standard (Table 2), and 
mass spectra. The mass spectra of all isomers of astaxanthin obtained in the positive ion mode showed 
the protonated molecule at m/z 597 and fragment ions in the MS/MS at m/z 579 [M + H − 18]+ and  
m/z 561 [M + H − 18 − 18]+, corresponding to the loss of one and two hydroxyl groups, respectively. 
However, the fragment at m/z 505 [M + H − 92]+, resulting from the loss of toluene from the polyene 
chain, was detected only in the all-trans-astaxanthin spectra of both sample and standard. In the low 
mass region of the positive ion APCI tandem mass spectra of astaxanthin isomers, fragment ions 
corresponding to cleavages of the polyene chain were detected at m/z 173, m/z 285 and m/z 379 [15]. 
In the negative ion mode, the molecular ion at m/z 596 was present in the MS spectra of all the isomers 
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and only all-trans-astaxanthin presented the deprotonated molecule at m/z 595 with the same intensity 
as the molecular ion. In addition, the MS/MS showed the presence of fragments at m/z 581 [M − 15]−, 
m/z 578 [M − 18]−, m/z 560 [M − 18 − 18]−, m/z 504 [M − 92]− or m/z 490 [M − 106]−, resulting from 
the losses of a methyl radical, one and two hydroxyl groups, toluene and xylene, respectively, and 
also the presence of other fragments from the polyene chain cleavage previously reported by 
van Breemen et al. [15] at m/z 203, m/z 233, m/z 297, m/z 323, m/z 337 [M − 167 − 92]−, m/z 363 
[M − 233]−, m/z 389 and m/z 429 [M − 167]−. The fragment ion at m/z 233 and its complementary ion 
at m/z 363 [M − 233]− were detected in all the MS/MS spectra of the astaxanthin isomers, and 
correspond to the cleavage of the 11,12 carbon-carbon bond with hydrogen transfer from the leaving 
group to the ion. The fragment at m/z 167, corresponding to the cleavage of the 7,8-bond with 
hydrogen transfer from the leaving group to the ion, was not detected; however, its complementary ion 
at m/z 429 [M − 167]− and the ion at m/z 337 [M − 167 − 92]−, which corresponds to the loss of toluene 
from the ion of m/z 429, were detected in all the MS/MS spectra of the astaxanthin isomers. 
Peak 2 (Figure 1, Table 1) was identified as crustaxanthin (3,4,3′,4′-tetrahydroxy-β,β-carotene), an 
astaxanthin metabolite, since it presented the same mass spectra of characteristics peaks 28 and 29 and 
UV-vis characteristics of peak 29 of the reduced astaxanthin chromatogram (Figure 3, Table 3). 
All-trans-canthaxanthin (peak 12) (Figure 1, Table 1), a carotenoid commonly used as a fish and 
poultry feed supplement, was identified, based on its UV-vis characteristics, molecular weight 
(564 Da) obtained from mass spectroscopic data, elution order on the C30 column and co-elution with 
an authentic standard. Peaks 6, 8 and 10 (Figure 1, Table 1) possess the same molecular weight and 
lack the fine structure as does astaxanthin (596 Da), thus they were assigned as astaxanthin derivative 
1, 2 and 3, respectively. The lack of a fine structure is an indicator for the conjugation of a carbonyl 
group with the chromophore.  
All-trans-lutein (peak 5) and all-trans-zeaxanthin (peak 7) (Figure 1, Table 1) have the same 
chemical formula (C40H56O2) and, consequently, identical protonated (m/z 569), deprotonated (m/z 567) 
molecules and molecular ions (m/z 568). The structural difference between these carotenoids is that 
zeaxanthin has two β-ring end-groups, while lutein has one β-ring and one ε-ring. Therefore, 
zeaxanthin has both double bonds in the β-ring conjugated to the polyene chain, resulting in a 
chromophore with eleven conjugated double bonds, and lutein has one hydroxyl allylic to the double 
bound in the ε-ring that is not conjugated to the polyene chain, resulting in a chromophore with 
10 conjugated double bonds. These characteristics allow differentiation between these two carotenoids, 
based on both UV-vis and mass spectra. As expected, zeaxanthin showed higher λmax values than 
lutein. In addition, zeaxanthin mass spectrum in positive ion mode presented higher intensity of the 
protonated molecule peak (569 u) in comparison to the fragment at m/z 551 [M + H − 18]+, which 
indicates that the hydroxyl group is not allylic to the double bond, whilst in the lutein spectrum the 
fragment at m/z 551 was more intense than the protonated molecule at m/z 569, as previously reported 
in the literature [1,9,17]. The MS/MS spectra obtained in the positive ion mode showed fragments at 
m/z 533 [M + H − 18 − 18]+, m/z 495 [M + H − 18 − 56]+, m/z 459 [M + H − 18 − 92]+, similarly to 
data reported in the literature [1,9,17]. In the negative ion mode, the MS/MS spectrum of lutein 
presented a fragment at m/z 429, which corresponds to the elimination of the terminal ring containing 
the unconjugated carbon-carbon double bond, and consequently can be used to distinguish between 
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lutein and zeaxanthin [15]. The identity of both lutein and zeaxanthin was confirmed by co-elution 
with authentic standards.  
All-trans-β-cryptoxanthin (peak 15) (Figure 1, Table 1) presented a similar UV-vis spectrum than 
that of all-trans-β-carotene and that of all-trans-zeaxanthin, since they possess the same chromophore. 
The identification of this carotenoid was also based on its molecular ion at m/z 552 obtained in the 
negative ion mode and the MS/MS fragments at m/z 534 [M − 18]−, m/z 519 [M − 18 − 15]−, m/z 269 
and m/z 243, since the protonated molecule was not detected in the positive ion mode. The 
identification was confirmed by co-elution with authentic standard. Peak 13 was assigned as  
5,6-epoxy-β-cryptoxanthin, considering the UV-vis, the MS characteristics and comparison with 
literature data [1,9,18]. The presence of a mass fragment at m/z 221 in the positive ion mode, which 
corresponds to the location of the epoxide group in the 3-hydroxy-β-ring, allowed the identification of 
this carotenoid as the 5,6-epoxide and not the 5′,6′-epoxide. 
Peaks 17, 18, 19 and 20 (Figure 1, Table 1) were identified as 15-cis-, 13-cis-, all-trans- and  
9-cis-β-carotene, respectively, based on the elution order on the C30 column, UV-vis and mass spectra 
characteristics and literature data [1,9,15,17]. The mass spectra of β-carotene isomers, which were 
obtained in the negative ion mode, showed the molecular ion at m/z 536, except for 9-cis-β-carotene, 
that presented the deprotonated molecule at m/z 535. The β-carotene isomers were present in very low 
concentrations, so the typical fragment ion in the MS/MS resulting from the loss of toluene ([M − 92]−) 
was observed only for 13-cis- and all-trans-β-carotene; other fragments in the low mass range 
described in the literature at m/z 269 and m/z 295 [15] were detected for all isomers. The identity of 
all-trans-β-carotene was confirmed by co-elution with authentic standard. 
Although it was not possible to identify the peaks 1, 11, 14 and 16 (Figure 1), these unknown 
compounds presented UV-vis spectra with characteristic typical for carotenoids, as can be seen  
in Table 1.  
Astaxanthin monoesters or diesters were not detected, since in the chromatographic conditions used, 
they should, respectively, elute between 20 min and all-trans-β-carotene elution (33.1 to 34.7 min) and 
after all-trans-β-carotene to 50 min. The protonated molecules or main mass ions from carotenoid 
esters where searched in the range of m/z 100 and m/z 1500, but not detected. In addition, previous 
studies have conducted alkaline hydrolysis in the extract of this organism, with no esters being  
found [8]. Other carotenoids usually found in marine echinoderms and algae, such as  
7,8-didehydroastaxanthin, 7,8,7′,8′-tetradehydroastaxanthin, fucoxanthin and echinenone, were also 
searched by observing the UV-vis spectra and the main ions of the mass spectra, but were not detected. 
Short chain products of astaxanthin, i.e., apo-8′-, apo-10′-, apo-12′-, apo-14′- and apo-15-astaxanthinal, 
were not noticed in the sea star. 
Recently, all-trans-astaxanthin, all-trans-lutein and all-trans-zeaxanthin were found in methanol 
and acetone extracts from M. glacialis and the purified methanol extract was able to inhibit cell 
proliferation against rat basophilic leukemia RBL-2H3 cancer cell line [8]. Both β-carotene and 
cryptoxanthin derivatives were searched, however they were not found. The fact that the work 
presented herein confirmed the presence of β-carotene and cryptoxanthin points to a possible  
inter-individual variation of this organism’s chemical composition. 
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Among the 20 carotenoids found in this study, this was the first time that the occurrence of 
crustaxanthin, all-trans-canthaxanthin, two astaxanthin and three β-carotene cis-isomers and  
5,6-epoxy-β-cryptoxanthin was reported in M. glacialis. 
3. Experimental Section  
3.1. Reagents and Standards  
HPLC grade solvents, methanol and methyl tert-butyl ether (MTBE) were obtained from Merck 
(Darmstadt, Germany) or Mallinckrodt Baker (Philipsburg, NJ, USA). Ethyl acetate, methanol, 
methylene chloride, hexane and chloroform, all analytical grade, were from Synth (Diadema, SP, 
Brazil). The solvents and samples were filtered through Millipore membranes (Bedford, MA, USA) of 
0.22 and 0.45 μm, respectively. 
The standards of all-trans-astaxanthin, all-trans-canthaxanthin and all-trans-β-carotene were acquired 
from Sigma-Aldrich (St. Louis, MO, USA). Standards of all-trans-lutein, all-trans-zeaxanthin and  
all-trans-β-cryptoxanthin were provided by DSM Nutritional Products (Basel, Switzerland). All 
standards showed at least 95% purity, determined by HPLC-DAD. 
3.2. Sample 
M. glacialis individuals were collected from the rocky coast at Cabo Carvoeiro, west Portugal, in 
March 2009, placed on ice and immediately transported to the laboratory in ice-boxes. The  
macro-invertebrates were then cleaned and washed with sea water and kept at −20 °C, prior to their 
lyophilization in a Labconco 4.5 Freezone apparatus (Kansas City, MO, USA). The dried material was 
powdered before extraction. The sample corresponded to a mixture of three individuals. 
3.3. Carotenoid Extraction 
In order to avoid carotenoid degradation during analysis, the manipulation of samples and extracts 
was carried out under dim light and at a controlled room temperature (22 ± 3 °C). The carotenoids 
were extracted from 2 g of freeze-dried samples using a mortar and a pestle with the aid of glass beads 
(Sigma-Aldrich, 150–212 µm) to break the cell walls. A total of nine consecutive extractions were 
performed: four with 10 mL of ethyl acetate, three with 10 mL of methanol and two with 10 mL of 
methylene chloride. The solvent was separated from the sample using a refrigerated centrifuge 
(Allegra 64R, Beckman Coulter, Palo Alto, CA, USA) at 10 °C and 1100 g for 10 min. To avoid the 
possible presence of glass beads in the final extract, each extract was filtered through a 0.45 μm 
membrane and the solvent was immediately evaporated at room temperature under nitrogen flux to 
avoid isomerization. The further extracts were added to the same tube. The dry extract was stored in 
darkness and under a nitrogen atmosphere (99.9% purity) at −80 °C until HPLC analysis. The 
extraction was carried out in triplicate. Immediately before HPLC analysis, the extracts were dissolved 
in 500 μL of methanol/MTBE (70:30, v/v) and sonicated for 3 min. 
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3.4. Preparation of Reference Compounds 
About 1 mg of all-trans astaxanthin authentic standard was dissolved in 4 mL of chloroform and 
hexane was used to make up the volume to 25 mL. The work solution was prepared by diluting a  
10 mL aliquot to 100 mL in a volumetric flask with 4 mL of chloroform with the volume being made 
up with hexane. The concentration of the work solution, 2.5 µM, was spectrophotometrically  
(Agilent, Palo Alto, CA, USA) determined using the absorption coefficient for astaxanthin  
(ܧ ଵ௖௠ଵ%  = 2100; 470 nm) [19].  
To obtain the astaxanthin cis isomers, the work solution was mixed with 100 mL hexane and heated 
under reflux at boiling temperature (~69 °C) for 5 h. The solvent was evaporated in a rotary evaporator 
(Buchi, Flawil, Switzerland) and the isomerized dry standard was stored in darkness and under a 
nitrogen atmosphere (99.9% purity) at −36 °C until HPLC analysis.  
To synthesize crustaxanthin, the all-trans astaxanthin work solution was dried under nitrogen flux, 
redissolved in 10 mL of anhydrous ethanol and reduced with NaBH4 for 1h at room temperature [20]. 
The reaction was ended by adding saturated NaCl solution after which the carotenoids were extracted 
with dichloromethane. The solvent was removed under nitrogen flux and the dry crustaxanthin 
standard was stored in darkness and under a nitrogen atmosphere (99.9% purity) at −36 °C until  
HPLC analysis.  
3.5. HPLC-DAD-MS/MS Analysis  
A Shimadzu HPLC (Kyoto, Japan) equipped with quaternary pumps (model LC-20AD), on-line 
degasser and a Rheodyne (Rheodyne LCC, Robert Park, USA) injection valve with a 20 µL loop, 
connected in series to a DAD detector (Shimadzu) and to a mass spectrometer with an ion trap 
analyzer and atmospheric pressure chemical ionization source (Bruker Daltonics, model Esquire 4000, 
Bremen, Germany) was used for all analysis.  
The carotenoids were separated on a C30 YMC column (3 μm, 250 × 4.6 mm i.d.) (Waters, 
Wilmington, USA) using as mobile phase a linear gradient of methanol/MTBE from 95:5 to 70:30 in 
30 min, followed by 50:50 in 20 min. The flow rate was 0.9 mL·min−1 and column temperature was set 
at 29 °C. The UV-vis spectra were obtained between 250 and 650 nm and the chromatograms were 
processed at 450 nm. The MS parameters were set as follows: positive or negative mode; current 
corona: 4000 nA; source temperature: 450 °C; dry gas (nitrogen) temperature: 350 °C, flow: 5 L·min−1; 
nebulizer: 60 psi. The MS/MS was set in automatic mode, applying 1.4 V fragmentation energy. The 
mass spectra were acquired with an m/z range from 100 to 700 [9].  
The identification of the carotenoids was performed, considering the combination of the following 
parameters: elution order on the C30 column, UV-vis spectrum features (maximum absorption 
wavelength (λmax), spectral fine structure (%III/II) and peak cis intensity (%AB/AII)), MS spectrum 
characteristics as compared to standards analyzed under the same conditions, co-chromatography with 
standards and data available in the literature. In addition, the assignment of the protonated molecule 
([M + H]+) and the molecular ions (M−•) or deprotonated molecule ([M − H]−) was confirmed by 
second order MS fragmentation. 
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4. Conclusions  
In this study, HPLC-DAD-APCI-MS/MS allowed the characterization of 20 carotenoids in the 
echinoderm M. glacialis, eight of them reported for the first time. Isomers of the main compounds 
identified before were reported. Overall, it seems that M. glacialis could be an interesting matrix for 
further studies as a source of antioxidant carotenoids with a positive impact in human health. 
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In this work a fast and simple multi-target gas chromatography–mass spectrometry (GC–MS) method
for the simultaneous detection and absolute quantification of amino acids, fatty acids, sterols and
lupanes in marine organisms is proposed. The methodology was applied to the characterization of the
echinoderm Marthasterias glacialis Linnaeus spiny sea star extracts. The main factors influencing the
extraction of target compounds were evaluated by using different extraction procedures, solvent
systems and temperature conditions and a comparison with a reference technique was performed. The
most suitable procedure, capable of successfully extract the three classes of target compounds, was
ethanol as solvent at 40 1C under magnetic stirring. Good analytical parameters were obtained since
calibrations curves for the 40 compounds under analysis (15 amino acids, 16 fatty acids, 6 sterols and 3
lupanes) showed regression coefficients (r2) ranging from 0.9844 to 0.9978, with low RSD (from 0.00 to
9.45%), and detection limits varying from 0.03 to 15.40 mg/L. The RSD values for intra- and interday
variations studies were also good (RSDo13.5%, for both) and recoveries were higher than 92%.
Variation in samples from different harvests and origins and their chemical composition during the
year is reported. The fact that no previous treatment of samples is required can make this a useful
technique for metabolite profiling in marine organisms, among others, both in biomedical and
nutritional studies. Moreover, due to the fast and robust character of the proposed method it seems
to be suitable for the implementation as routine analysis.
& 2012 Elsevier B.V. All rights reserved.1. Introduction
Nowadays multi-target approaches have been increasingly used,
thus allowing the identification of several classes of compounds in
different matrices [1–3]. Gas chromatography–mass spectrometry
(GC–MS) is a popular preference since it provides powerful structural
and quantitative information [4]. Adequate extraction procedures are
critical for obtaining a chemical profile that is representative of the
original sample, both qualitatively and quantitatively. Techniques
such as microwave assisted extraction [5], accelerated solvent
extraction [6] and supercritical fluid extraction [7,8] have been
developed and different derivatization procedures tested. Derivatizingll rights reserved.
x: þ351 226093390.
.agents are responsible for the increment of volatility of less volatile
and non-volatile compounds and, consequently, a higher sensitivity
and resolution can be obtained by GC–MS analysis. Currently,
silylation is widely used as derivatization method for GC–MS meta-
bolic profile studies, since it allows the determination of metabolites
from different classes. Among silylation agents, N-methyl-N-(tri-
methylsilyl)-trifluoroacetamide (MSTFA) has been increasingly used
due to its ability to react with primary amines and amides, alcohols,
phenols, carbohydrates and carboxylic groups [9,10].
Marine organisms have been paving their way as an interest-
ing source of bioactive molecules for biomedical research, as well
as alternative foodstuffs for nutrition. In both cases, the use of
these organisms must be guided by elevated standards in quality
control and hence analytical techniques for fast metabolite
profiling are required. Among the metabolites present in marine
species, lipids are growing in interest, especially by their content
Table 1
Validation parameters for amino acids, fatty acids, sterols and lupanes.
Compound Concentration
range (lg/mL)
Slope (7SD) Interception (7SD) Correlation
coefficient (7SD)
LOD
(lg/mL)
LOQ
(lg/mL)
RSD
Amino acids
Alanine 12.00–120.00 0.0086 (0.0001) 0.0035 (0.0092) 0.9952 (0.0260) 0.36 1.12 0.10
Glycine 20.00–200.00 0.0130 (0.0002) 0.0193 (0.0247) 0.9974 (0.0696) 1.75 5.83 0.77
Valine 1.50–150.00 0.0631 (0.0007) 0.1612 (0.0588) 0.9978 (0.1659) 0.13 0.43 0.27
Leucine 1.50–88.00 0.0727 (0.0012) 0.0290 (0.0581) 0.9958 (0.1544) 0.18 0.61 0.45
Isoleucine 1.50–150.00 0.0523 (0.0005) 0.0183 (0.0368) 0.9978 (0.0978) 0.22 0.75 0.38
Proline 12.00–120.00 0.0588 (0.0012) 0.0726 (0.0892) 0.9938 (0.2135) 0.03 0.11 0.06
Serine 12.00–120.00 0.0125 (0.0002) 0.0079 (0.0155) 0.9958 (0.0371) 2.51 8.35 1.04
Threonine 5.00–170.00 0.0375 (0.0005) 0.0290 (0.0365) 0.9972 (0.0970) 0.58 1.94 0.73
Aspartic acid 12.50–200.00 0.0574 (0.0010) 0.1894 (0.1217) 0.9972 (0.1100) 1.77 5.89 3.10
trans-4-Hydroxyproline 15.00–150.00 0.0180 (0.0004) 0.0254 (0.0334) 0.9940 (0.0799) 1.67 5.55 1.00
Cysteine 28.00–140.00 0.0440 (0.0013) 0.0041 (0.1016) 0.9888 (0.2424) 2.68 8.92 3.93
Methionine 12.50–200.00 0.0661 (0.0019) 0.5070 (0.2064) 0.9898 (0.1923) 1.46 4.85 1.52
Phenylalanine 13.00–130.00 0.0330 (0.0010) 0.1386 (0.0761) 0.9864 (0.1822) 0.54 1.81 2.19
Glutamic acid 6.25–200.00 0.0381 (0.0001) 0.1066 (0.0623) 0.9940 (0.0241) 0.61 2.03 1.75
Lysine 12.50–200.00 0.0730 (0.0016) 0.7400 (0.1570) 0.9926 (0.0450) 0.97 3.27 2.09
Fatty acids
Pelargonic 20.00–100.00 0.0054 (0.0001) 0.0216 (0.0078) 0.9910 (0.0188) 4.61 15.36 0.83
Capric 40.00–200.00 0.0039 (0.0001) 0.0123 (0.0117) 0.9902 (0.0281) 7.86 26.21 1.02
Lauric 5.00–130.00 0.0057 (0.0001) 0.0276 (0.0115) 0.9886 (0.0275) 0.61 2.04 0.11
Myristic 25.00–500.00 0.0027 (0.0001) 0.1516 (0.0229) 0.9938 (0.0382) 2.71 9.05 0.26
Pentadecanoic 10.00–250.00 0.0052 (0.0001) 0.0003 (0.0150) 0.9914 (0.0362) 2.27 7.58 0.38
Palmitic 60.00–300.00 0.0056 (0.0001) 0.0613 (0.0264) 0.9891 (0.0633) 7.72 25.75 1.44
Margaric 10.00–120.00 0.0106 (0.0003) 0.0153 (0.0191) 0.9920 (0.0457) 2.02 6.73 0.71
Oleic 10.00–140.00 0.0004 (0.0000) 0.0012 (0.0009) 0.9866 (0.0022) 0.14 0.48 0.00
Linoleic 10.00–100.00 0.0104 (0.0003) 0.0521 (0.0180) 0.9901 (0.0430) 1.34 4.45 0.71
Linolenic 10.00–500.00 0.0003 (0.0000) 0.0045 (0.0026) 0.9941 (0.0058) 1.77 5.91 0.02
Stearic 10.00–176.00 0.0094 (0.0003) 0.0215 (0.0373) 0.9953 (0.0892) 0.31 1.02 0.10
Arachidonic 10.00–500.00 0.0065 (0.0002) 0.0259 (0.0541) 0.9932 (0.1294) 3.18 10.61 0.07
Eicosapentaenoic 40.00–200.00 0.0138 (0.0003) 0.1064 (0.0413) 0.9903 (0.0989) 6.54 21.81 3.01
cis11-Eicosenoic 60.00–300.00 0.0002 (0.0000) 0.0091 (0.0013) 0.9909 (0.0019) 8.35 27.84 0.06
Eicosanoic 28.00–140.00 0.0136 (0.0002) 0.0249 (0.0203) 0.9951 (0.0485) 4.68 15.59 2.12
Docosahexaenoic 30.00–180.00 0.0094 (0.0002) 0.0642 (0.0385) 0.9947 (0.0866) 4.95 16.48 1.55
Sterols and lupanes
Cholesta-3,5-diene 14.00–70.00 0.0170 (0.0006) 0.0478 (0.0265) 0.9844 (0.0596) 3.22 10.73 1.82
Cholesterol 30.00–250.00 0.0108 (0.0004) 0.0397 (0.0359) 0.9913 (0.0807) 4.17 13.88 1.54
Cholestanol 5.00–100.00 0.0265 (0.0007) 0.0683 (0.0436) 0.9932 (0.0981) 0.27 0.89 0.23
Ergosterol 76.00–380.00 0.0103 (0.0003) 0.1466 (0.0684) 0.9903 (0.1538) 15.40 51.34 5.29
Fucosterol 6.25–200.00 0.0146 (0.0002) 0.0383 (0.0191) 0.9963 (0.0574) 0.95 3.17 9.45
Betuline 6.25–200.00 0.0170 (0.0003) 0.0903 (0.0294) 0.9937 (0.0882) 0.97 3.24 5.48
Lupeol 6.25–200.00 0.0154 (0.0003) 0.0743 (0.0269) 0.9935 (0.0854) 0.80 2.68 7.43
Lupeol acetate 6.25–200.00 0.0178 (0.0003) 0.1000 (0.0257) 0.9956 (0.0771) 0.83 2.74 8.94
b-Sitosterol 10.40–52.00 0.0178 (0.0005) 0.0201 (0.0168) 0.9896 (0.0377) 1.61 5.37 0.46
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and nutrition. The fatty acids (FA) composition of marine organ-
isms is often characteristic for each species and genus, but also
depends on environmental conditions [11–13]. Several protocols
have been established for the extraction and analysis of FA, and
recent reviews on this topic are available [11,14]. However, in
most cases, the protocol includes extensive pre-treatment for the
elimination of interferents [1,15] and quantification is not always
possible. Separation of polar and apolar constituents is also
common.
Other two classes of compounds with nutritional interest
found in marine organisms are amino acids and sterols. The first
is generally analyzed by GC–MS, GC-FID [16,17] or HPLC-UV/DAD
[18,19], while techniques for sterol analysis can be performed
either by HPLC-DAD/MS [20,21] or GC–MS [22]. However, pre-
treatment of samples is usually required for both classes, which
can result in high losses of analyte and low recovery rates.
In this work, a methodology for the simultaneous assessment
of the four classes of compounds (amino acids, fatty acids, sterols
and lupanes) in marine organisms was developed. The proposed
method includes the derivatization of a crude extract and further
identification and quantification by GC–MS, in 25 minchromatographic run, without sample pre-treatment or the use
of hazard extraction solvents.2. Experimental
2.1. Standards and reagents
Arginine (Z98%), asparagine (Z98%), aspartic acid (Z98%),
cysteine (Z98%), glutamic acid (Z98%), glutamine (Z98%),
histidine (Z98%), lysine (Z98%), methionine (Z98%), trypto-
phan (Z98%), tyrosine (Z98%), alanine (Z98%), glycine (Z99%),
valine (Z98%), leucine (Z98%), isoleucine (Z98%), proline
(Z99%), serine (Z99%), threonine (Z98%), trans-4-hydroxypro-
line (Z98%), phenylalanine (Z98%), norvaline (Z99%), methyl
linolelaidate (Z99%), cholesta-3,5-diene (Z95%), cholesterol
(Z95%), cholestanol (Z99%), ergosterol (Z95%) b-sitosterol
(Z97%), desmosterol (Z85%), fucosterol (Z95%), betulin
(Z95%), lupeol (Z95%), lupeol acetate (Z95%), N-methyl-N-
(trimethylsilyl) trifluoroacetamide (MSTFA), as well as pelargonic
(Z99%), decanoic (Z99%), capric (Z99%), lauric (Z95%), myr-
istic (Z99%), pentadecanoic (Z99%), palmitic (Z99%), margaric
Table 2
Recovery values for representative amino acids, fatty acids and sterols. For each
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(Z99%), arachidonic (Z99%), 5,8,11,14,17-eicosapentaenoic
(EPA) (Z99%), cis11,14-eicosadienoic (Z98%), cis11-eicosaenoic
(Z99%), docosahexaenoic (DHA) (Z98%) and eicosanoic acids
(Z97%) and dichloromethane were from Sigma (St. Louis,
MO, USA). The n-alkane series (C8C40) and boron trifluoride
(BF3) 10% methanolic solution were from Supelco (Bellefonte,
PA, USA). Chloroform, methanol, anhydrous sodium sulfate and
isooctane were from Panreac Quimica SA (Barcelona, Spain).
Potassium hydroxide was obtained from Pronalab (Lisboa,
Portugal).
2.2. Preparation of standard solutions
Stock solutions of amino acids, fatty acids, sterols and lupanes
and the internal standards (IS) norvaline, methyl linolelaidate and
desmosterol were prepared individually in ethanol and kept at
20 1C until analysis. Calibration solutions were then prepared
by mixing and diluting each stock solution in appropriate
amounts with ethanol to achieve the concentration range dis-
criminated in Table 1.
2.3. Marine organisms
Marthasterias glacialis Linnaeus individuals were collected at
the rocky coast at Cabo Carvoeiro, west Portugal, in July and
September of 2009 and at Praia do Baleal and Praia da Consolac- ~ao
in February of 2010 (Fig. 1). The organisms were placed on ice and
immediately transported to the laboratory in ice-boxes. The
macro-invertebrates were then cleaned and washed with sea
water and kept at 20 1C, prior to their freeze-drying in a
Labconco 4.5 Freezone apparatus (Kansas City. MO. USA). The
dried material was powdered and sifted (o910 mm) before
extraction. Each sample corresponds to a mixture of three
individuals.
2.4. GC–MS system and data acquisition
2.4.1. GC–MS general conditions
In all cases, analysis was performed with a Varian CP-3800 gas
chromatograph coupled to a Varian Saturn 4000 mass selective
ion trap detector (USA) and a Saturn GC–MS workstation software
version 6.8. A VF-5 ms (30 m0.25 mm0.25 mm) column (VAR-
IAN) was used. A CombiPAL automatic autosampler (Varian, Palo
Alto, CA) was used for all experiments. The injector port wasFig. 1. Collection sites of the organisms used in this study (west Portugal) and
respective sample identification.heated to 250 1C. Injections were performed in split mode, with a
ratio of 1/40. The carrier gas was helium C-60 (Gasin, Portugal), at
a constant flow of 1 ml/min. The ion trap detector was set as
follows: transfer line, manifold and trap temperatures were 280,
50, and 180 1C, respectively. The mass ranged from 50 to 600 m/z,
with a scan rate of 6 scan/s. The emission current was 50 mA and
the electron multiplier was set in relative mode to auto tune
procedure. The maximum ionization time was 25.000 ms, with an
ionization storage level of 35m/z. The injection volume was 2 mL
and the analysis was performed in Full Scan mode.
2.4.2. GC conditions for trimethylsilyl (TMS) derivatives analysis
The oven temperature was set at 100 1C for 1 min, then
increasing 20 1C/min to 250 1C and held for 2 min, 10 1C/min to
300 1C and held for 10 min. All mass spectra were acquired in
electron impact (EI) mode. Ionization was maintained off during
the first 4 min to avoid solvent overloading. For quantification
purposes, each sample was injected in triplicate and the amount
of metabolites present in samples was achieved from the calibra-
tion curves of the respective TMS derivatives. All compounds
were quantified in Full Scan mode, with the exceptions of linoleic
(m/z 262, 337 and 352), linolenic (m/z 191, 335 and 350), and oleic
(m/z 264, 339 and 354) derivatives that were quantified by the
area obtained from the re-processed chromatogram, using the
characteristic m/z fragments. Identification of compounds was
achieved by comparisons of their retention time and mass spectra
with those of pure standards TMS derivatives prepared and
injected under the same conditions, and from NIST 05 MS Library
Database. In addition, the retention index (RI) was experimentally
calculated and the values were compared with those reported in
the literature for GC columns with 5%-Phenyl-95%-dimethylpoly-
siloxane (Table 6). For the RI determination, an n-alkanes series
C8C40 was used.
2.4.3. GC conditions for fatty acids methyl esters (FAMEs) analysis
For comparison purposes, we have used chromatographic
conditions published before [23]. The oven temperature was set
at 40 1C for 1 min, then increasing 5 1C/min to 250 1C, 3 1C/min to
300 1C and held for 15 min. The injection volume for liquid
extracts was 1 mL and the analysis was performed in Full Scan
mode. Identification of compounds was achieved by comparisonscompound, three different concentration levels were tested.
Compounds Concentration (lg/mL) Recovery (%)
Isoleucine 2.00 94
4.00 94
20.00 99
trans-4-Hydroxyproline 10.00 96
50.00 97
150.00 103
Palmitic acid 15.00 95
30.00 93
150.00 95
Arachidonic acid 40.00 95
80.00 96
300.00 94
Cholesta-3,5-diene 10.00 92
20.00 95
80.00 98
Cholestanol 7.50 106
15.00 95
34.00 101
Table 3
Values of intra- and interday reproducibility for amino acids.
Compounds Concentration
(lg/mL)
Intraday
(RSD)
Interday
(RSD)
Alanine 12.00 4.87 12.94
72.00 3.30 7.76
120.00 0.49 7.30
Glycine 20.00 2.30 7.82
120.00 1.57 5.91
400.00 3.11 4.67
Valine 1.50 2.89 6.82
90.00 0.06 5.49
150.00 0.20 8.14
Leucine 1.50 0.41 6.55
66.00 3.67 8.26
88.00 2.27 3.66
Isoleucine 15.00 2.77 5.91
90.00 1.86 4.83
120.00 1.31 7.63
Proline 24.00 0.05 4.00
72.00 2.50 7.01
120.00 0.81 4.69
Serine 24.00 2.48 8.43
72.00 4.17 8.70
120.00 0.62 12.82
Threonine 17.00 1.17 5.14
102.00 3.26 5.55
136.00 1.04 7.22
Aspartic acid 12.50 3.10 7.17
50.00 4.18 6.18
200.00 1.57 8.75
trans-4-
Hydroxyproline
30.00 2.17 11.65
90.00 4.26 4.34
150.00 0.11 6.68
Cysteine 26.00 2.19 7.27
78.00 4.01 8.35
130.00 0.58 8.27
Methionine 1.52 1.52 6.73
5.06 2.73 3.69
2.45 2.45 8.68
Phenylalanine 13.00 1.92 9.19
78.00 2.29 10.61
130.00 2.73 8.22
Glutamic acid 6.25 1.75 9.89
50.00 1.05 8.15
200.00 2.06 8.06
Lysine 6.25 2.09 4.24
50.00 6.80 7.36
200.00 4.99 9.22
Table 4
Values of intra- and interday reproducibility for fatty acids.
Compounds Concentration
(lg/mL)
Intraday
(RSD)
Interday
(RSD)
Lauric acid 26.00 3.73 9.87
78.00 0.60 6.74
130.00 3.72 8.16
Myristic acid 25.00 1.31 5.15
300.00 2.46 7.80
500.00 0.98 9.71
Pentadecanoic acid 10.00 2.87 9.32
150.00 2.42 10.57
250.00 2.97 10.44
Palmitic acid 60.00 3.25 3.93
180.00 3.16 9.41
300.00 1.96 4.74
Margaric acid 10.00 8.70 8.73
72.00 6.64 10.12
120.00 1.93 8.88
Linoleic acid 10.00 7.85 10.77
40.00 5.47 7.13
100.00 0.77 5.54
Linolenic acid 10.00 9.92 11.51
300.00 2.76 10.83
500.00 3.11 8.02
Oleic acid 10.00 8.64 12.53
84.00 3.25 4.82
140.00 2.19 4.62
Stearic acid 10.00 3.74 10.18
132.00 3.25 9.20
220.00 0.99 9.98
Arachidonic acid 100.00 1.85 8.62
300.00 3.66 8.05
500.00 2.95 6.24
Eicosapentaenoic
acid
40.00 4.88 7.29
120.00 2.66 11.93
200.00 2.76 7.38
cis11-Eicosenoic acid 60.00 4.02 11.81
180.00 3.61 9.81
300.00 3.00 11.58
Eicosanoic acid 28.00 5.67 10.64
84.00 2.96 3.76
140.00 2.65 7.74
Docosahexaenoic
acid
30.00 10.45 11.96
180.00 4.86 12.37
300.00 2.54 8.68
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standards injected under the same conditions, and from NIST 05
MS Library Database.2.5. Metabolites extraction and derivatization
2.5.1. Procedure for TMS derivatives
In order to establish the most suitable method for the extrac-
tion and quantification of metabolites present in marine samples,
Table 5
Values of intra- and interday reproducibility for sterols and lupanes.
Compounds Concentration
(lg/mL)
Intraday
(RSD)
Interday
(RSD)
Cholesta-3,5-diene 14.00 0.54 7.39
42.00 3.56 10.49
70.00 8.63 12.47
Cholesterol 30.00 1.29 9.27
90.00 4.12 9.74
150.00 11.48 13.67
Cholestanol 5.00 5.70 11.51
80.00 1.84 13.39
100.00 1.95 10.97
Ergosterol 150.00 3.46 6.90
228.00 6.40 9.64
380.00 2.16 8.73
Fucosterol 6.25 6.55 6.63
50.00 3.76 4.79
200.00 0.45 6.69
b-Sitosterol 10.40 3.87 9.30
31.20 1.72 10.51
52.00 2.75 10.99
Betuline 6.25 5.25 6.28
50.00 1.63 5.42
200.00 4.91 6.96
Lupeol 6.25 5.68 7.24
50.00 4.50 5.90
200.00 4.97 5.19
Lupeol acetate 6.25 8.94 9.89
50.00 3.66 6.21
200.00 1.50 5.30
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pared. Briefly, 100.0071.00 mg of dried sample was transferred
to a glass vial and the internal standards were added: 80 mL of
norvaline (0.30 mg/mL), 20 mL of methyl linolelaidate (10.00 mg/
mL), and 80 mL of desmosterol (2.00 mg/mL). The volume was
then completed to 2.00 mL with either ethanol or a solution of
choloroform:methanol, according to the experiment being
carried.
Extractions with ethanol were performed at different tem-
peratures (40, 50 and 60 1C) by incubating for 20 min under
magnetic stirring (200 rpm). Ultra-sonication with ethanol was
also performed and all extracts were compared with the extrac-
tion with chloroform/methanol (2:1) [24] incubated for 20 min
under magnetic stirring 200 rpm. Samples were then filtered
through a 0.45 mm membrane (Millipore). Extractions were car-
ried out in triplicate.
An aliquot of 50 mL of extract was transferred to a glass vial,
the solvent was evaporated under nitrogen stream and 50 mL of
the derivatization reagent (MSTFA) was added to the dried
residue. The vial was capped, vortexed and heated for 20 min in
a dry block heater maintained at 40 1C. All analyses were
performed in triplicate.2.5.2. Procedure for FAMES
Methyl esters derivatives were obtained as described by
Ribeiro et al. [23], with some modifications: 100 mg of thepowdered sample plus 20 mL of methyl linolelaidate (10.00 mg/mL)
ethanol solution (internal standard) were mixed with chloroform:
methanol (2:1) (22mL) with magnetic stirring (500 rpm), for
10 min, at 40 1C. The resulting extract was filtered, concentrated to
dryness under reduced pressure (40 1C) and redissolved in 2 mL of
ethanol. Derivatization was assured by treatment with 1mL of BF3
methanolic solution (10%), at 90 1C, for 10 min. Derivatives were
purified with 26mL of isooctane and anhydrous sodium sulfate
was added to assure the total absence of water. The extract was then
evaporated under a stream of nitrogen and redissolved in 200 mL of
isooctane.
2.6. Method validation
At least six concentration levels of compounds’ trimethylsilyl
(TMS) derivatives were analyzed. Each calibration solution con-
tained norvaline, methyl linolelaidate and desmosterol as internal
standards, at a final concentration of 12.00, 100.00 and 80 mg/mL,
respectively. The ratios of the peak areas of compounds versus
those of IS were plotted against the corresponding concentration
to obtain the calibrations graphs. The derivatization procedure
was carried out as described in 2.5.1., using 50 mL of calibration
solution instead of the extract.
2.6.1. Linearity
Method linearity was determined by evaluation of the regres-
sion curve (ratio of analyte peak area/IS area versus analyte
concentration) and expressed by the correlation coefficient. The
linearity range of the method was analyzed by performing
calibration curves using at least six different concentration levels
of the analytes, according to the range of concentrations present
in the samples (Table 1).
2.6.2. Limits of detection and of quantification
Limit of detection (LOD) and limit of quantification (LOQ) were
determined from calibration curve data and were obtained by the
following formula [25]:
LOD¼ ð3:3 SDÞ=b and LOQ ¼ ð10 SDÞ=b
where SD is the residual standard deviation of the linear regres-
sion, and b is the slope of the regression line.
2.6.3. Precision, accuracy and recovery tests
Precisions and accuracies were determined using intra- and
interday assays at three different concentrations (low, medium
and high) and are expressed as coefficients of variation (CV).
Recovery tests were performed by spiking M. glacialis (sample
Sep09-A) with two compounds representative of each class:
isoleucine (2.00, 4.00 and 20.00 mg/mL), trans-4-hydroxyproline
(10.00, 50.00 and 150.00 mg/mL), palmitic (15.00, 30.00 and
150.00 mg/mL) and arachidonic acids (40.00, 80.00 and
300.00 mg/mL), cholesta-3,5-diene (10.00, 20.00, and 80.00 mg/mL)
and cholestanol (7.50, 15.00 and 34.00 mg/mL).3. Results and discussion
3.1. Optimization of the extraction procedure
For the development of the method, sample Sep09-A was
selected. A preliminary screening revealed that fatty acids were
the predominant compounds in M. glacialis. Given the fact that
fatty acids were important compounds in the samples, both from
a qualitative and quantitative point of view, we applied a
methodology available in the bibliography that is currently used
for the analysis of this class of metabolites derivatives (Folch
Table 6
Quantification of amino acids, fatty acids and sterols in M. glacialis samples.
Peak RIExp RILit Compound Marthasterias glacialis
Jul09-A Sep09-A FeB10-B Feb10-C
Amino acids Average mg/100 g (7SD)
1 1096 1095 [41] Alanine – 279.34 (19.87) 319.46 (1.20) 956.50 (73.61)
2 1115 Glycine 957.46 (89.13) 1520.42 (85.48) 1213.07 (251.30) 1969.08 (218.50)
3 1210 1210 [42] Valine 18.14 (0.01) 30.36 (0.11) 23.80 (3.47) 105.94 (5.22)
4 1250 1262 [43] Leucine 40.26 (5.26) 57.20 (2.60) 52.16 (1.08) 94.30 (3.39)
5 1274 1290 [41] Isoleucine 20.08 (0.87) 25.63 (2.33) 28.71 (0.97) 57.61 (5.21)
6 1286 1299 [42] Proline 48.91 (1.04) 29.28 (0.20) 23.91 (6.33) –
7 1352 1343 [43] Serine 100.57 (1.45) 69.62 (6.01) 56.24 (16.28) –
8 1364 1367 [43] Threonine 21.44 (0.72) 30.30 (4.19) 21.25 (3.47) 25.10 (3.79)
9 1500 trans-4-Hydroxyproline 94.88 (1.43) 131.26 (9.17) 37.79 (4.64) –
10 1619 1622 [43] Phenylalanine 11.22 (0.16) 38.94 (4.01) 33.80 (8.02) 65.46 (15.67)
Total 1312.96 (94.75) 2212.34 (133.98) 1810.19 (231.29) 3273.99 (269.27)
Fatty acids
11 1837 1843 [43] Myristic 316.46 (5.53) 96.15 (1.68) 23.87 (7.89) 334.74 (9.97)
12 1938 1943 [43] Pentadecanoic 141.37 (0.73) 71.53 (6.03) 74.64 (18.25) 147.69 (2.90)
13 2043 2040 [43] Palmitic 538.31 (68.28) 293.98 (4.68) 180.96 (14.99) 288.06 (10.37)
14 2147 Margaric 73.78 (0.33) 48.21 (0.43) 14.36 (0.20) 26.83 (0.21)
15 2214 2212 [44] Linoleic oLOQ – oLOQ –
16 2225 2218 [44] Linolenic – – 27.35 (2.20) 27.85 (0.32)
17 2238 2248 [44] Oleic 27.76 (0.69) 44.49 (9.19) 21.73 (2.68) 19.63 (0.38)
18 2253 2234 [44] Stearic 251.87 (0.88) 157.56 (0.92) 62.55 (0.69) 124.04 (0.66)
19 2389 2373 [43] Arachidonic 444.20 (10.23) 267.82 (0.35) 425.13 (16.61) 602.34 (7.05)
20 2398 2380 [44] Eicosapentaenoic 240.48 (9.14) 144.30 (1.04) 215.26 (5.52) 303.84 (5.30)
21 2404 2413 [39] cis11,14-Eicosedienoica 213.42 (18.77) 144.26 (7.12) 137.86 (3.96) 239.51 (22.14)
22 2425 cis11-Eicosenoic isomera 438.09 (38.03) 243.24 (2.74) 190.45 (11.84) 252.09 (17.61)
23 2430 2420 [39] cis11-Eicosenoic 374.67 (48.09) 265.36 (11.90) 181.42 (8.67) 207.19 (6.18)
24 2585 2562 [43] Docosahexaenoic 63.28 (3.25) 117.89 (3.89) 99.72 (3.79) 72.19 (2.58)
Total 3132.60 (23.82) 1895.12 (9.94) 1653.33 (14.10) 2645.16 (6.78)
Sterols
25 2938 Cholesta-3,5-diene – 34.72 (0.22) – 51.57 (0.50)
26 3176 Mþ 458 m/z (73(100), 369(88), 330(82), 75(75), 95(74), 129(72), 458(70), 81(51), 146(49), 91(48))b – – 22.29 (2.25) 90.16 (0.11)
27 3181 Mþ 456 m/z (344(100), 73(83), 81(70), 118(68), 95(60), 69(59), 148(58), 97(54), 75(54), 256(52))b – oLOQ 27.81 (2.65) –
28 3190 Mþ 462 m/z (75(100), 216(88), 217(51), 446(38), 93(30), 356(28), 148(25), 55(25), 202(25), 81(24))b – 29.24 (0.02) 64.05 (2.07)
29 3197 Cholesterol – oLOQ 40.69 (3.40) 44.28 (2.12)
30 3207 Cholestanol – 13.05 (0.20) –
31 3249 Mþ 460 m/z (460(100), 75(45), 255(45), 444(38), 460(35), 213(32), 133(25), 73(25)147(23), 145(23))b 89.87 (4.29) 84.65 (4.94) 169.80 (6.09) –
32 3271 3232 [45] Ergosterol 64.18 (2.66) 45.96 (0.29) 90.14 (5.02) 65.61 (2.06)
33 3353 Mþ 474 m/z (472(100), 214(45), 75(39), 55(38), 91(37), 79(34), 119(33), 57(32), 149(30), 256(29))c – 42.63 (1.23) 70.16 (4.48) 97.60 (1.04)
34 3443 Mþ 488 m/z (344(100), 75(80), 256(58), 487(55), 387(49), 93(41), 345(41), 81(36), 55(36), 214(33))d – 22.80 (0.89) 29.25 (4.42) 44.05 (1.60)
35 3454 Mþ 488 m/z (344(100), 387(44), 75(38), 345(37), 254(33), 69(28), 55(21), 214(18), 73(18), 93(17))d – oLOQ 25.71 (3.68) –
Total 152.17 (4.29) 241.89 (7.04) 505.09 (31.95) 457.31 (0.14)
n.i.: not identified.
a Quantified as cis11-eicosenoic acid.
b Quantified as cholesterol.
c Quantified as ergosterol.
d Quantified as b-sitosterol. RIExp—Retention Index obtained in this experiments; RILit—Retention Index described in literature.
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Fig. 2 displays the resulting chromatogram, where it can be seen
that, in addition to the absence of amino acids and sterols, only
6 compounds were identified. On the other hand, when the
method proposed herein was used, about 16 fatty acids were
determined.
Afterwards we used ethanol as extraction solvent, followed by
TMS derivatization, in order to verify if the qualitative and quanti-
tative profile would be affected. As shown in Fig. 3, ethanol
effectively extracted amino acids, fatty acids and sterols. From a
quantitative point of view, the amounts of fatty acids extracted
exceeded those obtained with chloroform:methanol (Fig. 4). Water:-
ethanol (1:1) was also tested as extraction solvent, but the high
lipidic content caused insolubilization in water and, for this reason,
this solvent was not used. Given the fact that our ethanol extraction
and chromatographic conditions allowed the simultaneous identifi-
cation of amino acids, fatty acids and sterols, we used them in
subsequent studies. In addition, it has the advantage of using a cheapand non-hazard solvent (ethanol). Also, derivatization with MSTFA
allows the use of mild temperatures (40 1C), while standard boron
trifluoride method requires temperatures around 90 1C [23].
After this point, we studied the effect of the temperature in the
extraction efficiency of ethanol: 40 1C, 50 1C and 60 1C were
tested. As it can be seen in Fig. 4, extraction at 40 1C was the
most effective for amino acids. The highest temperature assayed,
60 1C, resulted in high standard deviation indicating that some
loss or reaction took place.
Regarding fatty acids, no major differences were noticed between
different temperatures (Fig. 4). In the case of sterols, efficiency of
extraction was highly affected by temperature, 40 1C being the most
suitable one. After confirming that ethanol at 40 1C with magnetic
stirring at 200 rpm was the most effective extraction procedure, we
investigated the contribution of ultra-sonication (US) to the total
amount of metabolites extracted. Although US clearly increased the
level of extracted fatty acids, its low efficiency concerning both
sterols and amino acids (Fig. 4) prevented its use and hence, all the
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ethanol as extraction solvent, at 40 1C, for 20 min, with a magnetic
stirrer set at 200 rpm. This procedure represents an advantage when
compared with other methods for fatty acids [7], amino acids [4,19]
and sterols [5,23] that are time-consuming and employ high tem-
peratures, which can result in the advent of artifacts or loss of
analytes.
3.2. Method performance
In this work we developed a method for a quick screening
analysis that renders both identification and quantification ofthree distinct classes of metabolites, useful for routine analysis
and comparisons of samples. For this reason, among the several
experimental conditions assayed, we selected the one that repre-
sented a compromise between the three classes. In this matter,
ethanol at a temperature of 40 1C was the one that scored better
results for 2 out of 3 classes.
3.2.1. Linearity
The linearity of the method was tested using calibration
solutions prepared as described in the Experimental section.
Internal standards for each class of compounds were used in
order to account for analyte losses and matrix effect. Calibration
curves were constructed by plotting the analyte/IS peak areas
ratio obtained against the concentration values.
Good linearity for the concentration range studied was
obtained for all compounds from the different chemical classes,
as can be observed in Table 1, with correlations coefficients higher
than 0.9844. Among the three classes, amino acids were those
with best results (Table 1).
3.2.2. Recovery, precision and reproducibility
Ideally, all compounds addressed should be tested for recovery
values. However, this becomes increasingly harder as the number
of metabolites to be analyzed rises. Due to the diversity and
complexity of metabolites present, in metabolomics of natural
matrices it is not usual to determine the efficiency of the
extraction of all of the compounds and the most abundant or
more characteristic of each class are selected [26,27]. For this
reason, and taking into account that we describe the identification
and quantification of over 40 compounds, we decided to use two
compounds of each class: isoleucine and trans-4-hydroxyproline
for amino acids, palmitic acid and arachidonic acid for saturated
and unsaturated fatty acids, respectively, and cholesta-3,5-diene
and cholestanol for sterols, although we also tested other com-
pounds, for example eicosapentaenoic acid (40 mg/ml—91%
recovery; 80 mg/ml—95% recovery and 200 mg/ml—92% recovery)
in order to check whether the method was acceptable.
Given the fact that over 15 fatty acids can be analyzed with
this method, it is difficult to choose an internal standard that
represents all compounds present equally. Furthermore, the fact
that about 40 compounds are eluted in a 25 min run turns this
issue even more difficult. For this reason, we choose methyl
linolelaidate as internal standard for fatty acids as it was not
present in the samples and did not co-elutes with any of the
compounds.
Table 2 summarizes the results obtained for the analysis, in
triplicate, of three concentrations levels. As can be observed, in
the case of amino acids best recoveries were obtained for trans-
4-hydroxyproline when compared to isoleucine. Similar recovery
values were obtained for both palmitic and arachidonic acids
(higher than 93%). Finally, sterols also showed good recoveries,
varying between 92 and 106%.
Results for accuracy and precision can be found in Tables 3–5.
The intraday variations (RSD) for the standard compounds ranged
from 0.05 to 13.19% (n¼3), being generally lower than those of
the interday studies. Among the four classes, amino acids pre-
sented the smaller variations regarding both accuracy and
precision.
3.2.3. Limit of detection and limit of quantification
In general, amino acids were the class yielding the lowest LOD
and LOQ. LOD ranged between 0.03 and 2.68 mg/mL, for proline
and cysteine, respectively. LOQ varied from 0.11 to 8.92 mg/mL for
the same compounds, respectively (Table 1). Recently, a GC–MS
method for the analysis of several amino acids was described [28].
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different M. glacialis samples. Data are means 7SD (n¼3).
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methyl chloroformate derivatization; however, quantification
was obtained by applying deuterated derivatization reagents
and, for this reason, it can be too expensive for routine screening
analysis.
Regarding fatty acids, oleic acid was the compound with lower
LOD and LOQ, 0.14 mg/mL and 0.48 mg/mL, respectively. Some
recent works report the fatty acids profile of marine organisms
[29–32]. Nevertheless, in most cases no complete validation data
is available, which renders direct comparison difficult. Further-
more, quantification is frequently presented as percentage and
not as absolute amounts [29,31,33,34].
3.3. Profiling of the echinoderm M. glacialis
In 2010 it was possible to collect organisms in the same month
from two different sites (Praia do Baleal and Praia da Consolac- ~ao,
samples Fev10-B and Fev10-C, respectively) and, for this reason,
direct comparison regarding the influence of geographical origin
can be established. Sample Fev10-C presented ca. 80% higher
amounts of amino acids than that from Baleal (Fev10-B) (Table 6).
A similar trend was found for fatty acids, with organisms from
Consolac- ~ao having 40% more when compared to that of Baleal.
Unsaturated fatty acids are major compounds in both samples
(Table 6). In the case of sterols, no important changes between
both locations were noticed (Fig. 5).
For the study of the influence of the season in the chemical
composition, samples from the same geographical origin, Cabo
Carvoeiro (samples Jul09-A and Set09-A), were used. Overall,
samples from September had higher amounts of sterols and
amino acids, with both classes displaying an increase of around
70% when compared to their July homologs (Fig. 5). Glycine was
always the compound present in higher amounts (Table 6).
In the case of fatty acids, samples from September displayed a
decrease in total amounts of around 35%. Both saturated and
unsaturated free fatty acids have been described in echinoderms
from Asteroidea, Holothuroidea and Echinoidea [35–37]. In the
case of sea stars, palmitic acid is frequently the compound
present in higher amounts, which may constitute a defense
mechanism given its antifouling properties [36]. Our results show
that in the case of M. glacialis this is only true for samples
collected in July and September. As it can be seen in Table 6, in
samples collected in February arachidonic acid was the major
compound, far exceeding palmitic acid. It should be highlighted
that among all samples studied, unsaturated fatty acids were
present in higher amounts than saturated ones (Table 6).
Regarding sterols and lupanes, there was a clear distinction
between samples from February and July/September, with the
former displaying higher amounts of sterols and also greater
diversity. Compounds 26 and 28 were found solely in organisms
from February (Table 6). Ergosterol was the only compound
present in all analyzed samples, while b-sitosterol, fucosterol,
betulin, lupeol and lupeol acetate could not be found in any of
them. However, a compound similar to b-sitosterol (34) was
present in all samples, excepting in sample Jul09-A. In fact, when
analyzing sterols we found several compounds whose mass
spectra closely resembled those of cholesterol (compounds 26,
27 and 28), ergosterol (33) and b-sitosterol (compounds 34 and
35). We compared the mass fragmentation of these unknowns
with some published MS data for sterols, such as brassicasterol,
ergosta-7,22-dienol, ergosta-5,7-dienol, ergosta-7-enol [38], but
no matches were found.
Apart from the interest of these metabolites for their bioactiv-
ity, the knowledge of the composition of these organisms can also
be exploited from a chemico-ecological point of view. For
instance, in the case of fatty acids most animals are unable tosynthesize longer chain polyunsaturated fatty acids, such as EPA
and DHA, obtaining them by preying on organisms from lower
trophic levels, like bacteria and phytoplankton [31,39]. The same
trend can be found in the case of sterols, which are synthesized by
algae and plants [40].4. Conclusions
In this work, we report a GC–MS method for metabolite
profiling of extracts of marine organisms. This approach consti-
tutes a fast and powerful option for the identification and
quantification of amino acids, fatty acids, sterols and lupanes in
marine organisms. The extraction procedure is simple and
D.M. Pereira et al. / Talanta 100 (2012) 391–400400employs ethanol at mild temperatures, thus preventing degrada-
tion of sample or the production of artifacts. Since no purification
or pre-treatment of samples are required the loss of analytes is
minimized. The extraction method and the analytical method
here developed appear to be good analytical tools available to
researchers, for other matrices than marine organisms containing
amino acids, fatty acids, sterols and lupanes.Acknowledgments
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Marine organisms have been increasingly regarded as good sources of new drugs for human therapeutics
and also as nutrients for human diet. The amino acids, fatty acids and sterols profiles of the widely con-
sumed echinoderms Paracentrotus lividus Lamarck (sea urchin), Holothuria forskali Chiaje (sea cucumber),
the gastropod molluscs Aplysia fasciata Poiret and Aplysia punctata Cuvier (sea hares), from Portuguese
waters, were established by GC–MS analysis. Overall, 10 amino acids, 14 fatty acids and 4 sterols were
determined. In general, all species presented the 10 amino acids identified, with the exceptions of
H. forskali, in which no glycine, proline, trans-4-hydroxy-proline or phenylalanine were found, and of
A. fasciata which did not contain proline. Unsaturated fatty acids were predominant compounds, with
those from the x-6 series, being in higher amounts than their x-3 homologues, and cholesterol being
the main sterol. The amino acids, fatty acids and sterols qualitative and quantitative composition of A.
fasciata, A. punctata and H. forskali is reported here for the first time.
 2013 Elsevier Ltd. All rights reserved.1. Introduction
Marine organisms have been increasingly regarded as a promis-
ing source of new bioactive molecules for the pharmaceutical
industry. In addition, many echinoderms and molluscs are re-
garded as excellent sources of nutritionally important compounds,
such as fatty acids (Latyshev, Kasyanov, Kharlamenko, & Svetashev,
2009; Ozogul, Duysak, Ozogul, Özkütük, & Türeli, 2008; Usydus,
Szlinder-Richert, Adamczyk, & Szatkowska, 2011), amino acids
(Hamdi, 2011; Xu, Yan, & Xu, 2012; Zarai et al., 2011) and sterols
(Kanazawa, 2001; Kandyuk, 2006; Zhukova, 2007).
Fatty acids are essential for life, due to their pivotal role as a
source of energy, membrane constituents, as well as metabolic
and signalling mediators. Compounds with two or more double
bonds are named polyunsaturated fatty acids (PUFA) and the posi-
tion of the first double bound is given by the (n–x) notation, count-
ing the number of carbon atoms from themethyl group (thex end).
A review on the chemistry and distribution of fatty acids, in marine
animals, was recently published (Pereira et al., 2011). Due to their
positive impact on human health, alternative sources of PUFA are
being pursued, with marine sources being increasingly regarded
as good alternatives. Within PUFA,x-3 compounds are particularly
relevant, as they have already proved to have a positive impact onhuman health (Miles, Banerjee, & Calder, 2004; Miles & Calder,
2012; Rees et al., 2006). For example, x-3 fatty acids have been
shown to ameliorate some inflammatory conditions (Calder,
2008) and to improve cardiovascular status (Cawood et al., 2010;
Studer, Briel, Leimenstoll, Glass, & Bucher, 2005).
Amino acids are determinant metabolites in the homeostasis of
an organism, mainly due to their role as protein building blocks, in
the regulation of several cellular processes and also as precursors
of other molecules, such as hormones and nitrogenous bases
(Wu, 2009). Given the fact that some of these compounds (essen-
tial amino acids) cannot be synthesised by humans, a diet rich in
this class of metabolites is mandatory for a healthy organism.
The term sterol refers to a compound with a fused cyclopentan-
ophenanthrene ring with a 3-hydroxyl moiety. These compounds
have been regarded to have a positive impact on human health,
mainly due to their hypocholesterolemic activity, that arises from
their marked similarity with cholesterol, thus competing for
absorption (Plat et al., 2012; Vanstone, Raeini-Sarjaz, Parsons, &
Jones, 2002;Ostlund, 2002).
In a previous work, we have developed a method for the
simultaneous determination of several classes of metabolites in
marine organisms, including amino acids, fatty acids and sterols
(Pereira et al., 2012). In the present work, four macro invertebrates
were analysed. The metabolic profile of two molluscs (Aplysia
fasciata Poiret and Aplysia punctata Cuvier) is reported here for
the first time. Two echinoderms, Holothuria forskali Chiaje and
D.M. Pereira et al. / Food Chemistry 141 (2013) 2412–2417 2413Paracentrotus lividus Lamarck, were also studied and the metabolic
profile of the former is described here for the first time; some stud-
ies are available regarding the latter (Arafa, Chouaibi, Sadok, & El
Abed, 2012; Martínez-Pita, García, & Pita, 2010; Mol, Baygar,
Varlik, & Tosun, 2008), but, to our knowledge, no absolute
quantification has been reported. These echinoderms are
consumed worldwide (Andrew et al., 2002; FAO, 2008) and a
detailed knowledge of their chemical composition is needed.2. Material and methods
2.1. Standards and reagents
Nonanoic acid (P99%), decanoic acid (P99%), lauric acid
(P95%), myristic acid (P99%), pentadecanoic acid (P99%), pal-
mitic acid (P99%), margaric acid (P98%), stearic acid (P99%), ara-
chidonic acid (P99%), linolenic acid (P99%), methyl linolelaidate
(P99%), oleic acid (P99%), 5,8,11,14,17-eicosapentaenoic acid
(EPA) (P99%), cis-11,14-eicosadienoic acid (P98%), cis-11-eicosae-
noic acid (P99%), docosahexaenoic acid (DHA) (P98%), arachidic
acid (P97%), arginine (P98%), asparagine (P98%), aspartic acid
(P98%), cysteine (P98%), glutamic acid (P98%), glutamine
(P98%), histidine (P98%), lysine (P98%), methionine (P98%),
tryptophan (P98%), tyrosine (P98%), alanine (P98%), glycine
(P99%), valine (P98%), leucine (P98%), isoleucine (P98%), proline
(P99%), serine (P99%), threonine (P98%), trans-4-hydroxy-
proline (P98%), phenylalanine (P98%), norvaline (P99%), chole-
stan-3,5-diene (P95%), 5-a-cholestan-3-ol (P95%), cholestanol
(P99%), ergosterol (P95%), b-sitosterol (P97%), desmosterol
(P85%) and N-methyl-N-(trimethylsilyl) trifluoroacetamide
(MSTFA) were from Sigma and ethanol was from Panreac.
2.2. Organisms
Samples were from Portuguese waters: H. forskali and P. lividus
were collected in the area of Peniche (west Portugal coast), in Sep-
tember 2009; A. fasciata was collected in October, 2009 and A.
punctata in July, 2010, both in the Óbidos lagoon (Foz do Arelho).
Specimens were placed on ice and transported to the laboratory.
The organisms were then cleaned and washed with sea water. In
the case of P. lividus, individuals were cracked and the coelomic
fluid and gonads collected. Samples were kept at 20 C, prior to
freeze-drying in a Labconco 4.5 Freezone apparatus (Kansas City,
MO, USA). The dried material was powdered and sifted
(<910 lm) before extraction. Each sample corresponds to a mix-
ture of 2–4 individuals.
2.3. Metabolites extraction
Each sample (100 ± 1.00 mg) was transferred to a glass vial and
the internal standards for amino acids (norvaline), fatty acids
(methyl linolelaidate) and sterols (desmosterol) were added. The
volume was then made up to 2 ml with ethanol. The mixture
was stirred at 200 rpm, for 20 min, at 40 C. The extract was fil-
tered and 50 ll was transferred to a glass vial. The solvent was
evaporated under a nitrogen stream and 50 ll of the derivatization
reagent, MSTFA, was added to the residue. The vial was capped,
vortexed and heated for 20 min in a dry block heater, maintained
at 40 C. All extractions and analysis were performed in triplicate.
2.4. GC–MS analysis
The GC–MS conditions used herein were the ones used by Pere-
ira et al. (2012). A Varian CP-3800 gas chromatograph coupled to a
Varian Saturn 4000 mass selective ion trap detector (USA) and aSaturn GC/MS workstation software version 6.8 was used, with a
VF-5 ms (30 m  0.25 mm  0.25 lm) column (VARIAN). A Comb-
iPAL automatic autosampler (Varian, Palo Alto, CA) was used for
all experiments. The injector port was heated to 250 C and the
injections were performed in split mode, with a ratio of 1/40.
The carrier gas was helium C-60 (Gasin, Portugal), at a constant
flow of 1 ml/min. The Ion Trap detector was set as follows: transfer
line, manifold and trap temperatures were 280, 50, and 180 C,
respectively. The mass ranged from 50 to 600 m/z, with a scan rate
of 6 scan/s. The emission current was 50 lA and the electron mul-
tiplier was set in relative mode to an auto tune procedure. The
maximum ionisation time was 25.000 ls, with an ionisation stor-
age level of 35 m/z. The injection volume was 2 ll and the analysis
was performed in Full Scan mode. The oven temperature was set at
100 C for 1 min, then increasing 20 C/min to 250 C, held for
2 min, 10 C/min to 300 C and held for 10 min. All mass spectra
were acquired in the electron impact (EI) mode. Identification of
compounds was achieved by comparison of their mass spectra,
with those from pure standards analysed under the same condi-
tions, and from the NIST05 MS Library Database.
For quantification purposes, each sample was injected in tripli-
cate and the amount of metabolites was determined from the cal-
ibration curves of the respective trimethylsilyl (TMS) standards. All
compounds were quantified in Full Scan mode, with the exception
of linoleic (m/z 262, 337 and 352), linolenic (m/z 191, 335 and 350)
and oleic (m/z 264, 339 and 354) acids that were quantified, by the
area obtained from the re-processed chromatogram, using the
characteristic m/z fragments.3. Results and discussion
The technique used in this study was first validated with the
echinoderm Marthasterias glacialis L. (Pereira et al., 2012). For this
reason, in our work, recovery experiments for the analysed species
were conducted (Table 1). Representative compounds of the three
classes studied were used: isoleucine (amino acids), hexadecanoic
acid (fatty acids) and 5-a-cholestan-3-ol (sterols). Two different
concentrations were tested, one lower and the other higher, and
the values of recovery were in the ca. 89–117% range, with the
exception of the lower concentration of hexadecanoic acid in H.
forskali, which corresponded to ca. 65%. However, this low value
of recovery was found solely for H. forskali and for this particular
compound, which could be a consequence of a matrix effect and
not be related to the technique itself. Recovery for isoleucine was
in the range ca. 93–112% and 5-a-cholestan-3-ol was ca. 92–117%.3.1. Amino acids
The majority of the 10 amino acids detected (Fig. 1), could be
found in all samples, with the exception of glycine, trans-4-hydro-
xy-proline and phenylalanine, which were not detected in
H. forskali, and of proline which was not found in neither this spe-
cies or in A. fasciata (Table 2). A. punctata contained the highest
amount of amino acids, followed by P. lividus (Table 2).
In both Aplysia species and in H. forskali the major amino acid
was alanine, which accounted for over 49% of the determined ami-
no acids. In contrast to this, in the echinoderm P. lividus glycine
was the major amino acid (Table 2), a trend that has already been
reported in the echinoderm M. glacialis, collected in different sea-
sons and in locations similar to those of the sample used herein
(Pereira et al., 2012).
Threonine was the amino acid present in lower amounts in
Aplysia sp., whilst in the echinoderms P. lividus and H. forskali,
phenylalanine and valine were the minor amino acids, respectively
(Table 2).
Table 1
Recovery values (%) ± standard deviation obtained for representative compounds of amino acids, fatty acids and sterols.
Compound Concentration, lg/ml Mollusca Echinodermata
A. punctata H. forskali P. lividus
Isoleucine 1.66 93.7 ± 6.8 94.5 ± 1.2 99.9 ± 0.6
18.8 92.9 ± 1.7 113 ± 4.0 112 ± 5.8
Hexadecanoic acid 15.9 95.6 ± 8.6 64.6 ± 14.3 104 ± 3.7
110 117 ± 10.3 98.9 ± 2.3 88.6 ± 1.9
5-a-Cholestan-3-ol 7.41 117 ± 10.7 107 ± 15.1 98.9 ± 0.1
34.1 92.3 ± 1.5 92.3 ± 1.4 96.8 ± 8.7
Fig. 1. GC–MS profile of A. punctata and P. lividus. Peak identification as in Tables 2 and 3. A, norvaline; B, methyl linolelaidate; C, desmosterol.
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Regarding fatty acids, amongst all species studied, 14 com-
pounds were identified and 12 of them could be quantified
(Fig. 1, Table 2).
Differences between the four analysed species were found. A.
punctata, P. lividus and H. forskali displayed higher amounts of
unsaturated fatty acids when compared with saturated derivatives.
In contrast to this, in A. fasciata saturated fatty acids exceeded
unsaturated ones. In all samples, x-6 fatty acids were predominant
comparatively to x-3 compounds (Fig. 2). P. lividuswas the species
with higher amounts of fatty acids, and also with the highest
unsaturated/saturated compounds ratio (Fig. 2, Table 2). H. forskali
was the species with the lowest fatty acids content.Some work regarding the identification and quantification of
saturated fatty acids in sea cucumbers is available (Aydin, Sevgili,
Tufan, Emre, & Kose, 2011), although none addressed the species
studied herein (H. forskali). Aydin et al. (2011) evaluated the fatty
acids composition of Holothuria tubulosa Gmelin, Holothuria poli
Delle Chiaje and Holothuria mammata Grube, and found that pal-
mitic and stearic acids, were the saturated fatty acids present in
higher levels. The results were expressed as a percentage and no
absolute quantification was reported. Our results confirmed this
trend in H. forskali (Table 2). Regarding unsaturated fatty acids,
we found that cis-11-eicosaenoic and arachidonic acids were the
two compounds present in higher quantities in H. forskali (Table 2).
The former is not reported in H. tubulosa, H. poli and H. mammata;
however, it has been described before in Holothuria fuscogilva
Table 2
Primary metabolites in Mollusca and Echinodermata species analysed in this work (mg/100 g).a
Peak Compound Mollusca Echinodermata
A. fasciata A. punctata H. forskali P. lividus
Mean STD Mean STD Mean STD Mean STD
Amino acids
1 Alanine 340 46.0 353 30.6 181 22.9 199 41.8
2 Glycine 71.1 4.59 98.5 0.10 – – 323 14.0
3 Valine 35.5 2.81 19.7 1.90 7.74 0.91 15.9 0.14
4 Leucine 46.3 6.51 50.0 1.27 68.7 2.26 29.3 5.49
5 Isoleucine 17.0 0.29 17.5 2.82 14.7 2.61 18.3 2.00
6 Proline – – 19.8 2.42 – – 22.1 12.8
7 Serine 33.5 2.26 37.0 2.42 31.7 0.17 41.9 7.71
8 Threonine 9.92 1.36 16.2 1.00 7.87 1.49 18.2 0.40
9 trans-4-Hydroxy-proline 26.2 1.81 68.5 11.1 – – 18.1 0.40
10 Phenylalanine 27.8 6.34 34.3 8.04 – – 10.9 0.60
Total 608 54.1 714 30.2 311 25.9 697 82.3
Fatty acids
11 12:0 Dodecanoic – – – – <LoQ – – –
12 14:0 Tetradecanoic <LoQ – <LoQ – <LoQ 144 17.0
13 15:0 Pentadecanoic 61.1 1.07 49.6 5.36 <LoQ – <LoQ –
14 16:0 Palmitic 136 2.48 152 1.60 69.1 0.45 155 16.5
15 17:0 Heptadecanoic 24.9 1.46 15.7 0.54 – – <LoQ –
16 18:2 Linoleic <LoQ – <LoQ – – – <LoQ –
17 18:3 Linolenic 44.6 1.23 44.6 1.23 – – 29.4 0.81
18 19:1 Oleic 19.0 1.18 30.9 1.20 16.8 0.32 31.8 3.63
19 18:0 Stearic 55.5 1.84 91.8 0.66 50.4 10.0 60.1 2.07
20 20:4 Arachidonic 59.5 5.00 76.2 4.50 81.0 8.32 296 23.2
21 20:5 5,8,11,14,17-Eicosapentaenoic <LoQ – 42.4 1.95 <LoQ – 229 17.1
22 20:2 cis-11,14-Eicosadienoic 64.0 5.45 83.7 8.42 <LoQ – 199 13.4
23 20:1 cis-11-Eicosaenoic 84.3 5.86 153 11.2 83.4 4.04 105 2.91
24 22:6 Docosahexaenoic <LoQ – 63.5 0.96 <LoQ – 56.4 2.28
Total 529 9.62 711 12.2 301 14.4 1375 140
a Compounds listed correspond to their TMS derivatives and quantification results from three determinations. STD: standard deviation. LoQ: Limit of quantification.
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Fig. 2. Ratio of saturated/unsaturated fatty acids and x-3/x-6 compounds in the
studied species.
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was found not to be the major compound (Wen, Hu, & Fan,
2010). In the case of arachidonic acid, the available studies point
this compound as the predominant unsaturated fatty acid, in all
of the above-mentioned species (Aydin et al., 2011; Wen et al.,
2010).
To our knowledge, the work presented herein is the first to ad-
dress the absolute quantification of fatty acids in P. lividus. Previous
work concerning the fatty acid composition of this species, col-
lected in several locations, described palmitic, stearic and tetra-
decanoic acids as the predominant saturated fatty acids
(Kalogeropoulos, Mikellidi, Nomikos, & Chiou, 2012; Zlatanos,
Laskaridis, & Sagredos, 2009). Other studies, focused on the influ-
ence of the season on the fatty acids composition of this organism,
found that although the proportion of unsaturated/saturated fatty
acids varied during the year, the major compounds were usually
the same and indicated tetradecanoic and palmitic acids as the ma-
jor saturated fatty acids (Arafa et al., 2012; Mol et al., 2008). We
have confirmed this trend in our samples, collected in the Atlantic
sea, along the coast of Portugal.
Regarding the unsaturated fatty acids, we found arachidonic,
EPA and cis-11,14-eicosadienoic acids to be the predominant com-
pounds in P. lividus. Whilst a number of studies are in harmony
with these results (Arafa et al., 2012; Kalogeropoulos et al.,
2012), EPA was found to be the major compound in a study carried
out by Mol et al. (2008), but no arachidonic acid was reported. In-
stead, oleic and 13,16-docosadienoic acids were found to be the
major unsaturated fatty acids.
Little is known about the chemical composition of the species
from the Aplysia genus. Some bioactive compounds have been
characterised (Ortega, Zubía, & Salvá, 1997; Spinella et al., 1992),
but, as far as we are aware, the fatty acids composition of A. fasciata
Table 3
Sterols in Mollusca and Echinodermata species analysed in this work (mg/100 g).a
Peak Compound Molluska Echinodermata
A. fasciata A. punctata H. forskali P. lividus
Mean STD Mean STD Mean STD Mean STD
25 Cholesterol 177 11.8 202 7.55 <LoQ – 400 48.1
26 Cholesterol derivativeb – – 26.4 3.75 – – – –
27 Choleste-7-ene-3-ol – – – – <LoQ – – –
28 b-Sitosterol – – – – – – 17.7 1.72
Total 177 11.8 228 3.80 – – 418 49.8
a Compounds listed correspond to their TMS derivatives and quantification results from three determinations. STD: standard deviation. LoQ: limit of quantification.
b Tentatively identified based on its mass fragmentation.
2416 D.M. Pereira et al. / Food Chemistry 141 (2013) 2412–2417and A. punctata has not been addressed before. The chromato-
graphic profile of these two species revealed a marked similarity,
both from qualitative and quantitative points of view. Fatty acids
were present in higher amounts in A. punctata, although in both
species, palmitic acid was the main saturated fatty acid and cis-
11-eicosaenoic acid the predominant unsaturated fatty acid
(Table 2).
3.3. Sterols
In the past few years, the chemistry of marine sterols has grown
steadily, with the identification of several compounds with
remarkable chemical diversity. Over 200 ‘‘classical’’ sterols,
displaying a 3b-hydroxy-D5-cholestane nucleus and a C8–C10 side
chain, have been described (Goad, 1978). New classes of
compounds have been reported, remarkably in sponges (Sarma,
Sri Rama Krishna, & Ramakrishna Rao, 2005). Sterols are wide-
spread compounds in marine organisms due to their biological
importance, namely as components of membranes, but also as a
chemical defence against predation and environmental conditions
(Bernsdorff & Winter, 2003; Chen & Tripp, 2012; Edidin, 2003).
In general, only cholesterol, b-sitosterol and one cholesterol
derivative could be quantified in the analysed species. One minor
compound, choleste-7-ene-3-ol, was found in H. forskali (Fig. 1,
Table 3). The species with the highest sterols content was P. lividus.
Many other compounds were searched, including ergosterol
and its derivatives, stigmasterol, campsterol and other cholesterol
derivatives, though none could be found. The presence of high
amounts of cholesterol, in marine organisms, has been proved to
constitute a chemical defence, due to the antifouling properties
of this compound (Guenther, Wright, Burns, & de Nys, 2009).
4. Conclusion
The amino acids, fatty acids and sterols composition of twomol-
luscs and two echinoderms has been investigated. Twenty-eight
compounds were identified and quantified. To our knowledge, this
is the first report on the amino acids and fatty acids composition of
Aplysia spp. and H. forskali. Regarding P. lividus, our data confirms
most of the compounds identified previously and, in addition to
this, we provide the first quantification of these compounds.
This work shows that these species may constitute alternative
sources of molecules, with nutritional and biomedical interest. In
particular, the species presented herein can be interesting candi-
dates to be part of diets rich in amino acids and polyunsaturated
fatty acids.
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Abstract: Marine organisms have been increasingly regarded as an excellent source of bioactive 
molecules for human health. As part of an on-going study to elucidate the chemical composition and 
biological activity of this organism, we report here the lipidomic profile of this organism and screening 
for anticancer activity. Two classes of biologically active metabolites were identified and quantified by a 
GC-MS optimized for screening several classes of metabolites in a single run. Free fatty acids and sterols 
were found, including ergosterol, β-sitosterol and cholesterol derivatives, some of which are reported in 
this species for the first time. The extract was screened for its ability to affect cell viability (MTT), 
membrane integrity (LDH) and cell density (SRB) of three human cancer cell lines: human oestrogen 
receptor-positive (ER+) breast cancer (MCF-7), human neuroblastoma (SH-SY5Y) and human colon 
cancer (Caco-2). Differential activity towards the three cancer cell lines was found, with the SH-SY5Y 
cell line being the most susceptible. No activity was found for Caco-2 cell line. Non-cancer cell lines 
(human dermal fibroblasts and human foreskin fibroblasts) were also tested and revealed to be less 
susceptible. This work establishes M. glacialis as a potential source of bioactive molecules for further 
studies. 
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2. INTRODUCTION 
 
Natural sources have been very 
important from an historical point of view, 
given the fact that they were the origin of the 
first drugs and medicines used in human health 
[1]. Even today they play a relevant role in 
providing new molecules, which is easily 
pictured if we consider that nearly 60% of all 
drugs introduced in therapy between 1981 and 
2006 were first identified or inspired in natural 
products  [2].  
 Nowadays marine resources are paving 
their way as alternative sources of novel 
chemical entities with biological activities [3-6]. 
In fact, some drugs have already been approved 
to be used in human therapy [7, 8], a trend that 
is expected to increase in the next few years as a 
consequence of the high number of molecules 
that are currently involved in clinical trials. The 
most frequent bioactivities reported include 
anticancer, antibacterial, anti-inflammatory and 
immune modulation [4, 6, 9, 10]. 
Marthasterias glacialis (spiny sea-star) 
is an asteroid echinoderm, a group that has 
demonstrated to play one of the most influential 
roles in benthic ecosystems on a variety of 
scales [11]. During the 70’s-80’s this species 
received great attention, mainly due to its 
asterosaponins [12, 13]. 
In a previous work developing a non-
targeted approach, we have demonstrated that 
extracts of M. glacialis contained appreciable 
amounts of carotenoids and other lipids and an 
inhibitory effect upon the growth of two murine 
cell lines was shown [14, 15]. Given the fact 
that these preliminary studies showed the 
interest of this matrix from a biological point of 
view, the chemical composition and biological 
effects were further studied.  
 In this work a purification process 
optimized for lipophilic compounds was used 
and characterized using gas chromatography 
coupled to mass spectrometry (GC-MS). The 
biological effects of the resulting extract on 
viability, membrane integrity and cell density 
were investigated in three human cancer cell 
lines: colon cancer (Caco-2), oestrogen 
receptor-positive (ER+) breast cancer (MCF-7) 
and neuroblastoma (SH-SY5Y). In addition, in 
order to investigate the selective effect of the 
extract, non-tumour cells were used, namely 
human dermal fibroblasts (HDF) and human 
foreskin fibroblasts (HFF).  
 
 
3. MATERIALS AND METHODS 
 
2.1. Standards and Reagents 
 
 All GC-MS standards, as well as 
(trimethylsilyl) trifluoroacetamide (MSTFA), 
were of chromatographic grade and purchased 
to Sigma (St. Louis, MO, USA). Ergosta-7,22-
dien-3-ol was from BioBioPha Co., Ltd (China). 
Chloroform, methanol, anhydrous sodium 
sulphate and isooctane were from Panreac 
Quimica SA (Barcelona, Spain). Potassium 
hydroxide was obtained from Pronalab (Lisboa, 
Portugal). Dulbecco’s Modified Eagle Medium 
(DMEM), foetal bovine serum (FBS), phosphate 
buffer saline (PBS) and antibiotic were from 
GIBCO (Invitrogen, UK). Tris-base, acetic acid 
and trichloroacetic acid were from Merck 
(Germany). LDH CytoTox 96 non-radioactive 
assay kit was from Promega (Madison, WI, 
USA). 
2.2. Animal Material 
 
 M. glacialis individuals were collected 
in Cabo Carvoeiro, west Portugal, in September 
2009. Samples were immediately frozen, 
transported to the laboratory, lyophilized 
(Labconco 4.5 Freezone apparatus, Kansas City, 
MO) and powdered using an electric blender. 
 
2.3. Extract Preparation 
 
 Acetone:methanol (7:3) was used for 
extraction of 15 g of lyophilized powder. The 
extraction was repeated as many times as 
necessary to render the powder colourless. 
Partial evaporation of the solvent was used in 
order to concentrate the extract. Afterwards, the 
extract was added to a separating funnel with 
equal amount (20 mL) of an ether:hexane 
mixture (1:1). An equivalent volume of 5% 
NaCl was then added. The mixture was 
separated into two phases and the aqueous 
hypophase was collected and re-extracted with 
the ether:hexane mixture until no further 
pigment could be extracted. The organic 
epiphases were then collected and washed with 
water in order to remove all traces of acetone 
and evaporated until dryness in a rotary 
evaporator. All procedures were conducted 
under low light conditions, at room temperature 
and the final residue was kept at -80 ºC in an 
inert atmosphere (nitrogen). 
 
 
 
 
 
3 
 
Table 1 GC-MS Metabolite Profiling of the Lipophilic Purified Extract from M. glacialis 
(Trimethylsilyl Derivatives) 
Peak Compound Concentration (µM)1 
  Fatty Acids  
1 Dodecanoic acid <LoQ 
2 Tetradecanoic acid <LoQ 
3 Pentadecanoic acid 50.6±12.4 
4 Palmitic acid 124.0±14.2 
5 Linoleic acid <LoQ 
6 Linolenic acid <LoQ 
7 Oleic acid 74.2±11.8 
8 Stearic acid 46.4±6.5 
9 Arachidonic acid 75.3±17.26 
10 Eicosapentaenoic acid 36.3±6.7 
11 cis 11,14-Eicosadienoic acid 83.8±2.9 
12 cis 11-Eicosenoic acid 182.2±23.8 
 Sterols   
13 Cholesterol 101.7±7.47 
14 Cholesterol derivativeb 64.4±1.0 
15 Cholestanol 45.4±3.1 
16 Cholesten-7-en-3-ol* 1139.0±78.7 
17 Ergosta-7,22-dien-3-ol 160.5±16.4 
18 Ergosterol derivativec 227.9±25.44 
19 Ergosta-7-en-3-ol* 89.0±14.7 
20 β-Sitosterol derivatived* 112.1±4.1 
 
1 Concentration of compound in a 1 mg/mL solution  of purified extract; b quantified as cholesterol; c 
quantified as ergosta-7,22-dien-3-ol; d quantified as β-sitosterol; * Tentative identification based on mass 
fragmentation pattern. Values represent the mean ± standard deviation of three determinations. LoQ: 
Limit of quantification.  
 
 
2.4. Derivatization for GC-MS Analysis  
 
 A solution of 1 mg/mL of extract in 
ethanol was prepared. 50 μL were then 
transferred to a glass vial, the solvent was 
evaporated under nitrogen stream and 50 μL of 
MSTFA were added to the dried residue. The 
vial was capped, vortexed and heated for 
20 minutes in a dry block heater maintained at 
40º C. All analyses were performed in triplicate. 
 
2.5. GC-MS Analysis 
 
 A method previously developed by our 
group for the simultaneous analysis of amino 
acids, fatty acids, steroids and triterpenes was 
used [15]. All mass spectra were acquired in 
electron impact (EI) mode. For quantification 
purposes, triplicate injections were performed 
and the amount of metabolites was achieved 
from the calibration curves of the respective 
trimethylsilyl (TMS) derivatives. All 
compounds were quantified in Full Scan mode, 
with the exception of linoleic (m/z 262, 337 and 
352), linolenic (m/z 191, 335 and 350) and oleic 
(m/z 264, 339 and 354) that were quantified by 
the area obtained from the re-processed 
chromatogram, using the characteristic m/z 
fragments.  
 
2.6. Cell Culture 
 
 MCF-7 cell line was maintained in 
MEM media with 1 mmol/L pyruvate and 
glutamine, while SH-SY5Y, Caco-2, HDF and 
HFF cell lines were cultured in DMEM. Heat-
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inactivated FBS (10%) and 2% penicillin-
streptomycin (2%) was used in all cases. Caco-2 
and SH-SY5Y cell lines were additionally 
cultured with 1% non-essential amino acids and 
also with human transferrin in the case of the 
Caco-2 cell line. Cells were maintained in an 
incubator at 37 °C and atmosphere of 5% CO2. 
 
 
2.7. Cell Density Assay 
 
The sulphorhodamine B (SRB) method 
used was described before [16]. Briefly, cells 
were seeded in 96-well plates with a density of 
20x104 cells/well for SH-SY5Y and MCF-7 cell 
lines and 30x104 cells/well for Caco-2 cell line. 
Cells were allowed to attach for 24 hours, after 
which the purified extract was added (76–1250 
µg/mL).  
After 24, 48 and 72 hours of 
incubation, media was removed, cells were 
washed with PBS, 100 µL of cold 40% 
trichloroacetic acid was added and plates 
maintained at 4°C for 60 minutes. After this 
time, cells were washed, dried and incubated 
with 0.4% SRB (50 µL) in 1% acetic acid, for 
30 minutes at 4°C. After the incubation period, 
cells were washed with 1% acetic acid to 
remove unbound dye and tris-base (100 µL) was 
added. The absorbance was read at 492 nm and 
OD values were plotted against concentration. 
Three independent assays were conducted, each 
one of them in triplicate. Media was used as a 
negative control. 
 
2.8. Viability Assay 
 
 Cells were cultured in 96-well plates 
with the density mentioned above for SRB assay 
and allowed to attach for 24 hours. After this 
period, cells were cultured for 24, 48 or 72 
hours in the presence or absence of purified 
extract (76–1250 µg/mL) or palmitic acid (15-
30 µM). After incubation, (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT) (0.5 mg/ml final concentration) 
was added to each well and the plate was 
incubated for 2 hours at 37 °C. The formazan 
was dissolved by addition of a 
DMSO:isopropanol mixture (3:1) and quantified 
spectrophotometrically at 540 nm. The results of 
cell viability correspond to the mean of three 
independent experiments performed in triplicate 
and are expressed as percentage of the untreated 
control cells. 
  
2.9. Membrane Integrity 
 
 Lactate dehydrogenase (LDH) release 
was measured after 24, 48 and 72 hours in 
culture media supernatant using CytoTox 96 
non-radioactive cytotoxicity assay kit (Promega, 
Madison, WI, USA) according to the 
manufacturer’s protocol. Absorbance was read 
in a multiplate reader at 492 nm. The results 
correspond to the mean of three independent 
experiments performed in triplicate and 
expressed as fold increase of absorbance in 
treatments versus untreated control cells, 
expressed as arbitrary units. 
 
2.10. Statistical Analysis 
 
 Comparisons of data from different 
groups, controls and treatments, were performed 
using a one-way ANOVA test. Dunnet’s post-
test was used. A P value lower than 0.05 was 
considered statistically significant. 
 
 
3. RESULTS AND DISCUSSION 
 
3.1. Fatty Acids and Sterols in the Lipidome 
of M. glacialis  
 
 The first report regarding the chemical 
composition of M. glacialis addressed its 
carotenoid composition using organisms 
collected in the Adriatic Sea [17]. Subsequent 
works confirmed lutein, zeaxanthin and 
astaxanthin and some isomers as major 
carotenoids in samples from the Atlantic Ocean 
as well [14, 18]. Recently, other metabolites 
were described in crude extracts, namely amino 
acids, fatty acids and sterols [15]. 
In the present work, we used a 
lipophilic extract and subjected the sample to 
GC-MS analysis in order to deepen our 
knowledge on the extract’s chemical 
composition. Using a technique previously 
developed by our group [15], it was possible to 
identify and quantify fatty acids (saturated and 
unsaturated) and sterols. Amino acids were 
searched, however they were not detected, 
which is in line with the lipophilic nature of the 
extract. Fig. 1 shows a representative GC-MS 
chromatogram of the purified extract of M. 
glacialis. When compared with the previously 
published crude extract, in addition to amino 
acids, the fatty acid composition was also 
altered, as unsaturated fatty acids were found to 
be predominant compounds, while crude 
extracts exhibited similar amounts of saturated 
and unsaturated fatty acids [15]. 
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Fig. (1). GC-MS chromatogram of the M. glacialis purified extract. Identity of peaks as in Table 1. 
 
 
 
Palmitic acid (peak 4) was the major 
saturated fatty acid, while cis-11 eicosenoic acid 
(peak 12) was the unsaturated one present in 
higher amounts. In the case of sterols, eight 
compounds could be found. 
The compound present in higher 
amounts, peak 16,  displayed m/z 458 as 
molecular ion and m/z 353, 255 and 213 as the 
most representative fragments, which is 
compatible to a silylated derivative of 
cholesterol with an unsaturation in the B or C 
ring  (Fig. 1, Table 1) [19]. The presence of the 
ion at m/z 255 and the absence of m/z 229 point 
to a double bound in position 7 instead of 8-14 
and thus this compound was identified as 
[choleste-7-ene-3-oxy]trimethylsilane. The 
precursor compound, cholesterol, was also 
found (peak 13), albeit in lower amounts. Peak 
15 displayed the molecular ion at m/z 460, 
which is compatible with a trimethylsilane di-
hydro derivative of cholesterol. By comparison 
of its mass spectra and co-elution experiments, 
the compound was identified as cholestanol. 
Compound 17 presented a molecular ion at 470 
m/z and other prominent fragments at m/z 455, 
343, 255 and 229. This fragmentation pattern is 
in line with that described for [ergosta-7,22-
dien-3-oxy]trimethylsilane, both regarding 
diagnostic ions and their relative amounts  [19, 
20] and was later confirmed by comparison with 
an authentic standard.  
In the case of peak 19, the 
fragmentation pattern was similar to that of 
ergosta-7,22-dien-3-ol trimethylsilane, though 
the molecular ion was found at m/z 472, which 
is compatible with a trimethylsilane di-hydro 
derivative of 18, tentatively [ergosta-7-en-3-
oxy] trimethylsilane. 
Other sterols, such as stigmasterol, β-
sitosterol and campsterol were searched 
however they were not found. In addition, some 
representative triterpenes with lupane scaffolds 
were searched, though they were not detected. 
Due to the lipophilic nature of the 
extract, carotenoids, which have been described 
before in this species, were also present in the 
extract. In concordance with previous reports 
[14, 18], astaxanthin, lutein and zeaxanthin were 
major compounds in the purified extract of M. 
glacialis. Lutein, zeaxanthin and astaxanthin 
were present in concentrations around 74, 42 
and 2 µM, respectively, in a solution of 1 
mg/mL of extract.  In a general way, in the 
working concentrations of the extract, no 
biological effect could be noticed (data not 
shown). 
 
3.2. Effect of the Extract in Caco-2 Cell Line 
 
 The effect of the extract in all cell lines 
was studied at different times (24, 48 and 72 
hours) and concentrations, ranging from 76 to 
1250 µg/mL. Different techniques were used to 
study the biological effect of the extract on 
cells, namely MTT for evaluation of cell 
viability, SRB for cell density and LDH for 
membrane integrity.  
Among all cell lines tested, Caco-2 
cells were the most resistant to the extract tested 
herein (Fig. 2). In fact, in a general way, only 
the highest concentration (1250 µg/mL) 
displayed a reduction of cell viability and  
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Fig. (2). Effect of M. glacialis purified extract on a) viability, b) density and c) membrane integrity of Caco-2 cells. The results 
correspond to the mean of three independent experiments performed in triplicate. * P<0.05; ** P<0.01. 
 
 
 
density after 72 hours. No LDH release 
was detected.  
Although Caco-2 cells were originally 
derived from a human colon adenocarcinoma, 
they display several metabolic and 
morphological traits of enterocytes, namely 
efflux transporters, phase II conjugation 
enzymes and microvillus transporters [21, 22]. 
The high activity of proteins, such as 
glycoprotein P, usually results in an innate 
resistance of these cells against many drugs and, 
for this reason, low bioavailability of the extract 
inside the cell cannot be ruled out. 
 
 
3.3. Effect of the Extract in MCF-7 Cell Line 
 
  The purified extract reduced MCF-7 
cells’ viability in a time- and dose-dependent 
manner (Fig. 3). In both MTT and SRB assays, 
in concentrations in the range 312-1250 µg/mL, 
the effect was time- and concentration-
dependent, with a concentration of 625 µg/mL 
causing a decrease in 50% of viability after 72 
hours (Fig. 3a). At 24 hours of incubation only 
the highest concentration, 1250 µg/mL, caused a 
reduction of cell density, although lower 
concentrations were already affecting viability. 
However, with the extension of the time of 
treatment, lower concentrations also induced a 
decrease in cell viability, 625 µg/mL for 48 
hours and to 312 µg/mL at 72 hours, a trend that 
was noticed equally in the IC50 of the MTT 
assay (916 and 602 µg/mL at 48 and 72 hours, 
respectively). Regarding membrane integrity, 
LDH release was observed for the first time 
after 48 hours of incubation with the highest 
concentration. 
  
3.4. Effect of the Extract in SH-SY5Y, HDF 
and HFF Cell Lines 
 
 In the case of SH-SY5Y cells, only a 
concentration-dependent effect was found (Fig. 
4), with a reduction of cell viability and cell 
density more pronounced than that detected for 
MCF-7 cells (Fig. 3). A maximum of activity 
was found for 625 µg/mL and, for this reason, 
no data regarding higher concentrations is 
presented. In a general way, for any given 
concentration, no significant time-dependent 
effect was noticed, as shown by the similar 
values of IC50 in the MTT assay at 24, 48 and 72 
hours (206, 219 and 195 µg/mL, respectively). 
After 24 hours of incubation the concentration 
of 156 µg/mL caused a decrease of 30 and 20% 
in cell viability (Fig. 4a) and density (Fig. 4b), 
respectively. LDH release was not observed 
even for the higher concentrations and 
incubation times (Fig. 4c).  
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Fig. (3). Effect of M. glacialis purified extract on a) viability, b) density and c) membrane integrity of MCF-7 cells. The results 
correspond to the mean of three independent experiments performed in triplicate. * P<0.05 ; ** P<0.01; *** P<0.001. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (4). Effect of M. glacialis purified extract on a) viability, b) cell density and c) membrane integrity of SH-SY5Y cells. The 
results correspond to the mean of three independent experiments performed in triplicate. * P<0.05 ; ** P<0.01; *** P<0.001. 
a) b)
c)
Co
ntr
ol 15
6
31
2
62
5
12
50
Co
ntr
ol 15
6
31
2
62
5
12
50
Co
ntr
ol 15
6
31
2
62
5
12
50
0
50
100 24 h
48 h
72 h**
***
**
*** ***
***
*
[Extract] µg/mL
%
 V
ia
bi
lit
y
Co
ntr
ol 15
6
31
2
62
5
12
50
Co
ntr
ol 15
6
31
2
62
5
12
50
Co
ntr
ol 15
6
31
2
62
5
12
50
0
50
100 24 h
48 h
***
72 h
***
*
***
***
**
[Extract] µg/mL
%
 C
el
l d
en
si
ty
0 500 1000 1500
0
1
2
3
24 h
48 h
72 h
**
***
**
[Extract] µg/mL
LD
H
 le
ak
ag
e 
vs
 c
on
tr
ol
a)
c)
b)
Co
ntr
ol 15
6
31
2
62
5
Co
ntr
ol 15
6
31
2
62
5
Co
ntr
ol 15
6
31
2
62
5
0
50
100
24 h
48 h
***
******
***
** ** 72 h***
*** ***
[Extract] µg/mL
%
 V
ia
bi
lit
y
Co
ntr
ol 15
6
31
2
62
5
Co
ntr
ol 15
6
31
2
62
5
Co
ntr
ol 15
6
31
2
62
5
0
50
100
24 h
48 h*
***
*
*********
72 h
**
******
[Extract] µg/mL
%
 C
el
l d
en
si
ty
0 200 400 600 800
1
2
3
4
• • •
48 h
72 h
24 h•
[Extract] µg/mL
LD
H
 le
ak
ag
e 
vs
 c
on
tr
ol
 
8 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (5). Effect of purified extract from M. glacialis on the viability of the human non-tumour cell lines HDF and HFF (24 hours). 
The results correspond to the mean of three independent experiments performed in triplicate *** P<0.001. 
 
 
 
 
4. CONCLUSIONS 
 
In this work we investigated the 
chemical composition and biological activity of 
a purified fraction of the lipidome of M. 
glacialis. Fatty acids and sterols were identified 
and quantified and the presence of ergosta-7,22-
diene-3-ol and cholestan-7-ene-3-ol was 
confirmed for the first time in this species. 
From a biological point of view, we 
have tested this matrix in a panel of three human 
cancer cell lines: colon cancer, neuroblastoma 
and breast cancer. Overall, the extract displayed 
different activities against the different cells, 
with no significant activity being found for 
Caco-2 cells. In the case of the breast cancer 
MCF-7 and neuroblastoma SH-SY5Y cell lines, 
inhibitory activity was found and cells displayed 
different susceptibilities: while MCF-7 required 
higher incubation periods and concentrations, 
the SH-SY5Y cell line required lower 
concentrations and incubation periods and no 
loss of membrane integrity took place, which 
points to a process of regulated cell death. 
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Abstract 
 There has been increasing awareness to the potential interest of drug discovery from marine 
natural products to treat several pathological conditions, including inflammation. In this work we describe 
the anti-inflammatory activity of several compounds present in the echinoderm Marthasterias glacialis 
(spiny sea-star) in an inflammatory model using RAW 264.7 cells challenged with LPS. 
  Lipidomic profiling of the organism revealed two major classes of compounds: fatty acids and 
sterols. Among these, the predominant compounds cis 11-eicosenoic and cis 11,14 eicosadienoic acids 
and the unsaturated sterol ergosta-7,22-dien-3-ol were evaluated. 
 The mechanism of action of the compounds was distinct as they modulated different levels of the 
inflammation pathway. Classical inflammatory markers such as COX-2, iNOS, IL-6 and NF-κB were 
evaluated. We also studied the contribution of the CHOP pathway-mediated ER-stress to the 
inflammatory process. 
 Overall, the sterol ergosta-7,22-dien-3-ol was the most active compound, however maximum 
activity was obtained when all compounds were tested in combination, thus suggestion a synergic activity 
of both classes of metabolites. 
 This work establishes the echinoderm M. glacialis as an interested source of anti-inflammatory 
molecules. 
 
 
 
1. Introduction 
Inflammation is a complex process occurring in 
many animals and constitutes one of the first 
lines of defense against a number of stimuli that 
are perceived as harmful, such as bacteria, 
trauma and irritants. While acute inflammatory 
processes may serve to protect the organism, 
deregulated or chronic inflammatory processes 
are the base of a number of pathological 
conditions that include asthma, rheumatoid 
arthritis, cardiovascular diseases, among many 
others. 
In the continuous search of new 
molecules to counter and treat inflammatory 
conditions, Nature has been a prolific source of 
such compounds for many years. Recently, 
much interest has been given to anti-
inflammatory compounds from non-
conventional environments, with marine micro 
and macroorganisms being very important. 
Several compounds of marine origin have been 
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described in the last few years, such as 
avarol, cycloamphilectenes 1-6  , cavernolide   
and the lead compound manoalide  [1], among 
many others. Some of these compounds are 
already in advanced stages of clinical trials. 
Several factors are known to modulate 
the inflammatory process. Among these, NF-κB 
plays a pivotal role [2,3]. When free from its 
cytoplasmatic inhibitor proteins, the IκB family, 
it translocates to the nucleus, where it binds to 
the promoter region of several genes, thus 
exerting a number of actions. Target genes 
codify proteins that include cytokines, 
cyclooxygenase-2 (COX-2), inducible nitric 
oxide synthase (iNOS), proteases and many 
others [4].  
Marthasterias glacialis L., also known as 
spiny sea-star, is an echinoderm that can be 
found in several ecosystems. Previous works 
have addressed the chemical composition of this 
organism and several classes of compounds 
important in human diet were found, namely 
carotenoids [5-7], fatty acids, sterols and amino 
acids  [8,9]. Some biological properties were 
also evaluated, namely its anticancer activity 
against both non-human [6] and human cells 
[8]. In this work the anti-inflammatory effect of 
a lipophilic extract and its mains compounds 
was evaluated in the LPS-induced RAW 264.7 
macrophages model of inflammation. The effect 
of the extract on several inflammatory markers 
was assessed. 
 
2. Materials and methods 
2.1. Chemicals 
Lipopolysaccharide (LPS), acridine 
orange (AO), Triton X-100, sulphanilamide, 
dichlorodihydrofluorescein diacetate (DCDHF-
DA), 3-(4,5-dimethylthiazolyl- 2)-2,5-
diphenyltetrazolium bromide (MTT), palmitic 
acid, cis 11-eicosenoic acid (≥99%) and cis 
11,14-eicosadienoic acid (≥98%) were from 
Sigma-Aldrich. Ergosta-7,22-dien-3-ol was 
from BioBioPha Co., Ltd (China). Sodium 
nitroprusside dehydrate (SNP) from Riedel-de-
Haën (Seelze, Germany). N-(1-naphtyl)-
ethylene-diamine dihydrochloride were obtained 
from Merck (Darmstadt, Germany). Dulbecco’s 
Modified Eagle Medium (DMEM), foetal 
bovine serum (FBS), Dulbecco’s phosphate 
buffer saline (DPBS), Hank’s balanced salt 
solution (HBSS) and antibiotic were from 
GIBCO (Invitrogen, UK). COX-2, iNOS, IKB-
α, β-tubulin and CHOP primary antibodies, as 
well as anti-rabbit secondary antibody were 
from Santa Cruz, USA. IL-6 ELISA kit was 
from AbCam, UK. 
 
2.2. Sample preparation 
 M. glacialis individuals were collected 
in west Portugal (Cabo Carvoeiro) in September 
2009. Samples were frozen, transported to the 
laboratory, lyophilized (Labconco 4.5 Freezone 
apparatus, Kansas City, MO) and powdered 
using an electric blender. Lyophilized powder 
(15 g) were extracted with acetone:methanol 
(7:3) and the extraction was repeated as many 
times as necessary to render the powder 
colourless. Afterwards, the extract was added to 
a separating funnel with equal amount (20 mL) 
of an ether:hexane mixture (1:1). An equivalent 
volume of 5% NaCl was then added. The 
mixture was separated into two phases and the 
aqueous hypophase was collected and re-
extracted with the ether:hexane mixture until no 
further pigment could be extracted. The organic 
epiphases were then collected and washed with 
water in order to remove all traces of acetone 
and evaporated until dryness in a rotary 
evaporator. All procedures were conducted 
under low light conditions, at room temperature 
and the final residue was kept at -80 ºC in an 
inert atmosphere (nitrogen). 
 
2.3. Derivatization and GC-MS analysis  
A solution of 1 mg/mL of extract in ethanol was 
prepared. An aliquot of 50 μL was then 
transferred to a glass vial, the solvent was 
evaporated under nitrogen stream and 50 μL of 
MSTFA were added to the dried residue. The 
vial was capped, vortexed and heated for 
20 minutes at 40 ºC. All analysis were 
performed in triplicate. GC-MS conditions were 
as described previously by our group [9]. 
 
2.4. Cell culture 
RAW 264.7 macrophages were maintained in 
DMEM supplemented with 10% FBS and 1% 
penicillin/streptomycin and grown in an 
incubator at 37 °C and 5% CO2. 
For the Wright staining cells were seeded 
at a density of 3x10
5
 cells/well in 24-well plates. 
After incubation with different concentrations of 
the extract at different times, cells were washed 
twice with PBS. After fixation with cold 
methanol, at 4°C for 30 minutes, cells were 
stained with Wright solution. Cells were then 
mounted with DPX. 
 
2.5. Cell viability 
Cells were cultured in 96-well plates (2x10
4
 
cells/well) and allowed to attach for 24 hours. 
After this period, cells were treated with LPS, 
with or without pre-incubation with the 
extract/compounds for 2 hours. After incubation 
(24 hours), MTT (0.5 mg/ml final 
concentration) was added to each well and the 
plate was incubated for 2 hours at 37 °C.
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The formazan was dissolved by addition of a 
DMSO:isopropanol mixture (3:1) and quantified 
spectrophotometrically at 560 nm. The results of 
cell viability correspond to the mean of three 
independent experiments performed in triplicate 
and are expressed as percentage of the untreated 
control cells. LDH release was measured after 
24 hours in culture media supernatant using 
CytoTox 96 non-radioactive cytotoxicity assay 
kit (Promega, Madison, WI, USA) according to 
the manufacturer’s protocol. Absorbance was 
read in a multiplate reader at 492 nm. All the 
results correspond to the mean ± SD of three 
independent experiments performed in triplicate 
and expressed as fold increase of absorbance in 
treatments versus untreated control cells, 
expressed as arbitrary units. 
 
2.6. Acridine orange 
Cells were incubated as described before with 
LPS, with or without pre-incubation with the 
extract/pure compounds. After this period, cells 
were washed with HBSS and incubated with a 
0.1 µg/mL solution of acridine orange (AO) for 
15 minutes. After this period cells were washed 
with HBSS and observed in a fluorescence 
microscope equipped with a 490 nm band-pass 
blue excitation filter and a 515-nm long pass-
barrier filter. 
 
2.7. Nitric oxide scavenging activity and NO 
determination  
The ability of the extract to scavenge nitric 
oxide radical generated in a cell-free system was 
evaluated according to the method previously 
described [10]. A dilution series (five different 
concentrations of extract) was prepared in a 96-
well plate. The reaction mixtures in the sample 
wells consisted of 156 µg/mL extract and SNP. 
The plates were incubated at 25 ºC for 60 min 
under light.  
 Nitrite was quantified by mixing 50 µl 
of either extract solution or culture media with 
an equal volume of Griess reagent (1% 
sulphanilamide and 0.1% 
naphthylethylenediamine dihydrochloride in 2% 
H3PO4) and incubated for 10 minutes in the 
dark, after which absorbance was read in a 
multiplate reader set at 540 nm. 
 
2.8. Intracellular reactive oxygen species 
Cells were seed in 96-well black plates 
according to the above mentioned conditions for 
the MTT assay and exposed to LPS for 24 
hours, with or without pre-incubation with M. 
glacialis purified extract for 2 hours. Cells were 
washed with HBSS 30 minutes before the end 
of the incubation period, followed by incubation 
with a solution of DCDHF-DA (25 µM in 
HBSS) for 30 minutes. Afterwards they were 
mounted with VectaShield mounting media 
(Vector, UK). For the quantification of 
intracellular ROS the plate was read using 
fluorescence multiplate reader (Excitation: 490 
nm excitation; Emission: 520 nm) following 
incubation with DCDHF-DA. Cells in HBSS 
were used as negative control and LPS was used 
as a positive control. 
 
2.9. IL-6 
IL-6 levels were determined by ELISA in 
culture media as per the manufacturer’s 
instructions. 
 
2.10. Western-Blot 
Cells were seeded in 6-well plates with a 
density of 3,5x10
5
 cells/well. Cells were treated 
for 24 hours with LPS, with or without pre-
incubation with extract or pure compounds for 2 
hours. After this period, macrophages were 
washed with PBS, scraped and incubated with a 
lysis solution with protease inhibitors for 20 
minutes on ice. After this period the solution 
was centrifuged at 14,000 g for 15 minutes and 
the supernatant collected and protein content 
determined by the Bradford method. Samples 
(40 µg) were subjected to 10% SDS-PAGE and 
proteins were transferred onto nitrocellulose 
membranes and blocked for one hour at room 
temperature with a solution of 5% non-fat milk 
in 0.1% Triton X-100. Overnight incubation at 
4°C were performed with antibodies anti-COX-
2 (1:1000), anti-iNOS (1:100), anti-CHOP 
(1:100), anti-IKB-α (1000), anti-tubulin 
(1:1000) and then with peroxidase-conjugated 
secondary antibody (1:3000) at room 
temperature for 1 hour. β-Tubulin was used as a 
loading control. Finally blots were subjected to 
a chemiluminescence detection kit (Super 
Signal West Pico; Pierce, Rockford, USA).  
 
2.11. Statistical analysis 
Comparisons of data from different groups, 
controls and treatments, were performed using a 
one-way ANOVA test. Dunnet’s post-test was 
used. A p value lower than 0.05 was considered 
statistically significant.  All experiments were 
performed in triplicate. 
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Figure 1 - Evaluation of the effect of LPS and LPS+extract on cell morphology: A – phase contrast, B – Wright staining. Red 
arrows: cytoplasmatic vesicles. C - Acridine orange staining of control and LPS-treated macrophages. White arrows: 
autophagosomes. Incubation with LPS causes the characteristic morphology of activated macrophages, which includes the advent 
of autophagosomes. Pre-incubation with the extract attenuates the number of autophagosomes. Original magnification: 400x. 
 
3. Results 
3.1. Extract concentration screening and 
impact on cell morphology 
Given the fact that at the concentration of 312 
µg/ml a decrease of about 20% of cell viability 
was noticed (data not shown), in subsequent 
experiments lower concentrations (156 µg/mL) 
were used for testing the anti-inflammatory 
activity. LDH was not present in culture 
supernatants in any concentration tested (data 
not shown). 
 LPS treatment induced characteristic 
macrophage-like morphology (Fig. 1). 
Cytoplasmatic vesicles were noticed and were 
compatible with autophagosomes described as a 
result of toll-like receptor 4 (TLR 4) activation 
by LPS in macrophages [11]. In order to 
confirm the identity of these autophagosomes, 
acridine orange was used to confirm their acidic 
nature (Fig. 1C). As it can be found in Fig. 1A, 
pre-incubation of macrophages with the extract 
caused changes in cell morphology and reduced 
the number of visible autophagossomes.  
 After this point we evaluated the 
potential anti-inflammatory activity of the 
extract by screening its ability to 
prevent/ameliorate LPS-induced increase in IL-
6. As it can be seen in Fig. 2, LPS caused a 
marked increase in IL-6 levels, which were 
lowered by about 30% in the presence of the 
extract. 
 
 
3.2. Effect of LPS and M. glacialis extract / 
pure compounds upon macrophage viability  
LPS challenge resulted in a decrease to 70% of 
cell viability when compared to control. This 
effect was prevented by pre-incubation with the 
extract at a concentration of 156 µg/mL for 2 
hours, which restored cell viability of LPS-
treated cells to control levels (Fig. 3A). After 
this, we tested the individual effect of several 
compounds present in the extract on cell 
viability. 
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Figure 2 - IL-6 levels determined in culture media. 
Challenge with LPS causes a marked increase in IL-6 levels, 
which are partly prevented by pre-incubation with the 
extract (156 µg/mL) for 2 hours. Ext: extract (156 µg/mL). 
The results correspond to the mean ± SD of three 
independent experiments performed in triplicate. *** 
P<0.001 (vs LPS). 
 
Previous studies have identified and quantified 
major fatty acids and sterols in M. glacialis [9]. 
We used the same method for the determination 
of major compounds present in the purified 
extract used herein. Fatty acids and sterols were 
major classes in the extract and, at the 
concentration 156 µg/mL, the major candidates 
to exert a biological effect were palmitic acid 
(20 µM), cis 11-eicosenoic acid (30 µM), cis 
11,14-eicosadienoic acid (10 µM) and  µM 
ergosta-7,22-dien-3-ol (25 µM).  
All compounds tested individually had 
no effect in cell viability after 24 hours 
treatment as assed by the MTT assay (Fig. 3A). 
When compounds were tested in the presence of 
LPS, distinct behaviors were found. While cis 
11-eicosenoic acid had no effect in cell 
viability, cis-11,14- eicosadienoic acid and 
ergosta-7,22-dien-3-ol had a moderate reduction 
on LPS-induced loss of viability. Incubation 
with palmitic acid in a concentration of 20 µM 
resulted in a marked increase in LPS-induced 
toxicity. When all compounds were tested 
together, cell viability was restored to 90% of 
the control. 
 
3.3. M. glacialis extract/pure compounds 
modulate NO levels via down-regulation of 
iNOS expression 
NO was quantified in culture media after 
challenge with LPS for 24 hours with or without 
pre-incubation with the extract for 2 hours. NO 
was present in control samples in negligible 
amounts and, for this reason, NO production 
following LPS incubation was considered 
100%.  
 The extract (156 µg/mL) lowered the 
values of NO by about 50% of those obtained 
with LPS (Fig. 3B). After this, we investigated 
the contribution of the three major compounds: 
cis-11-eicosenoic acid, cis-11,14-eicosadienoic 
acid and ergosta-7,22,dien-3-ol. Palmitic acid 
was not tested isolated due to its above-
mentioned impact in cells (70% loss of 
viability) although it was included in the 
mixture of major compounds used to mimic the 
extract.  cis 11-Eicosenoic acid successfully 
caused a 10% reduction of NO levels, while cis 
11,14-eicosadienoic acid and ergosta-7,22,dien-
3-ol were capable of lowering NO levels by 
20%. When all compounds were incubated 
together, a 30% decrease in LPS-induced NO 
levels was found (Fig. 3B). 
Several natural products have displayed 
NO-scavenging capacity and, for this reason, 
the NO scavenging activity of the extract was 
evaluated. NO radical was generated in a cell-
free chemical system, as described before [12]. 
Several concentrations were tested and up to a 
concentration of 625 µg/mL, far higher than the 
ranges used in cells, no NO scavenging capacity 
was found (data not shown). We evaluated the 
effect of the extract on iNOS levels, the major 
enzyme responsible for the production of NO. 
While LPS induced a marked increase on iNOS 
levels, the extract was able to partially prevent 
this up-regulation (Fig. 4A). cis-11-Eicosenoic 
and cis-11,14-eicosadienoic acids were able to 
reduce LPS-induced increase in iNOS, albeit in 
low extent (Fig. 4B). The sterol ergosta-7,22-
dien-3-ol had a marked effect in iNOS protein 
levels, being able to revert those to near-control 
levels, a behavior also found for the 
combination of all compounds (Fig. 4B). 
 
 3.4. M. glacialis extract / pure compounds 
down-regulate  COX-2  
The study of COX-2 levels after LPS elicitation 
revealed a marked increase in the expression of 
this enzyme (Fig. 4A), which is in line with the 
pro-inflammatory effects described for LPS. 
When LPS was co-incubated with the extract 
the levels of COX-2 were significantly reduced, 
a trend that had already been noticed with iNOS 
protein expression (Fig. 4A). The study of the 
contribution of the major components of the 
extract revealed that, although some compounds 
had a significant activity, notably ergosta-7,22-
dien-3-ol, only the combination of all 
compounds was able to revert the levels of 
COX-2 to those of control cells (Fig. 4B). 
 
3.5. M. glacialis extract / pure compounds 
lower LPS-induced ROS  
We evaluated the effect of both LPS and the 
extract upon intracellular levels of ROS in 
RAW 264.7 cells. Initially, cells were incubated 
with either media, media with LPS or media 
with LPS after pre-incubation with the extract 
and cells were then observed in a fluorescence 
microscope.
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Figure 3 - A - Viability of macrophages after treatment with purified extract or individual compounds with or without LPS after 24 
hours of incubation.  
B - NO production in RAW 264.7 cells in the presence of a purified extract and of the major compounds in the extract, isolated and 
in combination after 24 hours of incubation. Compounds were used in the concentrations at which they occur in the extract; cis 11:  
35 µM cis 11-eicosenoic acid; cis 11,14: 10µM cis 11,14-eicosadienoic acid; E-7,22: 25 µM ergosta-7,22-dien-3-ol. Ext: extract 
(156 µg/mL); combination: Palmitc acid + cis 11-eicosenoic acid + cis 11,14-eicosadienoic + ergosta-7,22-dien-3-ol.The results 
correspond to the mean ± SD of three independent experiments performed in triplicate. * P<0.05; ** P<0.01; *** P<0.001 (vs LPS).  
 
 
 
As it can be seen in Fig. 5A, LPS caused an 
increase in total intracellular ROS when 
compared with control cells. Co-incubation of 
LPS with the extract resulted in a partial 
reversion of this behavior. These qualitative 
results were then confirmed by quantification of 
the signal in a fluorescent multi-plate reader. As 
shown in Fig. 5B, the extract was capable of 
preventing LPS-induced generation of ROS by 
around 50%, an effect that could be mimicked 
by the combination of all compounds tested. 
Interestingly, the sterol ergosta-7,22-dien-3-ol 
had no effect on ROS levels at the incubation 
time studied herein, with the unsaturated fatty 
acids causing partial reduction of ROS levels. 
 
 
 
3.6. M. glacialis extract / pure compounds 
prevent LPS-induced CHOP pathway-
mediated ER stress  
ER stress has been increasingly implied as a 
potential source and aggravation of 
inflammatory processes and CHOP is one of the 
most commonly used markers of ER-stress [13]. 
An increase in CHOP expression levels 
following incubation with LPS was observed, an 
effect significantly prevented by the extract 
(Fig. 4A). Unsaturated fatty acids cis 11-
eicosenoic and cis 11,14-eicosadienoic acids 
were unable to reduce CHOP expression levels 
in LPS-challenged cells. When cells were 
incubated in the presence of ergosta-7,22-dien-
3-ol CHOP expression was similar to untreated 
cells (Fig. 4B). 
 
3.7. M. glacialis extract / pure compounds 
prevents NF-κB activation by avoiding IκB-α 
degradation 
NF-κB is usually found in its inactive form in 
cytoplasm by action of the inhibitory protein 
IκB-α (Fig. 6). As it can be found in Fig. 5, 
incubation with LPS caused a decrease in the 
levels of IκB-α, which can explain all the 
classical traits of inflammatory process, namely 
the increase of COX-2, iNOS and IL-6 levels. 
When cells were pre-incubated with the extract, 
LPS was unable to cause a reduction in IκB-α 
levels (Fig. 4A). This protective effect was also 
found when all compounds tested were 
evaluated in combination (Fig. 4B). These 
results show that some of the above-presented 
findings may result from inhibition of the NF-
κB pathway. 
 
 
4. Discussion 
LPS treatment induced the characteristic 
morphology of activated macrophages. As a 
result of TLR4 activation by LPS, the advent of 
autophagosomes is known to occur. We 
demonstrated that incubation with the purified 
extract from M. glacialis lowered the number of 
autophagosomes.  
The use of LPS as a pro-inflammatory 
stimulus resulted in a loss of cell viability of 
about 30%, which could be prevented by pre-
incubation with the extract. When the major 
compounds of the extract were tested 
individually, no impact on cell viability was 
found: cis 11,14 and ergosta-7,22-dien-3-ol had 
a protective effect and palmitic acid exacerbated 
LPS-induced loss of viability. This result  
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Figure 4 - Effect of A) purified extract (156 µg/mL) from M. glacialis and B) major compounds in the extract in the expression of  
iNOS, COX-2, CHOP and IKB-α in LPS-treated RAW 264.7 cells. Densitometric analysis of the studied proteins after 
normalisation to β-tubulin levels. Results are expressed as mean ± SD of three experiments. * P<0.05 ; ** P<0.01; *** P<0.001 (vs 
LPS). Ext: extract (156 µg/mL); PA: 20 µM palmitic acid; cis 11:  35 µM cis 11-eicosenoic acid; cis 11,14: 10µM cis 11,14-
eicosadienoic acid; E-7,22: 25 µM ergosta-7,22-dien-3-ol. combination: Palmitic acid + cis 11-eicosenoic acid + cis 11,14-
eicosadienoic + ergosta-7,22-dien-3-ol. 
suggests a synergic pro-inflammatory 
effect of palmitic acid with LPS, which is in line 
with previous reports that describe palmitic acid 
as an activator of TLR 4, the same target 
activated by LPS [14]. When all compounds 
were combined, reversion of LPS-induced loss 
of viability occurred, as it had been found for 
the extract treatment.  
The inflammatory marker NO is 
synthesized from the conversion of arginine to 
citrulline by nitric oxide synthases, the inducible 
isoform (iNOS) being the main responsible for 
the large amounts of NO found in inflammatory 
processes [15,16]. On the other hand, excessive 
iNOS activity is known to be related with a 
number of pathological conditions, such as 
asthma, psoriasis, neurodegenerative diseases 
and can lead to NO-induced apoptosis in several 
cell lines [17-19]. We showed that the extract 
was able to significantly lower the levels of 
LPS-induced NO as a result of down-regulation 
of iNOS, an effect for which all compounds 
tested contributed, notably ergosta-7,22-dien-3-
ol.  
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Figure 5 - Evaluation of intracellular ROS assessed by the fluorescent probe DCDHF-DA. A – Fluorescence microscopy, 
qualitative evaluation of the effect of the extract in LPS-activated cells. B – Quantitative evaluation of the effect of the extract and 
its main compounds in LPS-challenged cells.  The results correspond to the mean ± SD of three independent experiments performed 
in triplicate. *** P<0.001 (vs LPS). Ext: extract (156 µg/mL); cis 11:  35 µM cis 11-eicosenoic acid; cis 11,14: 10µM cis 11,14-
eicosadienoic acid; E-7,22: 25 µM ergosta-7,22-dien-3-ol. combination: Palmitic acid + cis 11-eicosenoic acid + cis 11,14-
eicosadienoic + ergosta-7,22-dien-3-ol.  
 
Three isoforms of cyclooxygenase are 
known: COX-1, COX-2 and COX-3. In the 
inflammatory context the inducible isoform, 
COX-2, is the most significant. We evaluated 
the effect of both the extract and its compounds 
in LPS-induced up-regulation of COX-2. As it 
had been found in the case of iNOS, pre-
incubation with the extract prevented LPS-
induced increase of the expression levels by 
over 50%. However, while in the case of iNOS 
one compound, ergosta-7,22-dien-3ol, was 
found to be responsible for this activity, in the 
case of COX-2 no single compound could 
explain this activity. Instead, the combination of 
all compounds tested showed higher capacity to 
prevent LPS-induced up-regulation of COX-2. 
ROS are known to play a pivotal role in 
early stages of inflammation and in the 
particular case of LPS, the increase in ROS 
generation has been shown to be an upstream 
event taking place following exposure to this 
positive elicitor  [20]. We demonstrated that the 
purified extract from M. glacialis prevented 
LPS-induced increase in ROS levels by about 
50%. Differently from what had been found for 
other inflammatory markers, ergosta-7,22-dien-
3-ol had no effect in ROS levels. However, 
when all compounds were tested together, the 
activity was comparable to that found for the 
extract, a trend that had already been found for 
COX-2 expression levels.  
From a cellular point of view, activation 
of the NF-κB pathway is one of the most 
important events that trigger the inflammatory 
response. By studying the levels of the 
inhibitory protein IκB-α, we showed that the 
extract and some of its constituents successfully 
prevented the activation of the NF-κB pathway. 
Several cellular events, some of them caused by 
LPS challenge, may trigger the activation of this 
pathway and among these, ROS and ER-stress 
are particularly relevant. As we referred above, 
prevention of ROS generation by the extract and 
its components can contribute, at least in part, to 
the anti-inflammatory activity found.  
In order to evaluate the other possible 
causative agent of NF-κB activation, we studied 
ER-stress status by evaluating the expression of 
the endpoint protein of the CHOP pathway, 
which is known to be involved in the 
pathogenesis of inflammation [21], although the 
details and sequence of events are not 
completely understood [13,22]. At this point it 
is important to highlight that the contribution of 
CHOP to the fate of RAW 264.7 cells is largely 
influenced by the type of pro-inflammatory 
stimuli used. When LPS is used alone, CHOP-
mediated ER stress alters several metabolic and 
biochemical traits, though no apoptosis is 
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detected. Differently, when LPS and IFN-γ are 
used in combination, NO-induced apoptosis 
takes place. Further studies showed that these 
differences are a consequence of a delay in the 
induction of CHOP by LPS, which takes place 
only after the activation of ER-protective 
factors, such as BiP, p58IPK, EDEM, derlin-1 
and derlin-2 and, for this reason, an incomplete 
activation of the CHOP pathway takes place and 
does not lead to apoptosis. Full activation of 
ER-stress pathway via ER-stress inducers, such 
as thapsigargin or tunicamycin, is known to 
induce apoptosis in RAW 264.7 cells [23]. We 
demonstrated that CHOP expression levels were 
increased following exposure to LPS, an effect 
partly reverted by the extract and its 
components. As so, the attenuation of ER stress 
that we describe herein for several compounds 
can contribute, at least in part, to the inhibition 
of the NF-κB pathway. In addition, due to the 
established contribution of ROS to further 
propagate the inflammatory response, namely 
NF-κB activation and subsequent expression of 
some inflammatory markers, the above-
mentioned capacity of the extract and some of 
its compounds to attenuated oxidative stress 
may contribute to the anti-inflammatory activity 
found. 
 In summary, in this work we addressed 
the anti-inflammatory activity of a purified 
extract and individual compounds present in the 
spiny sea-star M. glacialis. Several markers for 
inflammation were tested. Overall, the extract 
reversed LPS-induced loss of viability in RAW 
264.7 cells and increase of ROS and NO levels, 
as well as of the expression of COX-2, iNOS 
and the ER-stress marker protein CHOP. A 
proposed mechanism for the anti-inflammatory 
activity found can be seen in Fig. 6. 
 A combination of the unsaturated fatty 
acids cis-11-eicosenoic and cis-11,14 
eicosadienoic acids and the sterol ergosta-7,22-
dien-3-ol was able to mimic the anti-
inflammatory effect displayed by the extract, 
although different compounds were active 
against distinct inflammatory parameters. For 
example, ergosta-7,22-dien-3-ol was effective 
against iNOS, CHOP and IKB-α expression, 
while its importance for the reduction of COX-2 
or ROS was limited or null, respectively. As so, 
we establish the importance of synergism 
between different classes of metabolites in order 
to mimic the protective effect of the extract. In 
addition, besides describing the anti-
inflammatory activity of the extract, this is the 
first report regarding the anti-inflammatory 
properties of the sterol ergosta-7,22-dien-3-ol, 
as well as of the unsaturated fatty acids cis-11-
eicosenoic and cis-11,14-eicosadienoic acids.  
We suggest that M glacialis may be a good 
source of nutraceuticals with application in 
inflammatory conditions. 
 
 
. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6 - Proposed mechanism for the anti-inflammatory activity of different compounds present in M. glacialis. 
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Abstract: We describe the effect of a chemically characterized lipophilic extract obtained from 
Marthasterias glacialis L. against human breast cancer (MCF-7) and human neuroblastoma (SH-
SY5Y) cell lines. Evaluation of DNA synthesis revealed that both cell lines were markedly affected in 
a concentration-dependent way, SH-SY5Y cell line being more susceptible. Cell cycle arrest was 
observed, an effect induced by the sterol ergosta-7,22-dien-3-ol present in the extract. Morphological 
evaluation of treated cells showed the advent of lipid droplets and chromatin condensation compatible 
with apoptosis, which was confirmed by the evaluation of caspase-3 and -9 activities. Palmitic acid 
was the main compound responsible for this apoptotic effect by a ceramide-independent mechanism 
that involved activation of the CHOP-mediated ER-stress pathway. 
Keywords: Marthasterias glacialis L.; Palmitic acid; ER-stress; CHOP; Apoptosis 
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1. Introduction 
Nature is an indisputable source of drugs for human pharmacotherapeutical arsenal [1-3]. In the 
recent years, marine-derived drugs have received great attention, with a steady increase in the number 
of molecules in clinical trials [4-7].  
The chemical composition of Marthasterias glacialis L. has been described before and amino acid, 
fatty acids, carotenoids and sterols have been identified [8-10]. In addition, the effect of a purified 
extract upon several human cancer and non-cancer cells was reported [8, 11], though the mechanism 
responsible for the anticancer activity has not been investigated. 
Nowadays, there has been increasing awareness regarding the role of the endoplasmic 
reticulum (ER) in the homeostasis of the cell. When ER homeostasis is disturbed, the unfolded protein 
response (UPR) can be activated and the ER stress associated is known to be the basis of several 
cellular aggressions, namely apoptosis. In order to monitor ER status, three stress sensor proteins are 
known: double-stranded RNA-dependent protein kinase PKR-like ER kinase (PERK), inositol-
requiring 1α (IRE1α) and activating transcription factor 6 (ATF6). In the particular case of PERK, its 
active form phosphorylates eIF2, which inhibits protein translation.  In this branch of UPR, the DNA-
damage-inducible gene 153 (GADD153), also known as C/EBP homologous protein (CHOP, a 
member of the C/EBP transcription factor family that heterodimerizes with other C/EBPs), is 
upregulated and, for this reason, it is a widely used marker of ER-stress [12-14]. Increased levels of 
CHOP have been associated with pro-apoptotic effects in several cancer cell lines, an effect attributed 
to CHOP-mediated repression of BCL2 gene family. 
In this work we evaluated the activity of a purified lipophilic extract from M. glacialis on the 
cancer cell lines MCF-7 (estrogen receptor positive human breast cancer cells) and SH-SY5Y (human 
neuroblastoma cells) and investigated the mechanism involved in cell death and cell cycle arrest. The 
contribution of the main compounds present in the extract is discussed. 
 
2. Results and Discussion 
2.1.  Screening of M. glacialis lipophilic extract effect on cell morphology and DNA synthesis 
We evaluated the effect of a broad range of concentrations (78-625 µg/mL) of M. glacialis 
lipophilic extract in DNA synthesis. As it can be seen in Figure 1, the extract caused a concentration-
dependent reduction of DNA synthesis in both cell lines. However, in neuroblastoma cells the effect 
was stronger and time-independent, while in MCF-7 it was time-dependent. These results are in line 
with previous reports that point to a similar behavior in what regards to cell viability [11]. The lowest 
concentrations that elicited a biological effect were selected for morphological studies, 156 and 312 
µg/mL for SH-SY5Y and MCF-7 cell lines, respectively. 
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Figure 1. Rate of DNA synthesis in MCF-7 and SH-SY5Y cells treated with the extract (78-625 
µg/mL for 24 or 48 hours) by the 
3
H-thymidine incorporation assay. The results correspond to the 
mean ± standard deviation of three independent experiments performed in triplicate. 
 
 
Several techniques were employed for the study of the effect of M. glacialis extract on cytoplasmic 
and nuclear morphology. Both Giemsa and Hoechst 33342 stainings showed chromatin condensation 
in MCF-7 and SH-SY5Y cells after incubation with the extract for 48 and 24 hours, respectively 
(Figures 2 and 3). In both cell lines, exposure to the extract resulted in cytoplasmic vesicles. Given the 
lipophilic nature of the extract we hypothesized that these vesicles could be the result of the 
accumulation of lipid compounds in the cell. For this reason, the Oil Red O staining was performed. 
As it can be seen in Figures 2 and 3, Oil Red O successfully stained the cytoplasmic vesicles, which is 
compatible with lipid droplets. This result was further confirmed by transmission electron microscopy, 
which showed that these structures displayed the homogeneous grey opacity commonly found in lipid-
containing organelles (Figure 2). 
As SH-SY5Y cell line showed higher susceptibility, it was selected for subsequent studies. 
 
 
2.2.  Ergosta-7,22-dien-3-ol is responsible for cell cycle arrest 
In light of the results from the thymidine incorporation assay, we evaluated the impact of the M. 
glacialis lipophilic extract and of the pure compounds that were present in higher amounts in the 
extract on the neuroblastoma cells cell cycle. At a concentration of 156 µg/mL, the purified extract 
caused a G0/G1 arrest, which resulted in an increase of 10% of the number of cells in this phase 
(Figure 4). 
In a previous work, we have established the identity of major compounds and their concentrations 
in the purified extract from M. glacialis [11]. At the working concentration of 156 µg/mL, major 
candidates to exert a biological effect were palmitic acid (20 µM), cis 11-eicosenoic acid (30 µM), cis 
11,14-eicosadienoic acid (10 µM) and  ergosta-7,22-dien-3-ol (25 µM).  In order to evaluate the 
compounds responsible for the cell cycle arrest capacity of the extract, these compounds were 
evaluated individually and in combination after 24 hours of incubation (Figure 4). None of the fatty 
acids tested showed significant effect in these values, while the sterol ergosta-7,22-dien-3-ol was able 
to cause an effect similar to that of the extract. When all compounds were tested in combination, 
similar values were found. Our data show that cell cycle arrest caused by the extract can be mostly 
attributed to the sterol ergosta-7,22-dien-3-ol. 
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Figure 2. Morphological assessment of MCF-7 cells (control vs treatment, 48 hours of incubation). 
Giemsa and Hoechst 33342 stainings show chromatin condensation (red and white arrows, 
respectively) following incubation with the extract. Cytoplasmic vesicles, visible in Giemsa staining, 
proved to harbor lipophilic compounds, as shown with Oil Red O staining and transmission electron 
microscopy (green arrows).  
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Figure 3. Morphological assessment of SH-SY5Y cells (control vs treatment, 24 hours of incubation). 
Giemsa and Hoechst 33342 stainings show chromatin condensation and fragmentation (red and white 
arrows). The advent of lipophilic cytosolic vesicles is demonstrated by the Oil Red O staining and 
transmission electron microscopy (TEM) micrographs.  
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Figure 4. Representative histograms of the effect of M. glacialis lipophilic extract and pure 
compounds on SH-SY5Y cell cycle. The extract caused a cell cycle arrest in the G0/G1 phase, an 
effect attributed to ergosta-7,22-dien-3-ol. Other major compounds found in the extract had no 
appreciable effect. Results are expressed as mean ± standard deviation of three experiments. * P<0.05 ; 
** P<0.01; *** P<0.001 (vs control). PA: 20 µM palmitic acid; cis 11:  35 µM cis 11-eicosenoic acid; 
cis 11,14: 10µM cis 11,14-eicosadienoic acid; E-7,22: 25 µM ergosta-7,22-dien-3-ol; combination: 
palmitic acid + cis 11-eicosenoic acid + cis 11,14-eicosadienoic + ergosta-7,22-dien-3-ol. 
 
 
2.3. Palmitic acid is responsible for the extract-induced ceramide-independent apoptosis via the 
intrinsic pathway 
In a previous work, we have described the impact of the purified lipophilic extract from M. 
glacialis in cell density, viability and membrane integrity of SH-SY5Y cells. At the concentration of 
156 µg/mL, the extract elicited about 30% of reduction in cell viability. Palmitic acid was the likely 
candidate for this activity however the mechanism of action was not investigated.  In the work herein, 
Control Palmitic acid
cis 11-eicosenoic acid cis 11,14-eicosadienoic acid Ergosta-7,22-dien-3-ol
Combination
G0/G1: 56.6
S : 14.2
G2/M: 19.8
G0/G1: 65.1
S : 11.8
G2/M: 21.7
G0/G1: 58.5
S : 10.7
G2/M: 20.5
G0/G1: 59.4
S : 12.0
G2/M: 19.5
G0/G1: 60.2
S : 13.0
G2/M: 21.1
G0/G1: 64.2
S : 8.12
G2/M: 21.9
G0/G1: 69.6
S : 5.58
G2/M: 19.0
Extract (156 µg/mL)
Control 56.7 ± 0.1 15.1 ± 1.3 20.9 ± 1.5
Ext 156 µg/mL 65.1 ± 1.0** 11.8 ± 0.6 21.7 ± 0.7
PA 59.9 ± 2.0 9.63 ± 1.5* 21.1 ± 0.9
cis  11 58.3 ± 1.6 12.6 ± 0.8 20.0 ± 0.6
cis  11,14 61.1 ± 1.3 11.9 ± 1.6 21.2 ± 0.1
E-7,22-dien-3-ol 66.2 ± 2.8** 8.6 ± 0.6** 20.1 ± 2.5
Combination 68.3 ± 1.8*** 4.9 ± 1.0*** 19.9 ± 1.2
G0/G1 S G2/M
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we confirmed these results and showed that, apart from palmitic acid, the other compounds had no 
impact in cell viability (Figure 5).  
 
 
Figure 5. Cell viability was evaluated following incubation with the compounds present in the extract 
for 24 hours.  PA - palmitic acid (20 µM); Cis 11 - cis 11-eicosenoic acid (30 µM); Cis 11,14 - cis 
11,14-eicosadienoic acid (10 µM); E-7,22 - ergosta-7,22-dien-3-ol (25 µM). Results are expressed as 
mean ± standard deviation of 3 experiments. *** P<0.001 (vs control). 
 
In addition, the morphological assays, by both Giemsa and Hoechst 33342 stainings, showed 
the appearance of chromatin condensation and the advent of structures compatible with apoptotic 
bodies. In order to confirm that apoptosis was taking place, we evaluated the activity of caspase-3/7, 
and -9. After 24 hours of incubation, the extract caused an increase of about 30% in both caspase-3/7 
and -9 activity (Figure 6). While cis 11-eicosenoic and cis 11-14,eicosadienoic acids and ergosta-7-22-
dien-3-ol had no impact on caspases activity (data not shown), palmitic acid elicited an increase in 
caspase-9 and -3/7 activity of approximately 12 and 20%, respectively. However, when all compounds 
were tested in combination, higher values,closer to those displayed by the extract (18 and 25%, 
respectively),were found. Taken together, these results suggest that, although palmitic acid is the main 
compound responsible for the pro-apoptotic activity of the extract, its effect is enhanced by the 
presence of the unsaturated fatty acids and sterol. 
Palmitic acid plays several physiological roles in cells, from energy production to structural 
support in membranes. In addition, it can be the biosynthetic precursor of ceramide. Ceramide is an 
intra-cellular lipid signaling molecule that is involved in several cellular processes, including 
differentiation, growth arrest and apoptosis [15, 16]. This process has been widely studied in neuronal 
cells [17, 18]. Ceramide can be synthesized from palmitic acid via the de novo pathway, by the action 
of serine-palmitoyl transferase (SPT) and also from sphyngomyelin, by the enzyme sphingomyelinase 
[19]. The importance of ceramide to the pro-apoptotic effects of palmitic acid is still in discussion and 
two distinct mechanisms are known: ceramide-mediated/caspase-3-independent cell death and 
ceramide-independent/caspase-3-dependent apoptosis [18]. We hypothesized that the high amount of 
palmitate in the purified extract could induce an increase of intra-cellular levels of ceramide, thus 
explaining the pro-apoptotic effect of the extract. In order to test this hypothesis, we evaluated the 
effect of two inhibitors of the key enzymes involved in the de novo biosynthesis of ceramide: L-
cycloserine and fumonisin B1. As it can be found in Figure 7, the co-incubation of the extract with the 
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two inhibitors had no significant impact on viability and hence we can conclude that the effects of 
palmitic acid are ceramide-independent. Taken together, these results show that the mechanism of cell 
death taking place is ceramide-independent and caspase-dependent. 
 
Figure 6. Caspase-3/7 and -9 activity. Ext - 156 µg/mL extract; PA - palmitic acid (20 µM); 
Combination: PA (20 µM) + cis 11-eicosenoic acid (30 µM) + cis 11,14-eicosadienoic acid (10 µM) 
+ ergosta-7,22-dien-3-ol (25 µM). Results are expressed as mean ± standard deviation of 3 
experiments. ** P<0.01; *** P<0.001 (vs control). 
 
 
 
 
Figure 7. Cell viability of SH-SY5Y cells treated with the extract (Ext, 156 µg/mL) for 24 hours. The 
ability of L-cycloserine (CSer, 500 µM) and fumonisin B1 (FumB1, 50 µM) to prevent the extract-
induced loss of viability was evaluated. Both inhibitors were not cytotoxic. Results are expressed as 
mean ± standard deviation of 3 experiments. * P<0.05( vs control). 
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9 
2.4. The extract and palmitic acid cause ER-stress via the CHOP pathway 
 
There has been increasing awareness regarding the role of the ER in the homeostasis of the cell. 
In particular, ER stress is known to be the basis of several cellular aggressions, namely apoptosis. In 
order to monitor ER status, CHOP was used due to its role in ER-stress [12-14].  
The effect of the extract in the expression of this stress marker was evaluated. As it can be found in 
Figure 8, incubation with the extract resulted in a marked increase of CHOP levels. Palmitic acid has 
been associated with ER-stress and apoptosis via ER-stress in pancreatic β-cells [20], liver cells [21] 
and Schwann cells [18]. Given the presence of this compound in the extract, it was also tested and, as 
seen in Figure 8, the levels of CHOP protein were residual in control cells and rose significantly in 
palmitic acid-treated cells. 
 
 
 
Figure 8. Effect of the extract (Ext, 156 µg/mL) and palmitic acid (PA, 20 µM) on the expression of 
CHOP by western blot. 
 
 
 
 
 
 
 
 
Nowadays the link between ER stress and apoptosis has been established, however the precise 
mechanisms underlying is not completely understood. Several studies suggest that CHOP-triggered 
apoptosis is a result of repression of the BCL2 gene family, thus favouring pro-apoptotic proteins, 
which ultimately led to the activation of caspase-9 and, subsequently, caspase-3. This result is in line 
with the caspase activation reported above and, for this reason, we suggest that extract/palmitic acid-
induced apoptosis is a consequence of ER-stress via the CHOP pathway (Figure 9). Another player, 
caspase-12, has been implicated before in mice, however the fact that most humans do not possess an 
active caspase-12 gene [22, 23] hinders our current understanding of its importance in ER-mediated 
apoptosis. 
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Figure 9. Proposed mechanism for the effect of the purified extract from M. glacialis. The anti-
proliferative effect is caused by ergosta-7,22-dien-3ol, which triggers cell cycle arrest. Palmitic acid is 
not involved in ceramide biosynthesis. Instead, it causes ER-stress, as depicted by the increase in 
CHOP expression levels. This protein then triggers apoptosis by interacting with mitochondrial 
proteins. SPT - Serine palmitoyl transferase; CERase - ceramidase; SM - sphingomyelin; SM 
synthase – sphingomyelin synthase; CS – ceramide synthase; SMase – Sphingomyelinase. 
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3. Experimental Section  
3.1. Reagents and standards 
Dulbecco’s Modified Eagle Medium (DMEM), trypsin, fetal bovine serum (FBS), phosphate buffer 
saline (PBS), fungizone and penicillin were from GIBCO (Invitrogen, UK). Oil Red O, glutaraldehyde, 
p-formaldehyde, DNase-free RNase A, palmitic acid (≥99%), cis 11-eicosenoic acid (≥99%), cis 
11,14-eicosadienoic acid (≥98%), Triton X-100 and propidium iodide were from Sigma-Aldrich (St. 
Louis, MO, USA). Thymidine was from PerkinElmer (Massachusetts, USA). Ergosta-7,22-dien-3-ol 
(≥98%) was from BioBioPha Co., Ltd (China). L-cycloserine, fumonisin B1, CHOP and β-tubulin 
primary antibodies, as well as anti-rabbit secondary antibody, were from Santa Cruz (Heidelberg, 
Germany).  
 
3.2. Extract preparation 
 
 M. glacialis individuals were collected in Cabo Carvoeiro, Portugal, in September 2009. 
Samples were frozen, transported to the laboratory, lyophilized (Labconco 4.5 Freezone apparatus, 
Kansas City, MO) and powdered using an electric blender. 
 The lyophilized powder (15 g) was extracted with acetone:methanol (7:3) and the extract was 
added to a separating funnel with 20 mL of an ether:hexane mixture (1:1). An equivalent volume of 
5% NaCl was then added. The mixture was separated into two phases and the aqueous hypophase was 
collected and re-extracted with the ether:hexane mixture. The organic epiphases were then collected, 
washed with water in order to remove traces of acetone and evaporated until dryness in a rotary 
evaporator. All procedures were conducted at room temperature and the final residue was kept at -80 
ºC in an inert atmosphere (nitrogen). 
 
3.3. Cell Culture 
SH-SY5Y and MCF-7 cells were maintained in DMEM and MEM, respectively, with 10% FBS 
and 1% penicillin/streptomycin. In the case of SH-SY5Y cells media was also supplemented with 1% 
non-essential amino acids. All cells were grown in an incubator at 37 °C and 5% CO2. 
 
3.4. Morphological studies  
 
For Giemsa staining cells were seeded at a density of 2×10
4
/well /well in 24-well plates. After 
incubation with different concentrations of the extract, cells were washed twice with PBS and fixed 
with cold methanol, at 4°C, for 30 minutes. Diluted Giemsa dye (1:10) was then added and kept for 20 
minutes, after which cells were repeatedly washed and then mounted in DPX. 
Changes in nuclear morphology were studied by employing the Hoëchst 33342 staining. Cells 
were fixed as described for Giemsa staining, but 4% p-formaldehyde was used as fixing agent. Cells 
were exposed to 0.5 mg/mL Hoëchst 33342 for 20 minutes at room temperature and mounted in 
Vectashield mounting medium. Preparations were examined under a fluorescence microscope (Eclipse 
E400, Nikon, Japan), equipped with an excitation filter with maximum transmission at 360/400 nm, 
and processed by Nikon ACT-2U image software. 
In order to study lipid bodies, methanol-fixed cells were rinsed with propylene glycol and 
exposed to Oil Red O (0.7% in propylene glycol) for 7 minutes, with agitation. Oil red O solution was 
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removed and 85% propylene glycol was added and maintained for 3 minutes, after which cells were 
washed with distilled water and mounted with aqueous mounting media. 
For electron microscopy studies, cells were harvested by trypsinization after 24 and 48 hours 
incubation with the extract, washed with phosphate buffer fixed with 1.25% glutaraldehyde/4% p-
formaldehyde and preserved at 4°C for further processing. The cells were post-fixed in 1% osmium 
tetroxide in the same buffer, dehydrated in graded alcohols and embebed in Epon 812. Ultra-thin 
sections obtained with a Reichert Supra Nova ultra-microtome were collected on copper grids, stained 
with uranyl acetate/lead citrate and examined in a Zeiss 902A transmission electron microscope. 
 
3.5. 3H-Thymidine incorporation assay 
 
Cells were seeded in 96-well plates (2×10
4
/well) and incubated with different concentrations of 
extract. Incubations were maintained for 24–48 hours and, for each exposure time, 3H-thymidine (0.5 
μCi) was added to each well and incubated at 37 °C in 5% CO2 for the last 8 hours. After two cycles of 
freezing/thawing, cells were harvested using a cell harvester (Skatron Instruments, Norway) and 1 ml 
scintillation cocktail was added. Incorporated 
3
H-thymidine was determined in a scintillation counter 
(LS 6500, Beckman Instruments, CA, USA). Assays were carried out in triplicate and results are 
representative of three independent experiments. 
 
3.6.  Cell cycle analysis 
 
Cell cycle analysis was performed by flow cytometry. Cells were seeded in 6-well plates 
(7×10
5
/well) and cultured with or without extract at different concentrations or with the compounds. 
After 48 hours of treatment, cells were harvested using 0.25% trypsin in EDTA, washed twice with 
PBS and fixed in 70% cold ethanol.Fixed cells were finally re-suspended in 0.5 ml DNA staining 
solution (5 μg/ml PI, 0.1% Triton X-100 and 200 μg/ml DNase-free RNase A in PBS) and kept 30 min 
at room temperature, in the dark. 
Flow cytometric analysis of DNA content was based on the acquisition of 20.000 events in a 
Becton Dickinson FACSCalibur (San Jose, CA, U.S.A) equipped with CELLQuest Pro software. 
Debris, cell doublets and aggregates were gated out using a two parameter plot of FL-2-Area to FL-2-
Width of PI fluorescence. Detectors for forward (FSC) and side (SSC) light scatter and the three 
fluorescence channels (FL-1, FL-2 and FL-3) were set on a linear scale. Cell cycle histograms were 
analyzed using FlowJo Software (Tree Star, Inc). Assays were carried out in triplicate and results are 
representative of three independent experiments. 
 
3.7. Cell viability 
  
 Cells were cultured in 96-well plates (2x10
4
 cells/well) and allowed to attach for 24 hours. 
Cells were pre-incubated with the extract/compounds for 2 hours, after which LPS was added and 
further incubated for 24 hours. After incubation, MTT (0.5 mg/mL, final concentration) was added to 
each well and incubated for 2 hours at 37 °C. The formazan was dissolved by addition of a 
DMSO:isopropanol mixture (3:1) and quantified spectrophotometrically at 560 nm. The results of cell 
viability correspond to the mean of three independent experiments performed in triplicate and are 
expressed as percentage of the untreated control cells. 
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3.8.  Caspase-3/7 and -9 activity assay 
 
For the evaluation of caspase-3/7 and -9 activity the luminescent assay kits Caspase-GloH 9, 
and Caspase-GloH 3/7 (Promega Corporation) were used.  Cells were seeded in white 96-well plates in 
the conditions reported above for MTT. As positive control, cells were incubated with STS (1 µM) for 
12 hours. Luminescence was measured in a 96-well Microplate Luminometer (BioTek Instruments) 
and presented as relative light units (RLU). Assays were carried out in triplicate and results are 
representative of three independent experiments. 
 
 
3.9. Western blot 
 
 Cells were seeded in 6-well plates with a density of 3.5x10
5
 cells/well. Cells were treated for 24 
hours with the extract or palmitic acid. After this period, cells were washed with PBS, scraped and 
incubated with a lysis solution with protease inhibitors for 20 minutes on ice. The solution was then 
centrifuged at 14,000 g for 15 minutes, the supernatant was collected and protein content was 
determined by the Bradford method. Samples (40 µg) were subjected to 10% SDS-PAGE and proteins 
were transferred onto nitrocellulose membranes and blocked for one hour at room temperature with a 
solution of 5% non-fat milk in 0.1% Triton X-100. Overnight incubation at 4°C was performed with 
anti-CHOP (1:100) and anti-tubulin (1:1000) and then with peroxidase-conjugated secondary antibody 
(1:3000) at room temperature for 1 hour. β-Tubulin was used as a loading control. Finally blots were 
subjected to a chemiluminescence detection kit (Super Signal West Pico; Pierce, Rockford, USA).  
4. Conclusions  
In this work we described the effect of a lipophilic extract obtained from M. glacialis against 
the human cancer cell lines MCF-7 and SH-SY5Y. Evaluation of DNA synthesis revealed that both 
cell lines were markedly affected in a concentration-dependent way, the latter being more susceptible. 
We showed that the extract was responsible for two distinct effects: cell cycle arrest and caspase-
dependent apoptosis. We evaluated the contribution of the main compounds and demonstrated that 
while ergosta-7-dien-3-ol was responsible for the cell cycle arrest, palmitic acid was responsible for 
the apoptotic effect via CHOP-mediated pathway of ER-stress. A proposed mechanism for the activity 
displayed by the extract can be found in Figure 9.  
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Discussion and Conclusion 
4.1. Chemical composition of M. glacialis 
The chemical composition of M. glacialis had been addressed for the first time in 
1977, in a work by Czeczuga et al (164). At the time, the only class of metabolites 
investigated was carotenoids, which were studied by TLC. In that work, astaxanthin, lutein 
and zeaxanthin were major compounds. 
In the work presented herein, the chemical composition of this organism was 
revisited and studied using HPLC-DAD and APCI/LC-MS. Identification and confirmation 
of the presence of several compounds was achieved, astaxanthin, zeaxanthin and lutein 
being the major carotenoids identified. However, many of the compounds previously 
described (β-carotene, cryptoxanthin, echinenone, lutein 5,6-epoxide, among others) 
could not be found (Paper 1). At this point, it is important to consider the geographical 
origin of the sample. While the original 1977 report used organisms collected in the Baltic 
sea, in the present work samples were collected along the coast of Portugal. Given the fact 
that animals are, in a general way, unable to synthesize carotenoids, their presence is a 
consequence of predation upon lower trophic levels. Thus, it is highly probable that 
organisms collected in distinct sites present different chemical compositions. As several 
carotenoid peaks could not be identified at the time, a different method, in which HPLC-
DAD-APCI-MS/MS was equipped with a C30 column instead of a C18, was used. This 
approach rendered the identification of twenty compounds, eight of them reported for the 
first time in this marine organism. Differentiation of carotenoid isomers was also achieved 
(Paper 2). 
After carotenoids, the chemical characterization of other classes of metabolites, 
namely FA, was pursued. In this regard, the need and opportunity to develop a GC-MS 
technique for a fast and cost-effective analysis of these compounds in marine organisms 
was identified. During the development of the method, not only saturated and unsaturated 
FA but also amino acids, sterols and triterpenes were included in the list of metabolites 
covered by the method. The main factors influencing the extraction of target compounds 
were evaluated by using different extraction procedures, solvent systems and temperature 
conditions and a comparison with a reference technique was performed. The most suitable 
procedure, capable of successfully extract the three classes of target compounds, was 
ethanol as solvent, at 40 °C under magnetic stirring. Good analytical parameters were 
obtained for the 40 compounds under analysis (15 amino acids, 16 FA, 6 sterols and 3 
lupanes) (Paper 3). 
Overall, the method proved to be fast (25 minutes run), reproducible and 
employing cheap and non-hazard solvents (ethanol), contrarily to the classic technique for 
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the analysis of FA, which requires several organic solvents, high temperatures and longer 
chromatographic runs. Crude ethanolic extracts of several individuals of M. glacialis, 
collected in different temporal and geographical points, were used for validating this 
technique and allowed a deeper knowledge of the chemical composition of M. glacialis 
(Paper 3). 
This method was later used in other marine organisms from Portuguese waters, the 
echinoderms Paracentrotus lividus (sea urchin) and Holothuria forskali (sea cucumber), 
the gastropod molluscs Aplysia fasciata and Aplysia punctata (sea hares). In general, all 
species presented all the ten amino acids identified, with the exceptions of H. forskali, in 
which no glycine, proline, trans 4-hydroxy-proline or phenylalanine were found, and of A. 
fasciata which did not contain proline. Unsaturated FA were predominant compounds, 
being those from the ω-6 series in higher amounts than their ω -3 homologues, with the 
exception of A. fasciata, in which saturated FA were predominant. 
In what regards sterols, cholesterol, β-sitosterol and one unidentified cholesterol 
derivative were the only compounds found. Several other compounds, including 
ergosterol, stigmasterol and campesterol were searched using their molecular weight and 
fragmentation spectra, however none were found. The species with the highest sterol 
content was P. lividus, with cholesterol being the sterol in higher amounts in all species 
studied. (Paper 4).  
 
  
4.2. Anti-inflammatory activity 
Several marine organisms have been the source of anti-inflammatory molecules 
(9). In light of the recognized capacity of some FA and molecules with a steroid backbone 
to act as anti-inflammatory compounds, the purified extract from M. glacialis was 
evaluated for its potential anti-inflammatory effect (Paper 6). 
In order to assess the potential anti-inflammatory effect of an extract M. glacialis 
and of its components, the murine macrophage cell line RAW 264.7 was used as a model 
of inflammation. This Mus musculus derived cell line was established from cells of a 
BAB/14 mouse tumor induced by Abelson murine leukemia virus (MuLV) in 1978 (248). 
In the particular case of this cell line, following LPS binding to TLR4 receptor and to its 
co-receptors, CD14 and MD-2, the adaptor protein myeloid  differentiation factor 88 
(MyD88) is recruited to the Toll/IL-1 receptor (TIR) domain (249, 250). The interaction of 
TIR and MyD88 leads to the activation of NF-κB. In fact, activation of TLR4/CD14/MD2 
receptor complex (251), is sufficient to induce NF-κB activation in several cell types, 
notably  macrophages and microglia (252, 253). 
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In the structure of LPS, it is important to highlight the lipid A moiety, which has 
been demonstrated to be the most relevant chemical trait to its pro-inflammatory effect 
(254). Taking into account the structure of the LPS molecule, it has been hypothesized 
that saturated FA can, per si, induce some pro-inflammatory factors. 
Upon LPS treatment, RAW 264.7 respond by activating the NF-κB pathway and 
rising the levels of some inflammatory markers, like COX-2, iNOS, IL-6, TNF-α, IL-1 and 
ROS (53, 249, 250, 252, 255). 
For the evaluation of the anti-inflammatory activity of the purified lipophilic 
extract from M. glacialis, studies were conducted with a concentration of 156 µg/mL, 
which was determined by screening studies and presented palmitic, cis 11-eicosenoic and 
cis 11,14-eicosadienoic acids and ergosta-7,22-dien-3-ol as main compounds. Incubation 
with the extract for 24 hours was able to prevent the characteristic morphology of 
activated macrophages and the LPS-induced autophagosomes. Initial screening assays 
also showed a reduction of about 30% in the IL-6 levels elicited by LPS. 
 In this model of inflammation, incubation with the pro-inflammatory stimuli LPS 
resulted in a reduction in cell viability of 30%. This effect was completely prevented by the 
extract and, from this point, the role of the individual compounds to the activity displayed 
by the lipophilic extract was studied. Among the compounds tested, none displayed any 
impact on the viability of unchallenged cells. After this point, the impact of M. glacialis 
extract and isolated compounds in several classical markers of the inflammatory process, 
like NO and ROS production as well as COX-2 and iNOS expression, was investigated. 
 The inflammatory mediator NO, synthesized from the conversion of arginine to 
citrulline by nitric oxide synthases, was quantified in culture media after challenge with 
LPS for 24 hours with or without pre-incubation with the extract for 2 hours. The extract 
reduced NO levels produced by LPS-challenged cells by around 50%. cis 11-Eicosenoic 
acid caused a 10% reduction of NO levels, while cis 11,14-eicosadienoic acid and ergosta-
7,22,dien-3-ol decreased NO levels by 20%. When all compounds were incubated together, 
a 30% decrease in LPS-induced NO levels were found. This impact on NO levels was 
shown to be a result of the down-regulation of iNOS, the major enzyme responsible for the 
production of NO. The extract was able to lower LPS-induced iNOS by about 50%, an 
effect to which cis-11-eicosenoic, cis-11,14-eicosadienoic and ergosta-7,22-dien-3-ol 
contributed, being the latter the most relevant compound for this effect. 
 In the case of COX-2 the extract was found to lower LPS-induced expression levels 
of this enzyme by about 50%.  However, differently to what was found for iNOS, in which 
ergosta-7,22-dien-3-ol was responsible for most of the activity, in COX-2 only the 
combination of all compounds tested was able to achieve maximum inhibition. This result 
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demonstrates the importance of using a mixture comprising several compounds that act in 
an additive or synergic way. 
ROS are known to play a pivotal role in several physiological and pathological 
processes, being increased in early stages of inflammation and apoptosis. The purified 
extract from M. glacialis also prevented LPS-induced increase in ROS levels by about 
50%. Differently from what had been found for the other inflammatory markers, ergosta-
7,22-dien-3-ol had no effect in ROS levels. However, when all compounds were tested 
together, the activity was comparable to that found for the extract. Several cellular 
organelles can be the source of these ROS, in particular the ER and mitochondria when 
undergoing stress (227, 231). 
 ER stress has been increasingly pointed out as a potential source and aggravation of 
inflammatory processes, being CHOP one of the most commonly used endpoint markers 
of ER stress. In accordance to previous studies (237), an increase in CHOP expression 
levels following incubation with LPS was observed, an effect significantly prevented by the 
extract. The unsaturated FA cis 11-eicosenoic and cis 11,14-eicosadienoic acids were unable 
to reduce CHOP expression levels in LPS-challenged cells. However, when cells were pre-
incubated with ergosta-7,22-dien-3-ol CHOP expression was similar to untreated cells, 
suggesting that this compound was the main responsible for the effect induced by the 
extract. 
On the other hand, it is known that the NF-κB pathway is a key orchestrator that can 
trigger and modulated the inflammatory response. Thus, by evaluating the levels of the 
main NF-κB protein inhibitor, IκB-α, the capacity of the extract and some of its 
constituents in preventing the activation of the NF-κB pathway was demonstrated. Several 
cellular events, some of them caused by LPS challenge, may trigger the activation of this 
pathway and among these, ROS and ER stress are particularly relevant. As referred above, 
prevention of ROS generation and down regulation of CHOP expression by the extract and 
its components can contribute, at least in part, to the anti-inflammatory activity found. As 
so, the attenuation of ER stress that we describe herein for several compounds can 
contribute to the inhibition of the NF-κB pathway. In addition, due to the established 
contribution of ROS to further propagate the inflammatory response, namely NF-κB 
activation and subsequent expression of some inflammatory markers, the above-
mentioned capacity of the extract and of some of its compounds to attenuate oxidative 
stress may contribute to the anti-inflammatory activity observed. 
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4.3. Pro-apoptotic activity 
In a preliminary study using a crude extract it was demonstrated that there was 
selectivity towards cancer cells when compared to non-cancer ones. The IC25 obtained for 
a lipophilic fraction rich in carotenoids was 268 µg/mL in the RBL-2H3 cancer cell line 
against 411 µg/mL in the non-cancer cell line V79 (Paper 1).  
In a subsequent study, using the purified and fully characterized lipophilic extract, 
the effect in cell viability, as well as membrane integrity, was evaluated against a panel of 5 
cell lines: 3 cancer cell lines (SH-Sy5Y, human neuroblastoma; MCF-7, human estrogen 
receptor positive breast cancer and Caco-2, human colon cancer) and 2 non-cancer cell 
lines (HDF, human dermal fibroblasts and HFF, human foreskin fibroblasts) (Paper 5). 
The effect of the extract in all cell lines was studied at different times (24, 48 and 72 
hours) and concentrations ranging from 76 to 1250 µg/mL. Among all cell lines tested, 
Caco-2 cell line was the most resistant as only the highest concentration, 1250 µg/mL, 
displayed a reduction of cell viability after 72 hours with no LDH release detected.  
 In the case of the breast cancer cell line, MCF-7, a time- and dose-dependent 
reduction of cell viability was found. The  concentration of 625 µg/mL caused a decrease 
in 50% in cell viability after 72 hours. However, regarding membrane integrity, LDH 
release was already observed after 48 hours of incubation for the highest concentration. 
 When SH-SY5Y cells were used, only a concentration-dependent effect was found. 
The reduction of cell viability was more pronounced than that detected for MCF-7 cells. 
After 24 hours of incubation the concentration of 156 µg/mL caused a decrease of 30% in 
cell viability. The extract was also tested against the non-cancer cell lines, HDF and HFF, 
and up to the concentration of 312 µg/mL, which elicited about 80% of cell viability loss in 
the neuroblastoma cell line, no effect could be noticed. 
FA are possible candidates for some of the effects reported herein due to their 
established role in several physiological and pathological processes. In particular, palmitic 
acid, the major FA present in the extract, has been reported as a potent inducer of 
apoptosis in several cell lines. In that way, the effect of palmitic acid in the viability of SH-
SY5Y cells, at the concentrations present in the extract, was evaluated. At the extract 
concentrations of 156 and 312 µg/mL, the concentration of palmitic acid was 15 and 30 
µM, respectively. Palmitic acid at 15 µM caused about 20% of cell viability loss in the 
neuroblastoma cell line, while the extract at 156 µg/mL induced a decrease of 
approximately 30% of. At higher concentrations, the behaviour was markedly different. 
While 312 µg/mL caused around 80% of viability loss, the concentration of palmitic acid 
present in this extract (30 µM), induced only a decrease of 40%. These results suggest 
that, although palmitic acid has a relevant contribution to the activity displayed by the 
extract, at higher concentrations the effect of other compounds must be considered. 
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After this preliminary screening had shown the ability of the extract to lower 
cancer cells’ viability (Paper 5), the underlying mechanisms were further explored 
(Paper 7). 
 Initial  studies addressed the effect of the extract on cell morphology. Incubation 
with the extract caused chromatin condensation and the advent of cytoplasmic structures 
that were shown, by Oil Red O staining and TEM, to be lipid droplets. These results 
indicate that the lipophilic compounds identified and quantified in the extract were able to 
enter the cells and to accumulate in the cytosol.  
 In light of the biochemical basis of the (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) assay, lower levels of reduced MTT in treated cells 
can have two possible explanations: decreased cell proliferation or occurrence of cell 
death. In order to elucidate the underlying mechanism, the effect of the extract in DNA 
synthesis in MCF-7 and SH-SY5Y cells was evaluated by taking into consideration the 
extract concentrations previously established. In both cell lines, the extract caused a 
concentration-dependent reduction in DNA synthesis, although different responses were 
registered. In the SH-SY5Y cells this effect was more potent and time-independent, while 
in the MCF-7 cell this effect was time-dependent. The reduction on DNA synthesis was 
further investigated only in the SH-SY5Y cells, as they showed higher susceptibility. The 
purified extract, at a concentration of 156 µg/mL, elicited a G0/G1 cell cycle arrest which 
resulted in an increase of about 10% in the number of cells in this phase. The FA tested 
showed no effect in cell cycle, while the sterol ergosta-7,22-dien-3-ol was able to cause an 
effect similar to that of the extract. When all compounds were tested in combination, the 
same values were found. For this reason, it is concluded that the cell cycle arrest caused by 
the extract can be attributed solely to the sterol ergosta-7,22-dien-3-ol. Several targets can 
be responsible for this cell cycle arrest, such as p53, CDK2 and CDK4 (163). 
Although it was demonstrated that the extract was causing a decrease in 
proliferation via G0/G1 cell cycle arrest, its ability to trigger cell death was also 
investigated. Morphological data had already showed that one of the traits of apoptosis, 
chromatin condensation, was present and, for this reason, caspase 3/7 and -9 activities 
were evaluated. Incubation with the extract induced an increase in caspase-9 and 3/7 
activities of 25% and 30%, respectively, thus showing the intervention of the 
mitochondrial pathway, an effect for which palmitic acid was responsible. As palmitic acid 
can be a ceramide precursor, a potent pro-apoptotic molecule, the relevance of this 
pathway to the effect displayed by the extract was evaluated. In that way, the ability of 
inhibitors of the key enzymes of ceramide biosynthesis to prevent palmitic acid-induced 
loss of cell viability was assessed. Experiments conducted with L-cycloserine (inhibitor of 
serine palmitoyltransferase) and fumonisin B1 (inhibitor of ceramide synthase) showed 
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that this effect was ceramide-independent. In this research area, there are contradicting 
reports regarding the role of ceramide in palmitate-induced apoptosis. Recently, a study 
addressing this topic in Schwann cells showed that, although inhibition of de novo 
ceramide biosynthesis could ameliorate palmitate-induced apoptosis, the effect was only 
partial. For this reason, the authors suggested that palmitate may induce apoptosis in a 
ceramide-dependent and –independent way (256). 
Due to the fact that palmitic acid has been implicated in ER stress (257, 258), and 
that there is a crosstalk between ER-stress and apoptosis, CHOP expression was analyzed. 
CHOP is an endpoint product in most of the mechanisms that are associated to ER stress, 
thus being generally used as a marker for ER stress. Results showed that both the extract 
and palmitic acid elicited an increase in CHOP expression levels, which were absent in 
control cells.  
Taken together, these results suggest that the effect exhibited by the extract involves 
ergosta-7,22-dien-3-ol-mediated cell cycle arrest and palmitic acid-caused activation  of 
the intrinsic pathway of apoptosis by a ceramide-independent way. In addition, this effect 
is associated to ER stress. Although not addressed in the work herein, the investigation of 
the contribution of caspase-4/12 to ER stress-derived apoptosis could also be a valuable 
tool. In these regards, it is important to highlight that the role of caspase-12 in ER stress-
mediated apoptosis is not unanimous. Some authors report that this caspase can, per si, 
trigger the apoptotic process, while others refer its importance in propagating and 
increasing the response of caspases-3 and -9 (239, 240). In addition, if we consider that 
most humans do express caspase-12, all together these information clearly highlight the 
importance of continuing to study the pathways involved in ER-mediated apoptosis (241, 
242). 
Several concluding remarks can be drawn from all the data obtained in this research 
project. 
Instrumental techniques for a fast and multi-target analysis of marine organisms 
were developed and their application across several taxonomic groups was demonstrated. 
In addition, the potential application of marine-derived molecules in several pathological 
conditions was confirmed. By conjugating metabolomic analysis with biological 
evaluation, several bioactive molecules were described and their effects in cancer and 
inflammation were demonstrated and, additionally, the mechanisms of action involved 
were elucidated. In both model systems, ER stress was shown to play an important role, 
although the effect of the extract and its components was distinct. Thus, while in cancer 
cells ER-stress was induced, hence triggering apoptosis, in the case of macrophages the 
anti-inflammatory effect was associated with ER protection. 
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